PREPAREDNESS FOR FUTURE HEALTH CRISES

The pivotal role of health in shaping a sustainable and inclusive recovery

The Covid-19 pandemic highlighted the pivotal role universal access to health plays in shaping a sustainable and inclusive recovery. It also underlined the importance of ensuring health for all in the struggle to achieve the 2030 Agenda. Yet, the world is struggling to cope with the pandemic’s aftermath. Not only has it delayed the achievement of the SDGs by years, it has also exacerbated the very inequalities that fueled the pandemic in the first place.

Almost half the world’s population lacks access to primary healthcare, the first line of defense against disease outbreaks. Training to manage emergency healthcare programs is also insufficient. These gaps are partly why Covid-19 has caused so much suffering. Public healthcare programs need to be inclusive and equitable.

The pandemic created a timely opportunity to reassess and strengthen surveillance systems, integrate emerging technologies, take better actions to recover, build preparedness for future epidemics, and control endemic diseases. It is time to pivot toward a “health for all” approach, starting with an inclusive preparedness plan that enables low- and middle-income countries to invest in the resilience of their health systems.

Conference programme

Health

Sessions labeled will take place in EXPO MAG, the Convention Center in Rio de Janeiro. Sessions labeled will be live-streamed from Rio de Janeiro and can be followed online.

Show session times in local time zone

13 February 2023

13:30
17:30
17:30
18:30
11:30
01:30
00:30
22:00
20:30
Plenary session: Strategies for a better Covid-19 recovery and preparedness for future healthcare crises

Health

×

Health

Plenary session: Strategies for a better Covid-19 recovery and preparedness for future healthcare crises

Share this session

13 February 2023, 13:30 - 14:45 BRT (Rio de Janeiro)

13 February 2023, 17:30 - 18:45 CET (Brussels)

13 February 2023, 17:30 - 18:45 WAT (Nigeria)

13 February 2023, 18:30 - 19:45 SAST (Cape Town)

13 February 2023, 11:30 - 12:45 EST (New York)

13 February 2023, 01:30 - 02:45 KST (Seoul)

13 February 2023, 00:30 - 01:45 CST (Beijing)

13 February 2023, 22:00 - 23:15 IST (New Delhi)

13 February 2023, 20:30 - 21:45 GST (Dubai)

Room Manguinhos & online

International leaders, scientists, and policymakers will present the lessons they learned about recovering from the pandemic and how to prepare for future outbreaks. They will debate the fundamental steps that must be taken to build preparedness and resilience and ensure equity and inclusiveness in the face of future healthcare crises. This includes financial planning, international cooperation, decision-making, and investments in research and development. They will discuss the following questions:

  • What are the key lessons from these three years of Covid-19?
  • What issues must be prioritized and addressed in pandemic recovery plans?
  • How to establish a pandemic recovery plan in a world fraught with inequality?
  • How to establish an inclusive global preparedness plan that enables low- and middle-income countries to provide the necessary investments in their health systems and production?
  • Which national policies should be implemented to build resilience for future health emergencies?
  • In face of a failed multilateralism system, how to rebuild trust and incentives between countries for more effective international cooperation and a coordinated preparedness plan?
  • What role can disinformation play in global health crises and how to fight disinformation?

Marco Krieger

Marco Krieger

Oswaldo Cruz Foundation (Fiocruz)

Vice-president of Health Production and Innovation in Health

Sylvain  Aldighieri

Sylvain Aldighieri

Pan American Health Organization (PAHO)

Incident manager for COVID-19

Frank Vandenbroucke

Frank Vandenbroucke

Belgium

Deputy Prime Minister and Minister of Social Affairs and Public Health

Jeremy Farrar

Jeremy Farrar

Wellcome Trust

Director

Naveen  Rao

Naveen Rao

Global Health Rockefeller Foundation

Senior Executive Vice President

Lieve Fransen

Lieve Fransen

European Policy Centre

Senior Adviser on Health, Social, and Migration Policies

Antoni Plasència

Antoni Plasència

Barcelona Institute of Global Health (ISGlobal)

Director-General

Chaired by

Paulo Gadelha

Paulo Gadelha

Fiocruz Strategy for 2030 Agenda

Coordinator

As coordinator of the Fiocruz Strategy for the 2030 Agenda, Gadelha is in charge of promoting strategic engagement between Fiocruz and the UN Sustainable Development Goals (SDGs). His background includes studies of the application of technology in public health, healthcare models, and enhancing Science, Technology, and Innovation (STI) for the SDGs.

Gadelha served as president of Fiocruz from 2009 to 2016, leading scientific achievements in biomedical sciences, generation of scientific and technological knowledge, and health and social development promotion. Between 2016 and 2021, Dr. Gadelha was appointed by the UN Secretary-General as a member of the Technology Facilitation Mechanism (UN-TFM) ‘10-Member Group’ to provide expertise and support to the UN Inter-agency Task Team (IATT) on STI for the SDGs.

Previously, he founded and directed the “Casa de Oswaldo Cruz,” a Fiocruz institute dedicated to the sociology and history of science and health. Dr. Gadelha also served as a member of the National Health Council’s Science and Technology Intersectoral Commission. As President of the Brazilian Association of Collective Health, he chaired the 11th World Congress on Public Health. In 2017, with UN/DESA, he chaired the efforts of Fiocruz in organizing the 1st Consultation on Health and STI in the 2030 Agenda’s implementation.

Health

Plenary session: Strategies for a better Covid-19 recovery and preparedness for future healthcare crises

Share this session

13 February 2023, 13:30 - 14:45 BRT (Rio de Janeiro)

13 February 2023, 17:30 - 18:45 CET (Brussels)

13 February 2023, 17:30 - 18:45 WAT (Nigeria)

13 February 2023, 18:30 - 19:45 SAST (Cape Town)

13 February 2023, 11:30 - 12:45 EST (New York)

13 February 2023, 01:30 - 02:45 KST (Seoul)

13 February 2023, 00:30 - 01:45 CST (Beijing)

13 February 2023, 22:00 - 23:15 IST (New Delhi)

13 February 2023, 20:30 - 21:45 GST (Dubai)

Room Manguinhos & online

International leaders, scientists, and policymakers will present the lessons they learned about recovering from the pandemic and how to prepare for future outbreaks. They will debate the fundamental steps that must be taken to build preparedness and resilience and ensure equity and inclusiveness in the face of future healthcare crises. This includes financial planning, international cooperation, decision-making, and investments in research and development. They will discuss the following questions:

  • What are the key lessons from these three years of Covid-19?
  • What issues must be prioritized and addressed in pandemic recovery plans?
  • How to establish a pandemic recovery plan in a world fraught with inequality?
  • How to establish an inclusive global preparedness plan that enables low- and middle-income countries to provide the necessary investments in their health systems and production?
  • Which national policies should be implemented to build resilience for future health emergencies?
  • In face of a failed multilateralism system, how to rebuild trust and incentives between countries for more effective international cooperation and a coordinated preparedness plan?
  • What role can disinformation play in global health crises and how to fight disinformation?

Marco Krieger

Marco Krieger

Oswaldo Cruz Foundation (Fiocruz)

Vice-president of Health Production and Innovation in Health

Sylvain  Aldighieri

Sylvain Aldighieri

Pan American Health Organization (PAHO)

Incident manager for COVID-19

Frank Vandenbroucke

Frank Vandenbroucke

Belgium

Deputy Prime Minister and Minister of Social Affairs and Public Health

Jeremy Farrar

Jeremy Farrar

Wellcome Trust

Director

Naveen  Rao

Naveen Rao

Global Health Rockefeller Foundation

Senior Executive Vice President

Lieve Fransen

Lieve Fransen

European Policy Centre

Senior Adviser on Health, Social, and Migration Policies

Antoni Plasència

Antoni Plasència

Barcelona Institute of Global Health (ISGlobal)

Director-General

Chaired by

Paulo Gadelha

Paulo Gadelha

Fiocruz Strategy for 2030 Agenda

Coordinator

As coordinator of the Fiocruz Strategy for the 2030 Agenda, Gadelha is in charge of promoting strategic engagement between Fiocruz and the UN Sustainable Development Goals (SDGs). His background includes studies of the application of technology in public health, healthcare models, and enhancing Science, Technology, and Innovation (STI) for the SDGs.

Gadelha served as president of Fiocruz from 2009 to 2016, leading scientific achievements in biomedical sciences, generation of scientific and technological knowledge, and health and social development promotion. Between 2016 and 2021, Dr. Gadelha was appointed by the UN Secretary-General as a member of the Technology Facilitation Mechanism (UN-TFM) ‘10-Member Group’ to provide expertise and support to the UN Inter-agency Task Team (IATT) on STI for the SDGs.

Previously, he founded and directed the “Casa de Oswaldo Cruz,” a Fiocruz institute dedicated to the sociology and history of science and health. Dr. Gadelha also served as a member of the National Health Council’s Science and Technology Intersectoral Commission. As President of the Brazilian Association of Collective Health, he chaired the 11th World Congress on Public Health. In 2017, with UN/DESA, he chaired the efforts of Fiocruz in organizing the 1st Consultation on Health and STI in the 2030 Agenda’s implementation.

Health

Plenary session: Strategies for a better Covid-19 recovery and preparedness for future healthcare crises

Share this session

13 February 2023, 13:30 - 14:45 BRT (Rio de Janeiro)

13 February 2023, 17:30 - 18:45 CET (Brussels)

13 February 2023, 17:30 - 18:45 WAT (Nigeria)

13 February 2023, 18:30 - 19:45 SAST (Cape Town)

13 February 2023, 11:30 - 12:45 EST (New York)

13 February 2023, 01:30 - 02:45 KST (Seoul)

13 February 2023, 00:30 - 01:45 CST (Beijing)

13 February 2023, 22:00 - 23:15 IST (New Delhi)

13 February 2023, 20:30 - 21:45 GST (Dubai)

Room Manguinhos & online

International leaders, scientists, and policymakers will present the lessons they learned about recovering from the pandemic and how to prepare for future outbreaks. They will debate the fundamental steps that must be taken to build preparedness and resilience and ensure equity and inclusiveness in the face of future healthcare crises. This includes financial planning, international cooperation, decision-making, and investments in research and development. They will discuss the following questions:

  • What are the key lessons from these three years of Covid-19?
  • What issues must be prioritized and addressed in pandemic recovery plans?
  • How to establish a pandemic recovery plan in a world fraught with inequality?
  • How to establish an inclusive global preparedness plan that enables low- and middle-income countries to provide the necessary investments in their health systems and production?
  • Which national policies should be implemented to build resilience for future health emergencies?
  • In face of a failed multilateralism system, how to rebuild trust and incentives between countries for more effective international cooperation and a coordinated preparedness plan?
  • What role can disinformation play in global health crises and how to fight disinformation?

Marco Krieger

Marco Krieger

Oswaldo Cruz Foundation (Fiocruz)

Vice-president of Health Production and Innovation in Health

Sylvain  Aldighieri

Sylvain Aldighieri

Pan American Health Organization (PAHO)

Incident manager for COVID-19

Frank Vandenbroucke

Frank Vandenbroucke

Belgium

Deputy Prime Minister and Minister of Social Affairs and Public Health

Jeremy Farrar

Jeremy Farrar

Wellcome Trust

Director

Naveen  Rao

Naveen Rao

Global Health Rockefeller Foundation

Senior Executive Vice President

Lieve Fransen

Lieve Fransen

European Policy Centre

Senior Adviser on Health, Social, and Migration Policies

Antoni Plasència

Antoni Plasència

Barcelona Institute of Global Health (ISGlobal)

Director-General

Chaired by

Paulo Gadelha

Paulo Gadelha

Fiocruz Strategy for 2030 Agenda

Coordinator

As coordinator of the Fiocruz Strategy for the 2030 Agenda, Gadelha is in charge of promoting strategic engagement between Fiocruz and the UN Sustainable Development Goals (SDGs). His background includes studies of the application of technology in public health, healthcare models, and enhancing Science, Technology, and Innovation (STI) for the SDGs.

Gadelha served as president of Fiocruz from 2009 to 2016, leading scientific achievements in biomedical sciences, generation of scientific and technological knowledge, and health and social development promotion. Between 2016 and 2021, Dr. Gadelha was appointed by the UN Secretary-General as a member of the Technology Facilitation Mechanism (UN-TFM) ‘10-Member Group’ to provide expertise and support to the UN Inter-agency Task Team (IATT) on STI for the SDGs.

Previously, he founded and directed the “Casa de Oswaldo Cruz,” a Fiocruz institute dedicated to the sociology and history of science and health. Dr. Gadelha also served as a member of the National Health Council’s Science and Technology Intersectoral Commission. As President of the Brazilian Association of Collective Health, he chaired the 11th World Congress on Public Health. In 2017, with UN/DESA, he chaired the efforts of Fiocruz in organizing the 1st Consultation on Health and STI in the 2030 Agenda’s implementation.

Health

Plenary session: Strategies for a better Covid-19 recovery and preparedness for future healthcare crises

Share this session

13 February 2023, 13:30 - 14:45 BRT (Rio de Janeiro)

13 February 2023, 17:30 - 18:45 CET (Brussels)

13 February 2023, 17:30 - 18:45 WAT (Nigeria)

13 February 2023, 18:30 - 19:45 SAST (Cape Town)

13 February 2023, 11:30 - 12:45 EST (New York)

13 February 2023, 01:30 - 02:45 KST (Seoul)

13 February 2023, 00:30 - 01:45 CST (Beijing)

13 February 2023, 22:00 - 23:15 IST (New Delhi)

13 February 2023, 20:30 - 21:45 GST (Dubai)

Room Manguinhos & online

International leaders, scientists, and policymakers will present the lessons they learned about recovering from the pandemic and how to prepare for future outbreaks. They will debate the fundamental steps that must be taken to build preparedness and resilience and ensure equity and inclusiveness in the face of future healthcare crises. This includes financial planning, international cooperation, decision-making, and investments in research and development. They will discuss the following questions:

  • What are the key lessons from these three years of Covid-19?
  • What issues must be prioritized and addressed in pandemic recovery plans?
  • How to establish a pandemic recovery plan in a world fraught with inequality?
  • How to establish an inclusive global preparedness plan that enables low- and middle-income countries to provide the necessary investments in their health systems and production?
  • Which national policies should be implemented to build resilience for future health emergencies?
  • In face of a failed multilateralism system, how to rebuild trust and incentives between countries for more effective international cooperation and a coordinated preparedness plan?
  • What role can disinformation play in global health crises and how to fight disinformation?

Marco Krieger

Marco Krieger

Oswaldo Cruz Foundation (Fiocruz)

Vice-president of Health Production and Innovation in Health

Sylvain  Aldighieri

Sylvain Aldighieri

Pan American Health Organization (PAHO)

Incident manager for COVID-19

Frank Vandenbroucke

Frank Vandenbroucke

Belgium

Deputy Prime Minister and Minister of Social Affairs and Public Health

Jeremy Farrar

Jeremy Farrar

Wellcome Trust

Director

Naveen  Rao

Naveen Rao

Global Health Rockefeller Foundation

Senior Executive Vice President

Lieve Fransen

Lieve Fransen

European Policy Centre

Senior Adviser on Health, Social, and Migration Policies

Antoni Plasència

Antoni Plasència

Barcelona Institute of Global Health (ISGlobal)

Director-General

Chaired by

Paulo Gadelha

Paulo Gadelha

Fiocruz Strategy for 2030 Agenda

Coordinator

As coordinator of the Fiocruz Strategy for the 2030 Agenda, Gadelha is in charge of promoting strategic engagement between Fiocruz and the UN Sustainable Development Goals (SDGs). His background includes studies of the application of technology in public health, healthcare models, and enhancing Science, Technology, and Innovation (STI) for the SDGs.

Gadelha served as president of Fiocruz from 2009 to 2016, leading scientific achievements in biomedical sciences, generation of scientific and technological knowledge, and health and social development promotion. Between 2016 and 2021, Dr. Gadelha was appointed by the UN Secretary-General as a member of the Technology Facilitation Mechanism (UN-TFM) ‘10-Member Group’ to provide expertise and support to the UN Inter-agency Task Team (IATT) on STI for the SDGs.

Previously, he founded and directed the “Casa de Oswaldo Cruz,” a Fiocruz institute dedicated to the sociology and history of science and health. Dr. Gadelha also served as a member of the National Health Council’s Science and Technology Intersectoral Commission. As President of the Brazilian Association of Collective Health, he chaired the 11th World Congress on Public Health. In 2017, with UN/DESA, he chaired the efforts of Fiocruz in organizing the 1st Consultation on Health and STI in the 2030 Agenda’s implementation.

Health

Plenary session: Strategies for a better Covid-19 recovery and preparedness for future healthcare crises

Share this session

13 February 2023, 13:30 - 14:45 BRT (Rio de Janeiro)

13 February 2023, 17:30 - 18:45 CET (Brussels)

13 February 2023, 17:30 - 18:45 WAT (Nigeria)

13 February 2023, 18:30 - 19:45 SAST (Cape Town)

13 February 2023, 11:30 - 12:45 EST (New York)

13 February 2023, 01:30 - 02:45 KST (Seoul)

13 February 2023, 00:30 - 01:45 CST (Beijing)

13 February 2023, 22:00 - 23:15 IST (New Delhi)

13 February 2023, 20:30 - 21:45 GST (Dubai)

Room Manguinhos & online

International leaders, scientists, and policymakers will present the lessons they learned about recovering from the pandemic and how to prepare for future outbreaks. They will debate the fundamental steps that must be taken to build preparedness and resilience and ensure equity and inclusiveness in the face of future healthcare crises. This includes financial planning, international cooperation, decision-making, and investments in research and development. They will discuss the following questions:

  • What are the key lessons from these three years of Covid-19?
  • What issues must be prioritized and addressed in pandemic recovery plans?
  • How to establish a pandemic recovery plan in a world fraught with inequality?
  • How to establish an inclusive global preparedness plan that enables low- and middle-income countries to provide the necessary investments in their health systems and production?
  • Which national policies should be implemented to build resilience for future health emergencies?
  • In face of a failed multilateralism system, how to rebuild trust and incentives between countries for more effective international cooperation and a coordinated preparedness plan?
  • What role can disinformation play in global health crises and how to fight disinformation?

Marco Krieger

Marco Krieger

Oswaldo Cruz Foundation (Fiocruz)

Vice-president of Health Production and Innovation in Health

Sylvain  Aldighieri

Sylvain Aldighieri

Pan American Health Organization (PAHO)

Incident manager for COVID-19

Frank Vandenbroucke

Frank Vandenbroucke

Belgium

Deputy Prime Minister and Minister of Social Affairs and Public Health

Jeremy Farrar

Jeremy Farrar

Wellcome Trust

Director

Naveen  Rao

Naveen Rao

Global Health Rockefeller Foundation

Senior Executive Vice President

Lieve Fransen

Lieve Fransen

European Policy Centre

Senior Adviser on Health, Social, and Migration Policies

Antoni Plasència

Antoni Plasència

Barcelona Institute of Global Health (ISGlobal)

Director-General

Chaired by

Paulo Gadelha

Paulo Gadelha

Fiocruz Strategy for 2030 Agenda

Coordinator

As coordinator of the Fiocruz Strategy for the 2030 Agenda, Gadelha is in charge of promoting strategic engagement between Fiocruz and the UN Sustainable Development Goals (SDGs). His background includes studies of the application of technology in public health, healthcare models, and enhancing Science, Technology, and Innovation (STI) for the SDGs.

Gadelha served as president of Fiocruz from 2009 to 2016, leading scientific achievements in biomedical sciences, generation of scientific and technological knowledge, and health and social development promotion. Between 2016 and 2021, Dr. Gadelha was appointed by the UN Secretary-General as a member of the Technology Facilitation Mechanism (UN-TFM) ‘10-Member Group’ to provide expertise and support to the UN Inter-agency Task Team (IATT) on STI for the SDGs.

Previously, he founded and directed the “Casa de Oswaldo Cruz,” a Fiocruz institute dedicated to the sociology and history of science and health. Dr. Gadelha also served as a member of the National Health Council’s Science and Technology Intersectoral Commission. As President of the Brazilian Association of Collective Health, he chaired the 11th World Congress on Public Health. In 2017, with UN/DESA, he chaired the efforts of Fiocruz in organizing the 1st Consultation on Health and STI in the 2030 Agenda’s implementation.

Health

Plenary session: Strategies for a better Covid-19 recovery and preparedness for future healthcare crises

Share this session

13 February 2023, 13:30 - 14:45 BRT (Rio de Janeiro)

13 February 2023, 17:30 - 18:45 CET (Brussels)

13 February 2023, 17:30 - 18:45 WAT (Nigeria)

13 February 2023, 18:30 - 19:45 SAST (Cape Town)

13 February 2023, 11:30 - 12:45 EST (New York)

13 February 2023, 01:30 - 02:45 KST (Seoul)

13 February 2023, 00:30 - 01:45 CST (Beijing)

13 February 2023, 22:00 - 23:15 IST (New Delhi)

13 February 2023, 20:30 - 21:45 GST (Dubai)

Room Manguinhos & online

International leaders, scientists, and policymakers will present the lessons they learned about recovering from the pandemic and how to prepare for future outbreaks. They will debate the fundamental steps that must be taken to build preparedness and resilience and ensure equity and inclusiveness in the face of future healthcare crises. This includes financial planning, international cooperation, decision-making, and investments in research and development. They will discuss the following questions:

  • What are the key lessons from these three years of Covid-19?
  • What issues must be prioritized and addressed in pandemic recovery plans?
  • How to establish a pandemic recovery plan in a world fraught with inequality?
  • How to establish an inclusive global preparedness plan that enables low- and middle-income countries to provide the necessary investments in their health systems and production?
  • Which national policies should be implemented to build resilience for future health emergencies?
  • In face of a failed multilateralism system, how to rebuild trust and incentives between countries for more effective international cooperation and a coordinated preparedness plan?
  • What role can disinformation play in global health crises and how to fight disinformation?

Marco Krieger

Marco Krieger

Oswaldo Cruz Foundation (Fiocruz)

Vice-president of Health Production and Innovation in Health

Sylvain  Aldighieri

Sylvain Aldighieri

Pan American Health Organization (PAHO)

Incident manager for COVID-19

Frank Vandenbroucke

Frank Vandenbroucke

Belgium

Deputy Prime Minister and Minister of Social Affairs and Public Health

Jeremy Farrar

Jeremy Farrar

Wellcome Trust

Director

Naveen  Rao

Naveen Rao

Global Health Rockefeller Foundation

Senior Executive Vice President

Lieve Fransen

Lieve Fransen

European Policy Centre

Senior Adviser on Health, Social, and Migration Policies

Antoni Plasència

Antoni Plasència

Barcelona Institute of Global Health (ISGlobal)

Director-General

Chaired by

Paulo Gadelha

Paulo Gadelha

Fiocruz Strategy for 2030 Agenda

Coordinator

As coordinator of the Fiocruz Strategy for the 2030 Agenda, Gadelha is in charge of promoting strategic engagement between Fiocruz and the UN Sustainable Development Goals (SDGs). His background includes studies of the application of technology in public health, healthcare models, and enhancing Science, Technology, and Innovation (STI) for the SDGs.

Gadelha served as president of Fiocruz from 2009 to 2016, leading scientific achievements in biomedical sciences, generation of scientific and technological knowledge, and health and social development promotion. Between 2016 and 2021, Dr. Gadelha was appointed by the UN Secretary-General as a member of the Technology Facilitation Mechanism (UN-TFM) ‘10-Member Group’ to provide expertise and support to the UN Inter-agency Task Team (IATT) on STI for the SDGs.

Previously, he founded and directed the “Casa de Oswaldo Cruz,” a Fiocruz institute dedicated to the sociology and history of science and health. Dr. Gadelha also served as a member of the National Health Council’s Science and Technology Intersectoral Commission. As President of the Brazilian Association of Collective Health, he chaired the 11th World Congress on Public Health. In 2017, with UN/DESA, he chaired the efforts of Fiocruz in organizing the 1st Consultation on Health and STI in the 2030 Agenda’s implementation.

Health

Plenary session: Strategies for a better Covid-19 recovery and preparedness for future healthcare crises

Share this session

13 February 2023, 13:30 - 14:45 BRT (Rio de Janeiro)

13 February 2023, 17:30 - 18:45 CET (Brussels)

13 February 2023, 17:30 - 18:45 WAT (Nigeria)

13 February 2023, 18:30 - 19:45 SAST (Cape Town)

13 February 2023, 11:30 - 12:45 EST (New York)

13 February 2023, 01:30 - 02:45 KST (Seoul)

13 February 2023, 00:30 - 01:45 CST (Beijing)

13 February 2023, 22:00 - 23:15 IST (New Delhi)

13 February 2023, 20:30 - 21:45 GST (Dubai)

Room Manguinhos & online

International leaders, scientists, and policymakers will present the lessons they learned about recovering from the pandemic and how to prepare for future outbreaks. They will debate the fundamental steps that must be taken to build preparedness and resilience and ensure equity and inclusiveness in the face of future healthcare crises. This includes financial planning, international cooperation, decision-making, and investments in research and development. They will discuss the following questions:

  • What are the key lessons from these three years of Covid-19?
  • What issues must be prioritized and addressed in pandemic recovery plans?
  • How to establish a pandemic recovery plan in a world fraught with inequality?
  • How to establish an inclusive global preparedness plan that enables low- and middle-income countries to provide the necessary investments in their health systems and production?
  • Which national policies should be implemented to build resilience for future health emergencies?
  • In face of a failed multilateralism system, how to rebuild trust and incentives between countries for more effective international cooperation and a coordinated preparedness plan?
  • What role can disinformation play in global health crises and how to fight disinformation?

Marco Krieger

Marco Krieger

Oswaldo Cruz Foundation (Fiocruz)

Vice-president of Health Production and Innovation in Health

Sylvain  Aldighieri

Sylvain Aldighieri

Pan American Health Organization (PAHO)

Incident manager for COVID-19

Frank Vandenbroucke

Frank Vandenbroucke

Belgium

Deputy Prime Minister and Minister of Social Affairs and Public Health

Jeremy Farrar

Jeremy Farrar

Wellcome Trust

Director

Naveen  Rao

Naveen Rao

Global Health Rockefeller Foundation

Senior Executive Vice President

Lieve Fransen

Lieve Fransen

European Policy Centre

Senior Adviser on Health, Social, and Migration Policies

Antoni Plasència

Antoni Plasència

Barcelona Institute of Global Health (ISGlobal)

Director-General

Chaired by

Paulo Gadelha

Paulo Gadelha

Fiocruz Strategy for 2030 Agenda

Coordinator

As coordinator of the Fiocruz Strategy for the 2030 Agenda, Gadelha is in charge of promoting strategic engagement between Fiocruz and the UN Sustainable Development Goals (SDGs). His background includes studies of the application of technology in public health, healthcare models, and enhancing Science, Technology, and Innovation (STI) for the SDGs.

Gadelha served as president of Fiocruz from 2009 to 2016, leading scientific achievements in biomedical sciences, generation of scientific and technological knowledge, and health and social development promotion. Between 2016 and 2021, Dr. Gadelha was appointed by the UN Secretary-General as a member of the Technology Facilitation Mechanism (UN-TFM) ‘10-Member Group’ to provide expertise and support to the UN Inter-agency Task Team (IATT) on STI for the SDGs.

Previously, he founded and directed the “Casa de Oswaldo Cruz,” a Fiocruz institute dedicated to the sociology and history of science and health. Dr. Gadelha also served as a member of the National Health Council’s Science and Technology Intersectoral Commission. As President of the Brazilian Association of Collective Health, he chaired the 11th World Congress on Public Health. In 2017, with UN/DESA, he chaired the efforts of Fiocruz in organizing the 1st Consultation on Health and STI in the 2030 Agenda’s implementation.

Health

Plenary session: Strategies for a better Covid-19 recovery and preparedness for future healthcare crises

Share this session

13 February 2023, 13:30 - 14:45 BRT (Rio de Janeiro)

13 February 2023, 17:30 - 18:45 CET (Brussels)

13 February 2023, 17:30 - 18:45 WAT (Nigeria)

13 February 2023, 18:30 - 19:45 SAST (Cape Town)

13 February 2023, 11:30 - 12:45 EST (New York)

13 February 2023, 01:30 - 02:45 KST (Seoul)

13 February 2023, 00:30 - 01:45 CST (Beijing)

13 February 2023, 22:00 - 23:15 IST (New Delhi)

13 February 2023, 20:30 - 21:45 GST (Dubai)

Room Manguinhos & online

International leaders, scientists, and policymakers will present the lessons they learned about recovering from the pandemic and how to prepare for future outbreaks. They will debate the fundamental steps that must be taken to build preparedness and resilience and ensure equity and inclusiveness in the face of future healthcare crises. This includes financial planning, international cooperation, decision-making, and investments in research and development. They will discuss the following questions:

  • What are the key lessons from these three years of Covid-19?
  • What issues must be prioritized and addressed in pandemic recovery plans?
  • How to establish a pandemic recovery plan in a world fraught with inequality?
  • How to establish an inclusive global preparedness plan that enables low- and middle-income countries to provide the necessary investments in their health systems and production?
  • Which national policies should be implemented to build resilience for future health emergencies?
  • In face of a failed multilateralism system, how to rebuild trust and incentives between countries for more effective international cooperation and a coordinated preparedness plan?
  • What role can disinformation play in global health crises and how to fight disinformation?

Marco Krieger

Marco Krieger

Oswaldo Cruz Foundation (Fiocruz)

Vice-president of Health Production and Innovation in Health

Sylvain  Aldighieri

Sylvain Aldighieri

Pan American Health Organization (PAHO)

Incident manager for COVID-19

Frank Vandenbroucke

Frank Vandenbroucke

Belgium

Deputy Prime Minister and Minister of Social Affairs and Public Health

Jeremy Farrar

Jeremy Farrar

Wellcome Trust

Director

Naveen  Rao

Naveen Rao

Global Health Rockefeller Foundation

Senior Executive Vice President

Lieve Fransen

Lieve Fransen

European Policy Centre

Senior Adviser on Health, Social, and Migration Policies

Antoni Plasència

Antoni Plasència

Barcelona Institute of Global Health (ISGlobal)

Director-General

Chaired by

Paulo Gadelha

Paulo Gadelha

Fiocruz Strategy for 2030 Agenda

Coordinator

As coordinator of the Fiocruz Strategy for the 2030 Agenda, Gadelha is in charge of promoting strategic engagement between Fiocruz and the UN Sustainable Development Goals (SDGs). His background includes studies of the application of technology in public health, healthcare models, and enhancing Science, Technology, and Innovation (STI) for the SDGs.

Gadelha served as president of Fiocruz from 2009 to 2016, leading scientific achievements in biomedical sciences, generation of scientific and technological knowledge, and health and social development promotion. Between 2016 and 2021, Dr. Gadelha was appointed by the UN Secretary-General as a member of the Technology Facilitation Mechanism (UN-TFM) ‘10-Member Group’ to provide expertise and support to the UN Inter-agency Task Team (IATT) on STI for the SDGs.

Previously, he founded and directed the “Casa de Oswaldo Cruz,” a Fiocruz institute dedicated to the sociology and history of science and health. Dr. Gadelha also served as a member of the National Health Council’s Science and Technology Intersectoral Commission. As President of the Brazilian Association of Collective Health, he chaired the 11th World Congress on Public Health. In 2017, with UN/DESA, he chaired the efforts of Fiocruz in organizing the 1st Consultation on Health and STI in the 2030 Agenda’s implementation.

Health

Plenary session: Strategies for a better Covid-19 recovery and preparedness for future healthcare crises

Share this session

13 February 2023, 13:30 - 14:45 BRT (Rio de Janeiro)

13 February 2023, 17:30 - 18:45 CET (Brussels)

13 February 2023, 17:30 - 18:45 WAT (Nigeria)

13 February 2023, 18:30 - 19:45 SAST (Cape Town)

13 February 2023, 11:30 - 12:45 EST (New York)

13 February 2023, 01:30 - 02:45 KST (Seoul)

13 February 2023, 00:30 - 01:45 CST (Beijing)

13 February 2023, 22:00 - 23:15 IST (New Delhi)

13 February 2023, 20:30 - 21:45 GST (Dubai)

Room Manguinhos & online

International leaders, scientists, and policymakers will present the lessons they learned about recovering from the pandemic and how to prepare for future outbreaks. They will debate the fundamental steps that must be taken to build preparedness and resilience and ensure equity and inclusiveness in the face of future healthcare crises. This includes financial planning, international cooperation, decision-making, and investments in research and development. They will discuss the following questions:

  • What are the key lessons from these three years of Covid-19?
  • What issues must be prioritized and addressed in pandemic recovery plans?
  • How to establish a pandemic recovery plan in a world fraught with inequality?
  • How to establish an inclusive global preparedness plan that enables low- and middle-income countries to provide the necessary investments in their health systems and production?
  • Which national policies should be implemented to build resilience for future health emergencies?
  • In face of a failed multilateralism system, how to rebuild trust and incentives between countries for more effective international cooperation and a coordinated preparedness plan?
  • What role can disinformation play in global health crises and how to fight disinformation?

Marco Krieger

Marco Krieger

Oswaldo Cruz Foundation (Fiocruz)

Vice-president of Health Production and Innovation in Health

Sylvain  Aldighieri

Sylvain Aldighieri

Pan American Health Organization (PAHO)

Incident manager for COVID-19

Frank Vandenbroucke

Frank Vandenbroucke

Belgium

Deputy Prime Minister and Minister of Social Affairs and Public Health

Jeremy Farrar

Jeremy Farrar

Wellcome Trust

Director

Naveen  Rao

Naveen Rao

Global Health Rockefeller Foundation

Senior Executive Vice President

Lieve Fransen

Lieve Fransen

European Policy Centre

Senior Adviser on Health, Social, and Migration Policies

Antoni Plasència

Antoni Plasència

Barcelona Institute of Global Health (ISGlobal)

Director-General

Chaired by

Paulo Gadelha

Paulo Gadelha

Fiocruz Strategy for 2030 Agenda

Coordinator

As coordinator of the Fiocruz Strategy for the 2030 Agenda, Gadelha is in charge of promoting strategic engagement between Fiocruz and the UN Sustainable Development Goals (SDGs). His background includes studies of the application of technology in public health, healthcare models, and enhancing Science, Technology, and Innovation (STI) for the SDGs.

Gadelha served as president of Fiocruz from 2009 to 2016, leading scientific achievements in biomedical sciences, generation of scientific and technological knowledge, and health and social development promotion. Between 2016 and 2021, Dr. Gadelha was appointed by the UN Secretary-General as a member of the Technology Facilitation Mechanism (UN-TFM) ‘10-Member Group’ to provide expertise and support to the UN Inter-agency Task Team (IATT) on STI for the SDGs.

Previously, he founded and directed the “Casa de Oswaldo Cruz,” a Fiocruz institute dedicated to the sociology and history of science and health. Dr. Gadelha also served as a member of the National Health Council’s Science and Technology Intersectoral Commission. As President of the Brazilian Association of Collective Health, he chaired the 11th World Congress on Public Health. In 2017, with UN/DESA, he chaired the efforts of Fiocruz in organizing the 1st Consultation on Health and STI in the 2030 Agenda’s implementation.

15:00
19:00
19:00
20:00
13:00
03:00
02:00
23:30
22:00
Special session: Challenges and opportunities in planetary health

Health

×

Health

Special session: Challenges and opportunities in planetary health

Share this session

13 February 2023, 15:00 - 16:15 BRT (Rio de Janeiro)

13 February 2023, 19:00 - 20:15 CET (Brussels)

13 February 2023, 19:00 - 20:15 WAT (Nigeria)

13 February 2023, 20:00 - 21:15 SAST (Cape Town)

13 February 2023, 13:00 - 14:15 EST (New York)

13 February 2023, 03:00 - 04:15 KST (Seoul)

13 February 2023, 02:00 - 03:15 CST (Beijing)

13 February 2023, 23:30 - 00:45 IST (New Delhi)

13 February 2023, 22:00 - 23:15 GST (Dubai)

Room Estácio & online

Life expectancy has increased considerably over the last two centuries. However, the unsustainable development model that facilitated this progress has a devastating impact on the Earth’s natural systems. Climate change, biodiversity loss, and pollution are pushing the Earth beyond its limits and represent a major threat to planetary health and everything it supports.

There is a direct correlation between healthy ecosystems and healthy human communities. The damage we are causing to the planet, combined with increasing inequalities and poverty, is leading to an increase in climate-related deaths, non-communicable, infectious, and respiratory diseases, as well as malnutrition in all its forms, with severe consequences on mental health and wellbeing.

The speakers will highlight the current threats to human health, threats to the sustainability of the planet, and threats to the natural and human-made systems that support us. They will then discuss how to use integrated solutions to respond to the effects of environmental drivers of disease outbreaks and disease control strategies.

Maria Neira

Maria Neira

WHO headquarters

Assistant Director-General a.i., Division of UHC/Healthier Populations

Daniel Buss

Daniel Buss

Pan American Health Organization (PAHO)

Unit Chief Climate Change and Environmental Determinants of Health (CDE-CE)

Andrew Haines

Andrew Haines

London School of Hygiene and Tropical Medicine

Professor of Environmental Change and Public Health

Phoebe Koundouri

Phoebe Koundouri

Athens University of Economics and Business and Technical University of Denmark

Professor in Economics

Maurício Barreto

Maurício Barreto

Oswaldo Cruz Foundation

Senior Researcher

Vital Ribeiro

Vital Ribeiro

Healthy Hospitals Project

President of the Board

Chaired by

Luiz Augusto Galvão

Luiz Augusto Galvão

Oswaldo Cruz Foundation

Senior Researcher

Health

Special session: Challenges and opportunities in planetary health

Share this session

13 February 2023, 15:00 - 16:15 BRT (Rio de Janeiro)

13 February 2023, 19:00 - 20:15 CET (Brussels)

13 February 2023, 19:00 - 20:15 WAT (Nigeria)

13 February 2023, 20:00 - 21:15 SAST (Cape Town)

13 February 2023, 13:00 - 14:15 EST (New York)

13 February 2023, 03:00 - 04:15 KST (Seoul)

13 February 2023, 02:00 - 03:15 CST (Beijing)

13 February 2023, 23:30 - 00:45 IST (New Delhi)

13 February 2023, 22:00 - 23:15 GST (Dubai)

Room Estácio & online

Life expectancy has increased considerably over the last two centuries. However, the unsustainable development model that facilitated this progress has a devastating impact on the Earth’s natural systems. Climate change, biodiversity loss, and pollution are pushing the Earth beyond its limits and represent a major threat to planetary health and everything it supports.

There is a direct correlation between healthy ecosystems and healthy human communities. The damage we are causing to the planet, combined with increasing inequalities and poverty, is leading to an increase in climate-related deaths, non-communicable, infectious, and respiratory diseases, as well as malnutrition in all its forms, with severe consequences on mental health and wellbeing.

The speakers will highlight the current threats to human health, threats to the sustainability of the planet, and threats to the natural and human-made systems that support us. They will then discuss how to use integrated solutions to respond to the effects of environmental drivers of disease outbreaks and disease control strategies.

Maria Neira

Maria Neira

WHO headquarters

Assistant Director-General a.i., Division of UHC/Healthier Populations

Daniel Buss

Daniel Buss

Pan American Health Organization (PAHO)

Unit Chief Climate Change and Environmental Determinants of Health (CDE-CE)

Andrew Haines

Andrew Haines

London School of Hygiene and Tropical Medicine

Professor of Environmental Change and Public Health

Phoebe Koundouri

Phoebe Koundouri

Athens University of Economics and Business and Technical University of Denmark

Professor in Economics

Maurício Barreto

Maurício Barreto

Oswaldo Cruz Foundation

Senior Researcher

Vital Ribeiro

Vital Ribeiro

Healthy Hospitals Project

President of the Board

Chaired by

Luiz Augusto Galvão

Luiz Augusto Galvão

Oswaldo Cruz Foundation

Senior Researcher

Health

Special session: Challenges and opportunities in planetary health

Share this session

13 February 2023, 15:00 - 16:15 BRT (Rio de Janeiro)

13 February 2023, 19:00 - 20:15 CET (Brussels)

13 February 2023, 19:00 - 20:15 WAT (Nigeria)

13 February 2023, 20:00 - 21:15 SAST (Cape Town)

13 February 2023, 13:00 - 14:15 EST (New York)

13 February 2023, 03:00 - 04:15 KST (Seoul)

13 February 2023, 02:00 - 03:15 CST (Beijing)

13 February 2023, 23:30 - 00:45 IST (New Delhi)

13 February 2023, 22:00 - 23:15 GST (Dubai)

Room Estácio & online

Life expectancy has increased considerably over the last two centuries. However, the unsustainable development model that facilitated this progress has a devastating impact on the Earth’s natural systems. Climate change, biodiversity loss, and pollution are pushing the Earth beyond its limits and represent a major threat to planetary health and everything it supports.

There is a direct correlation between healthy ecosystems and healthy human communities. The damage we are causing to the planet, combined with increasing inequalities and poverty, is leading to an increase in climate-related deaths, non-communicable, infectious, and respiratory diseases, as well as malnutrition in all its forms, with severe consequences on mental health and wellbeing.

The speakers will highlight the current threats to human health, threats to the sustainability of the planet, and threats to the natural and human-made systems that support us. They will then discuss how to use integrated solutions to respond to the effects of environmental drivers of disease outbreaks and disease control strategies.

Maria Neira

Maria Neira

WHO headquarters

Assistant Director-General a.i., Division of UHC/Healthier Populations

Daniel Buss

Daniel Buss

Pan American Health Organization (PAHO)

Unit Chief Climate Change and Environmental Determinants of Health (CDE-CE)

Andrew Haines

Andrew Haines

London School of Hygiene and Tropical Medicine

Professor of Environmental Change and Public Health

Phoebe Koundouri

Phoebe Koundouri

Athens University of Economics and Business and Technical University of Denmark

Professor in Economics

Maurício Barreto

Maurício Barreto

Oswaldo Cruz Foundation

Senior Researcher

Vital Ribeiro

Vital Ribeiro

Healthy Hospitals Project

President of the Board

Chaired by

Luiz Augusto Galvão

Luiz Augusto Galvão

Oswaldo Cruz Foundation

Senior Researcher

Health

Special session: Challenges and opportunities in planetary health

Share this session

13 February 2023, 15:00 - 16:15 BRT (Rio de Janeiro)

13 February 2023, 19:00 - 20:15 CET (Brussels)

13 February 2023, 19:00 - 20:15 WAT (Nigeria)

13 February 2023, 20:00 - 21:15 SAST (Cape Town)

13 February 2023, 13:00 - 14:15 EST (New York)

13 February 2023, 03:00 - 04:15 KST (Seoul)

13 February 2023, 02:00 - 03:15 CST (Beijing)

13 February 2023, 23:30 - 00:45 IST (New Delhi)

13 February 2023, 22:00 - 23:15 GST (Dubai)

Room Estácio & online

Life expectancy has increased considerably over the last two centuries. However, the unsustainable development model that facilitated this progress has a devastating impact on the Earth’s natural systems. Climate change, biodiversity loss, and pollution are pushing the Earth beyond its limits and represent a major threat to planetary health and everything it supports.

There is a direct correlation between healthy ecosystems and healthy human communities. The damage we are causing to the planet, combined with increasing inequalities and poverty, is leading to an increase in climate-related deaths, non-communicable, infectious, and respiratory diseases, as well as malnutrition in all its forms, with severe consequences on mental health and wellbeing.

The speakers will highlight the current threats to human health, threats to the sustainability of the planet, and threats to the natural and human-made systems that support us. They will then discuss how to use integrated solutions to respond to the effects of environmental drivers of disease outbreaks and disease control strategies.

Maria Neira

Maria Neira

WHO headquarters

Assistant Director-General a.i., Division of UHC/Healthier Populations

Daniel Buss

Daniel Buss

Pan American Health Organization (PAHO)

Unit Chief Climate Change and Environmental Determinants of Health (CDE-CE)

Andrew Haines

Andrew Haines

London School of Hygiene and Tropical Medicine

Professor of Environmental Change and Public Health

Phoebe Koundouri

Phoebe Koundouri

Athens University of Economics and Business and Technical University of Denmark

Professor in Economics

Maurício Barreto

Maurício Barreto

Oswaldo Cruz Foundation

Senior Researcher

Vital Ribeiro

Vital Ribeiro

Healthy Hospitals Project

President of the Board

Chaired by

Luiz Augusto Galvão

Luiz Augusto Galvão

Oswaldo Cruz Foundation

Senior Researcher

Health

Special session: Challenges and opportunities in planetary health

Share this session

13 February 2023, 15:00 - 16:15 BRT (Rio de Janeiro)

13 February 2023, 19:00 - 20:15 CET (Brussels)

13 February 2023, 19:00 - 20:15 WAT (Nigeria)

13 February 2023, 20:00 - 21:15 SAST (Cape Town)

13 February 2023, 13:00 - 14:15 EST (New York)

13 February 2023, 03:00 - 04:15 KST (Seoul)

13 February 2023, 02:00 - 03:15 CST (Beijing)

13 February 2023, 23:30 - 00:45 IST (New Delhi)

13 February 2023, 22:00 - 23:15 GST (Dubai)

Room Estácio & online

Life expectancy has increased considerably over the last two centuries. However, the unsustainable development model that facilitated this progress has a devastating impact on the Earth’s natural systems. Climate change, biodiversity loss, and pollution are pushing the Earth beyond its limits and represent a major threat to planetary health and everything it supports.

There is a direct correlation between healthy ecosystems and healthy human communities. The damage we are causing to the planet, combined with increasing inequalities and poverty, is leading to an increase in climate-related deaths, non-communicable, infectious, and respiratory diseases, as well as malnutrition in all its forms, with severe consequences on mental health and wellbeing.

The speakers will highlight the current threats to human health, threats to the sustainability of the planet, and threats to the natural and human-made systems that support us. They will then discuss how to use integrated solutions to respond to the effects of environmental drivers of disease outbreaks and disease control strategies.

Maria Neira

Maria Neira

WHO headquarters

Assistant Director-General a.i., Division of UHC/Healthier Populations

Daniel Buss

Daniel Buss

Pan American Health Organization (PAHO)

Unit Chief Climate Change and Environmental Determinants of Health (CDE-CE)

Andrew Haines

Andrew Haines

London School of Hygiene and Tropical Medicine

Professor of Environmental Change and Public Health

Phoebe Koundouri

Phoebe Koundouri

Athens University of Economics and Business and Technical University of Denmark

Professor in Economics

Maurício Barreto

Maurício Barreto

Oswaldo Cruz Foundation

Senior Researcher

Vital Ribeiro

Vital Ribeiro

Healthy Hospitals Project

President of the Board

Chaired by

Luiz Augusto Galvão

Luiz Augusto Galvão

Oswaldo Cruz Foundation

Senior Researcher

Health

Special session: Challenges and opportunities in planetary health

Share this session

13 February 2023, 15:00 - 16:15 BRT (Rio de Janeiro)

13 February 2023, 19:00 - 20:15 CET (Brussels)

13 February 2023, 19:00 - 20:15 WAT (Nigeria)

13 February 2023, 20:00 - 21:15 SAST (Cape Town)

13 February 2023, 13:00 - 14:15 EST (New York)

13 February 2023, 03:00 - 04:15 KST (Seoul)

13 February 2023, 02:00 - 03:15 CST (Beijing)

13 February 2023, 23:30 - 00:45 IST (New Delhi)

13 February 2023, 22:00 - 23:15 GST (Dubai)

Room Estácio & online

Life expectancy has increased considerably over the last two centuries. However, the unsustainable development model that facilitated this progress has a devastating impact on the Earth’s natural systems. Climate change, biodiversity loss, and pollution are pushing the Earth beyond its limits and represent a major threat to planetary health and everything it supports.

There is a direct correlation between healthy ecosystems and healthy human communities. The damage we are causing to the planet, combined with increasing inequalities and poverty, is leading to an increase in climate-related deaths, non-communicable, infectious, and respiratory diseases, as well as malnutrition in all its forms, with severe consequences on mental health and wellbeing.

The speakers will highlight the current threats to human health, threats to the sustainability of the planet, and threats to the natural and human-made systems that support us. They will then discuss how to use integrated solutions to respond to the effects of environmental drivers of disease outbreaks and disease control strategies.

Maria Neira

Maria Neira

WHO headquarters

Assistant Director-General a.i., Division of UHC/Healthier Populations

Daniel Buss

Daniel Buss

Pan American Health Organization (PAHO)

Unit Chief Climate Change and Environmental Determinants of Health (CDE-CE)

Andrew Haines

Andrew Haines

London School of Hygiene and Tropical Medicine

Professor of Environmental Change and Public Health

Phoebe Koundouri

Phoebe Koundouri

Athens University of Economics and Business and Technical University of Denmark

Professor in Economics

Maurício Barreto

Maurício Barreto

Oswaldo Cruz Foundation

Senior Researcher

Vital Ribeiro

Vital Ribeiro

Healthy Hospitals Project

President of the Board

Chaired by

Luiz Augusto Galvão

Luiz Augusto Galvão

Oswaldo Cruz Foundation

Senior Researcher

Health

Special session: Challenges and opportunities in planetary health

Share this session

13 February 2023, 15:00 - 16:15 BRT (Rio de Janeiro)

13 February 2023, 19:00 - 20:15 CET (Brussels)

13 February 2023, 19:00 - 20:15 WAT (Nigeria)

13 February 2023, 20:00 - 21:15 SAST (Cape Town)

13 February 2023, 13:00 - 14:15 EST (New York)

13 February 2023, 03:00 - 04:15 KST (Seoul)

13 February 2023, 02:00 - 03:15 CST (Beijing)

13 February 2023, 23:30 - 00:45 IST (New Delhi)

13 February 2023, 22:00 - 23:15 GST (Dubai)

Room Estácio & online

Life expectancy has increased considerably over the last two centuries. However, the unsustainable development model that facilitated this progress has a devastating impact on the Earth’s natural systems. Climate change, biodiversity loss, and pollution are pushing the Earth beyond its limits and represent a major threat to planetary health and everything it supports.

There is a direct correlation between healthy ecosystems and healthy human communities. The damage we are causing to the planet, combined with increasing inequalities and poverty, is leading to an increase in climate-related deaths, non-communicable, infectious, and respiratory diseases, as well as malnutrition in all its forms, with severe consequences on mental health and wellbeing.

The speakers will highlight the current threats to human health, threats to the sustainability of the planet, and threats to the natural and human-made systems that support us. They will then discuss how to use integrated solutions to respond to the effects of environmental drivers of disease outbreaks and disease control strategies.

Maria Neira

Maria Neira

WHO headquarters

Assistant Director-General a.i., Division of UHC/Healthier Populations

Daniel Buss

Daniel Buss

Pan American Health Organization (PAHO)

Unit Chief Climate Change and Environmental Determinants of Health (CDE-CE)

Andrew Haines

Andrew Haines

London School of Hygiene and Tropical Medicine

Professor of Environmental Change and Public Health

Phoebe Koundouri

Phoebe Koundouri

Athens University of Economics and Business and Technical University of Denmark

Professor in Economics

Maurício Barreto

Maurício Barreto

Oswaldo Cruz Foundation

Senior Researcher

Vital Ribeiro

Vital Ribeiro

Healthy Hospitals Project

President of the Board

Chaired by

Luiz Augusto Galvão

Luiz Augusto Galvão

Oswaldo Cruz Foundation

Senior Researcher

Health

Special session: Challenges and opportunities in planetary health

Share this session

13 February 2023, 15:00 - 16:15 BRT (Rio de Janeiro)

13 February 2023, 19:00 - 20:15 CET (Brussels)

13 February 2023, 19:00 - 20:15 WAT (Nigeria)

13 February 2023, 20:00 - 21:15 SAST (Cape Town)

13 February 2023, 13:00 - 14:15 EST (New York)

13 February 2023, 03:00 - 04:15 KST (Seoul)

13 February 2023, 02:00 - 03:15 CST (Beijing)

13 February 2023, 23:30 - 00:45 IST (New Delhi)

13 February 2023, 22:00 - 23:15 GST (Dubai)

Room Estácio & online

Life expectancy has increased considerably over the last two centuries. However, the unsustainable development model that facilitated this progress has a devastating impact on the Earth’s natural systems. Climate change, biodiversity loss, and pollution are pushing the Earth beyond its limits and represent a major threat to planetary health and everything it supports.

There is a direct correlation between healthy ecosystems and healthy human communities. The damage we are causing to the planet, combined with increasing inequalities and poverty, is leading to an increase in climate-related deaths, non-communicable, infectious, and respiratory diseases, as well as malnutrition in all its forms, with severe consequences on mental health and wellbeing.

The speakers will highlight the current threats to human health, threats to the sustainability of the planet, and threats to the natural and human-made systems that support us. They will then discuss how to use integrated solutions to respond to the effects of environmental drivers of disease outbreaks and disease control strategies.

Maria Neira

Maria Neira

WHO headquarters

Assistant Director-General a.i., Division of UHC/Healthier Populations

Daniel Buss

Daniel Buss

Pan American Health Organization (PAHO)

Unit Chief Climate Change and Environmental Determinants of Health (CDE-CE)

Andrew Haines

Andrew Haines

London School of Hygiene and Tropical Medicine

Professor of Environmental Change and Public Health

Phoebe Koundouri

Phoebe Koundouri

Athens University of Economics and Business and Technical University of Denmark

Professor in Economics

Maurício Barreto

Maurício Barreto

Oswaldo Cruz Foundation

Senior Researcher

Vital Ribeiro

Vital Ribeiro

Healthy Hospitals Project

President of the Board

Chaired by

Luiz Augusto Galvão

Luiz Augusto Galvão

Oswaldo Cruz Foundation

Senior Researcher

Health

Special session: Challenges and opportunities in planetary health

Share this session

13 February 2023, 15:00 - 16:15 BRT (Rio de Janeiro)

13 February 2023, 19:00 - 20:15 CET (Brussels)

13 February 2023, 19:00 - 20:15 WAT (Nigeria)

13 February 2023, 20:00 - 21:15 SAST (Cape Town)

13 February 2023, 13:00 - 14:15 EST (New York)

13 February 2023, 03:00 - 04:15 KST (Seoul)

13 February 2023, 02:00 - 03:15 CST (Beijing)

13 February 2023, 23:30 - 00:45 IST (New Delhi)

13 February 2023, 22:00 - 23:15 GST (Dubai)

Room Estácio & online

Life expectancy has increased considerably over the last two centuries. However, the unsustainable development model that facilitated this progress has a devastating impact on the Earth’s natural systems. Climate change, biodiversity loss, and pollution are pushing the Earth beyond its limits and represent a major threat to planetary health and everything it supports.

There is a direct correlation between healthy ecosystems and healthy human communities. The damage we are causing to the planet, combined with increasing inequalities and poverty, is leading to an increase in climate-related deaths, non-communicable, infectious, and respiratory diseases, as well as malnutrition in all its forms, with severe consequences on mental health and wellbeing.

The speakers will highlight the current threats to human health, threats to the sustainability of the planet, and threats to the natural and human-made systems that support us. They will then discuss how to use integrated solutions to respond to the effects of environmental drivers of disease outbreaks and disease control strategies.

Maria Neira

Maria Neira

WHO headquarters

Assistant Director-General a.i., Division of UHC/Healthier Populations

Daniel Buss

Daniel Buss

Pan American Health Organization (PAHO)

Unit Chief Climate Change and Environmental Determinants of Health (CDE-CE)

Andrew Haines

Andrew Haines

London School of Hygiene and Tropical Medicine

Professor of Environmental Change and Public Health

Phoebe Koundouri

Phoebe Koundouri

Athens University of Economics and Business and Technical University of Denmark

Professor in Economics

Maurício Barreto

Maurício Barreto

Oswaldo Cruz Foundation

Senior Researcher

Vital Ribeiro

Vital Ribeiro

Healthy Hospitals Project

President of the Board

Chaired by

Luiz Augusto Galvão

Luiz Augusto Galvão

Oswaldo Cruz Foundation

Senior Researcher

16:30
20:30
20:30
21:30
14:30
04:30
03:30
01:00
23:30
Special session: Challenges in building health surveillance systems

Health

×

Health

Special session: Challenges in building health surveillance systems

Share this session

13 February 2023, 16:30 - 17:45 BRT (Rio de Janeiro)

13 February 2023, 20:30 - 21:45 CET (Brussels)

13 February 2023, 20:30 - 21:45 WAT (Nigeria)

13 February 2023, 21:30 - 22:45 SAST (Cape Town)

13 February 2023, 14:30 - 15:45 EST (New York)

13 February 2023, 04:30 - 05:45 KST (Seoul)

13 February 2023, 03:30 - 04:45 CST (Beijing)

13 February 2023, 01:00 - 02:15 IST (New Delhi)

13 February 2023, 23:30 - 00:45 GST (Dubai)

Room Estácio & online

The Covid-19 pandemic demonstrated an urgent need for effective international health surveillance systems. At the moment, most health surveillance systems only operate locally or nationally. An integrated and multi-disciplinary surveillance system, focused on data sharing between countries and a global intelligence network for disease control, will be an essential first step to preparing and responding to new outbreaks.

Community-based citizen science can make substantial contributions to building effective health surveillance systems. Community members can provide valuable updated information that helps identify problems, prioritize local solutions, and mobilize support and advocacy. Empowering communities through access to information and training is an important step toward this goal.

Creating a global surveillance system is highly complex. On the one hand, it must incorporate environmental and animal components into health assessment – the One Health approach. This includes multi-disciplinary efforts to understand the interactions between the oceans, air, freshwater, biodiversity, climate, and many other factors that influence human health and well-being.

On the other hand, there are tricky administrative and procedural concerns that need to be considered. The launch of the World Health Organization (WHO) Hub for Pandemic and Epidemic Intelligence was a good start. Among other important questions, the Hub aims to address issues such as how to foster a trustful global network of collaboration; how to ensure technology transfer and development in low-income countries, how to establish continuous technical guidance and training between countries, and how to standardize and interpret data collection from different sources.

The speakers will discuss the challenges and potential solutions to developing local and global health surveillance systems.

Oliver Morgan

Oliver Morgan

World Health Organization

Director Health Emergency Information and Risk Assessment

John Haynes

John Haynes

Applied Sciences Program of the NASA Earth Science Division

Program Manager for Health and Air Quality Applications

Ana Bento

Ana Bento

The Rockefeller Foundation

Director of Science, Pandemic Prevention Institute Health Initiative

Ethel Maciel

Ethel Maciel

Brazilian Ministry of Health

Secretary of Health and Environment Surveillance

Juliette Morgan

Juliette Morgan

US Centers for Disease Control and Prevention (CDC)

South America Regional Director

Moderated by

Manoel Barral

Manoel Barral

Fiocruz

CIDACs Senior Researcher

Health

Special session: Challenges in building health surveillance systems

Share this session

13 February 2023, 16:30 - 17:45 BRT (Rio de Janeiro)

13 February 2023, 20:30 - 21:45 CET (Brussels)

13 February 2023, 20:30 - 21:45 WAT (Nigeria)

13 February 2023, 21:30 - 22:45 SAST (Cape Town)

13 February 2023, 14:30 - 15:45 EST (New York)

13 February 2023, 04:30 - 05:45 KST (Seoul)

13 February 2023, 03:30 - 04:45 CST (Beijing)

13 February 2023, 01:00 - 02:15 IST (New Delhi)

13 February 2023, 23:30 - 00:45 GST (Dubai)

Room Estácio & online

The Covid-19 pandemic demonstrated an urgent need for effective international health surveillance systems. At the moment, most health surveillance systems only operate locally or nationally. An integrated and multi-disciplinary surveillance system, focused on data sharing between countries and a global intelligence network for disease control, will be an essential first step to preparing and responding to new outbreaks.

Community-based citizen science can make substantial contributions to building effective health surveillance systems. Community members can provide valuable updated information that helps identify problems, prioritize local solutions, and mobilize support and advocacy. Empowering communities through access to information and training is an important step toward this goal.

Creating a global surveillance system is highly complex. On the one hand, it must incorporate environmental and animal components into health assessment – the One Health approach. This includes multi-disciplinary efforts to understand the interactions between the oceans, air, freshwater, biodiversity, climate, and many other factors that influence human health and well-being.

On the other hand, there are tricky administrative and procedural concerns that need to be considered. The launch of the World Health Organization (WHO) Hub for Pandemic and Epidemic Intelligence was a good start. Among other important questions, the Hub aims to address issues such as how to foster a trustful global network of collaboration; how to ensure technology transfer and development in low-income countries, how to establish continuous technical guidance and training between countries, and how to standardize and interpret data collection from different sources.

The speakers will discuss the challenges and potential solutions to developing local and global health surveillance systems.

Oliver Morgan

Oliver Morgan

World Health Organization

Director Health Emergency Information and Risk Assessment

John Haynes

John Haynes

Applied Sciences Program of the NASA Earth Science Division

Program Manager for Health and Air Quality Applications

Ana Bento

Ana Bento

The Rockefeller Foundation

Director of Science, Pandemic Prevention Institute Health Initiative

Ethel Maciel

Ethel Maciel

Brazilian Ministry of Health

Secretary of Health and Environment Surveillance

Juliette Morgan

Juliette Morgan

US Centers for Disease Control and Prevention (CDC)

South America Regional Director

Moderated by

Manoel Barral

Manoel Barral

Fiocruz

CIDACs Senior Researcher

Health

Special session: Challenges in building health surveillance systems

Share this session

13 February 2023, 16:30 - 17:45 BRT (Rio de Janeiro)

13 February 2023, 20:30 - 21:45 CET (Brussels)

13 February 2023, 20:30 - 21:45 WAT (Nigeria)

13 February 2023, 21:30 - 22:45 SAST (Cape Town)

13 February 2023, 14:30 - 15:45 EST (New York)

13 February 2023, 04:30 - 05:45 KST (Seoul)

13 February 2023, 03:30 - 04:45 CST (Beijing)

13 February 2023, 01:00 - 02:15 IST (New Delhi)

13 February 2023, 23:30 - 00:45 GST (Dubai)

Room Estácio & online

The Covid-19 pandemic demonstrated an urgent need for effective international health surveillance systems. At the moment, most health surveillance systems only operate locally or nationally. An integrated and multi-disciplinary surveillance system, focused on data sharing between countries and a global intelligence network for disease control, will be an essential first step to preparing and responding to new outbreaks.

Community-based citizen science can make substantial contributions to building effective health surveillance systems. Community members can provide valuable updated information that helps identify problems, prioritize local solutions, and mobilize support and advocacy. Empowering communities through access to information and training is an important step toward this goal.

Creating a global surveillance system is highly complex. On the one hand, it must incorporate environmental and animal components into health assessment – the One Health approach. This includes multi-disciplinary efforts to understand the interactions between the oceans, air, freshwater, biodiversity, climate, and many other factors that influence human health and well-being.

On the other hand, there are tricky administrative and procedural concerns that need to be considered. The launch of the World Health Organization (WHO) Hub for Pandemic and Epidemic Intelligence was a good start. Among other important questions, the Hub aims to address issues such as how to foster a trustful global network of collaboration; how to ensure technology transfer and development in low-income countries, how to establish continuous technical guidance and training between countries, and how to standardize and interpret data collection from different sources.

The speakers will discuss the challenges and potential solutions to developing local and global health surveillance systems.

Oliver Morgan

Oliver Morgan

World Health Organization

Director Health Emergency Information and Risk Assessment

John Haynes

John Haynes

Applied Sciences Program of the NASA Earth Science Division

Program Manager for Health and Air Quality Applications

Ana Bento

Ana Bento

The Rockefeller Foundation

Director of Science, Pandemic Prevention Institute Health Initiative

Ethel Maciel

Ethel Maciel

Brazilian Ministry of Health

Secretary of Health and Environment Surveillance

Juliette Morgan

Juliette Morgan

US Centers for Disease Control and Prevention (CDC)

South America Regional Director

Moderated by

Manoel Barral

Manoel Barral

Fiocruz

CIDACs Senior Researcher

Health

Special session: Challenges in building health surveillance systems

Share this session

13 February 2023, 16:30 - 17:45 BRT (Rio de Janeiro)

13 February 2023, 20:30 - 21:45 CET (Brussels)

13 February 2023, 20:30 - 21:45 WAT (Nigeria)

13 February 2023, 21:30 - 22:45 SAST (Cape Town)

13 February 2023, 14:30 - 15:45 EST (New York)

13 February 2023, 04:30 - 05:45 KST (Seoul)

13 February 2023, 03:30 - 04:45 CST (Beijing)

13 February 2023, 01:00 - 02:15 IST (New Delhi)

13 February 2023, 23:30 - 00:45 GST (Dubai)

Room Estácio & online

The Covid-19 pandemic demonstrated an urgent need for effective international health surveillance systems. At the moment, most health surveillance systems only operate locally or nationally. An integrated and multi-disciplinary surveillance system, focused on data sharing between countries and a global intelligence network for disease control, will be an essential first step to preparing and responding to new outbreaks.

Community-based citizen science can make substantial contributions to building effective health surveillance systems. Community members can provide valuable updated information that helps identify problems, prioritize local solutions, and mobilize support and advocacy. Empowering communities through access to information and training is an important step toward this goal.

Creating a global surveillance system is highly complex. On the one hand, it must incorporate environmental and animal components into health assessment – the One Health approach. This includes multi-disciplinary efforts to understand the interactions between the oceans, air, freshwater, biodiversity, climate, and many other factors that influence human health and well-being.

On the other hand, there are tricky administrative and procedural concerns that need to be considered. The launch of the World Health Organization (WHO) Hub for Pandemic and Epidemic Intelligence was a good start. Among other important questions, the Hub aims to address issues such as how to foster a trustful global network of collaboration; how to ensure technology transfer and development in low-income countries, how to establish continuous technical guidance and training between countries, and how to standardize and interpret data collection from different sources.

The speakers will discuss the challenges and potential solutions to developing local and global health surveillance systems.

Oliver Morgan

Oliver Morgan

World Health Organization

Director Health Emergency Information and Risk Assessment

John Haynes

John Haynes

Applied Sciences Program of the NASA Earth Science Division

Program Manager for Health and Air Quality Applications

Ana Bento

Ana Bento

The Rockefeller Foundation

Director of Science, Pandemic Prevention Institute Health Initiative

Ethel Maciel

Ethel Maciel

Brazilian Ministry of Health

Secretary of Health and Environment Surveillance

Juliette Morgan

Juliette Morgan

US Centers for Disease Control and Prevention (CDC)

South America Regional Director

Moderated by

Manoel Barral

Manoel Barral

Fiocruz

CIDACs Senior Researcher

Health

Special session: Challenges in building health surveillance systems

Share this session

13 February 2023, 16:30 - 17:45 BRT (Rio de Janeiro)

13 February 2023, 20:30 - 21:45 CET (Brussels)

13 February 2023, 20:30 - 21:45 WAT (Nigeria)

13 February 2023, 21:30 - 22:45 SAST (Cape Town)

13 February 2023, 14:30 - 15:45 EST (New York)

13 February 2023, 04:30 - 05:45 KST (Seoul)

13 February 2023, 03:30 - 04:45 CST (Beijing)

13 February 2023, 01:00 - 02:15 IST (New Delhi)

13 February 2023, 23:30 - 00:45 GST (Dubai)

Room Estácio & online

The Covid-19 pandemic demonstrated an urgent need for effective international health surveillance systems. At the moment, most health surveillance systems only operate locally or nationally. An integrated and multi-disciplinary surveillance system, focused on data sharing between countries and a global intelligence network for disease control, will be an essential first step to preparing and responding to new outbreaks.

Community-based citizen science can make substantial contributions to building effective health surveillance systems. Community members can provide valuable updated information that helps identify problems, prioritize local solutions, and mobilize support and advocacy. Empowering communities through access to information and training is an important step toward this goal.

Creating a global surveillance system is highly complex. On the one hand, it must incorporate environmental and animal components into health assessment – the One Health approach. This includes multi-disciplinary efforts to understand the interactions between the oceans, air, freshwater, biodiversity, climate, and many other factors that influence human health and well-being.

On the other hand, there are tricky administrative and procedural concerns that need to be considered. The launch of the World Health Organization (WHO) Hub for Pandemic and Epidemic Intelligence was a good start. Among other important questions, the Hub aims to address issues such as how to foster a trustful global network of collaboration; how to ensure technology transfer and development in low-income countries, how to establish continuous technical guidance and training between countries, and how to standardize and interpret data collection from different sources.

The speakers will discuss the challenges and potential solutions to developing local and global health surveillance systems.

Oliver Morgan

Oliver Morgan

World Health Organization

Director Health Emergency Information and Risk Assessment

John Haynes

John Haynes

Applied Sciences Program of the NASA Earth Science Division

Program Manager for Health and Air Quality Applications

Ana Bento

Ana Bento

The Rockefeller Foundation

Director of Science, Pandemic Prevention Institute Health Initiative

Ethel Maciel

Ethel Maciel

Brazilian Ministry of Health

Secretary of Health and Environment Surveillance

Juliette Morgan

Juliette Morgan

US Centers for Disease Control and Prevention (CDC)

South America Regional Director

Moderated by

Manoel Barral

Manoel Barral

Fiocruz

CIDACs Senior Researcher

Health

Special session: Challenges in building health surveillance systems

Share this session

13 February 2023, 16:30 - 17:45 BRT (Rio de Janeiro)

13 February 2023, 20:30 - 21:45 CET (Brussels)

13 February 2023, 20:30 - 21:45 WAT (Nigeria)

13 February 2023, 21:30 - 22:45 SAST (Cape Town)

13 February 2023, 14:30 - 15:45 EST (New York)

13 February 2023, 04:30 - 05:45 KST (Seoul)

13 February 2023, 03:30 - 04:45 CST (Beijing)

13 February 2023, 01:00 - 02:15 IST (New Delhi)

13 February 2023, 23:30 - 00:45 GST (Dubai)

Room Estácio & online

The Covid-19 pandemic demonstrated an urgent need for effective international health surveillance systems. At the moment, most health surveillance systems only operate locally or nationally. An integrated and multi-disciplinary surveillance system, focused on data sharing between countries and a global intelligence network for disease control, will be an essential first step to preparing and responding to new outbreaks.

Community-based citizen science can make substantial contributions to building effective health surveillance systems. Community members can provide valuable updated information that helps identify problems, prioritize local solutions, and mobilize support and advocacy. Empowering communities through access to information and training is an important step toward this goal.

Creating a global surveillance system is highly complex. On the one hand, it must incorporate environmental and animal components into health assessment – the One Health approach. This includes multi-disciplinary efforts to understand the interactions between the oceans, air, freshwater, biodiversity, climate, and many other factors that influence human health and well-being.

On the other hand, there are tricky administrative and procedural concerns that need to be considered. The launch of the World Health Organization (WHO) Hub for Pandemic and Epidemic Intelligence was a good start. Among other important questions, the Hub aims to address issues such as how to foster a trustful global network of collaboration; how to ensure technology transfer and development in low-income countries, how to establish continuous technical guidance and training between countries, and how to standardize and interpret data collection from different sources.

The speakers will discuss the challenges and potential solutions to developing local and global health surveillance systems.

Oliver Morgan

Oliver Morgan

World Health Organization

Director Health Emergency Information and Risk Assessment

John Haynes

John Haynes

Applied Sciences Program of the NASA Earth Science Division

Program Manager for Health and Air Quality Applications

Ana Bento

Ana Bento

The Rockefeller Foundation

Director of Science, Pandemic Prevention Institute Health Initiative

Ethel Maciel

Ethel Maciel

Brazilian Ministry of Health

Secretary of Health and Environment Surveillance

Juliette Morgan

Juliette Morgan

US Centers for Disease Control and Prevention (CDC)

South America Regional Director

Moderated by

Manoel Barral

Manoel Barral

Fiocruz

CIDACs Senior Researcher

Health

Special session: Challenges in building health surveillance systems

Share this session

13 February 2023, 16:30 - 17:45 BRT (Rio de Janeiro)

13 February 2023, 20:30 - 21:45 CET (Brussels)

13 February 2023, 20:30 - 21:45 WAT (Nigeria)

13 February 2023, 21:30 - 22:45 SAST (Cape Town)

13 February 2023, 14:30 - 15:45 EST (New York)

13 February 2023, 04:30 - 05:45 KST (Seoul)

13 February 2023, 03:30 - 04:45 CST (Beijing)

13 February 2023, 01:00 - 02:15 IST (New Delhi)

13 February 2023, 23:30 - 00:45 GST (Dubai)

Room Estácio & online

The Covid-19 pandemic demonstrated an urgent need for effective international health surveillance systems. At the moment, most health surveillance systems only operate locally or nationally. An integrated and multi-disciplinary surveillance system, focused on data sharing between countries and a global intelligence network for disease control, will be an essential first step to preparing and responding to new outbreaks.

Community-based citizen science can make substantial contributions to building effective health surveillance systems. Community members can provide valuable updated information that helps identify problems, prioritize local solutions, and mobilize support and advocacy. Empowering communities through access to information and training is an important step toward this goal.

Creating a global surveillance system is highly complex. On the one hand, it must incorporate environmental and animal components into health assessment – the One Health approach. This includes multi-disciplinary efforts to understand the interactions between the oceans, air, freshwater, biodiversity, climate, and many other factors that influence human health and well-being.

On the other hand, there are tricky administrative and procedural concerns that need to be considered. The launch of the World Health Organization (WHO) Hub for Pandemic and Epidemic Intelligence was a good start. Among other important questions, the Hub aims to address issues such as how to foster a trustful global network of collaboration; how to ensure technology transfer and development in low-income countries, how to establish continuous technical guidance and training between countries, and how to standardize and interpret data collection from different sources.

The speakers will discuss the challenges and potential solutions to developing local and global health surveillance systems.

Oliver Morgan

Oliver Morgan

World Health Organization

Director Health Emergency Information and Risk Assessment

John Haynes

John Haynes

Applied Sciences Program of the NASA Earth Science Division

Program Manager for Health and Air Quality Applications

Ana Bento

Ana Bento

The Rockefeller Foundation

Director of Science, Pandemic Prevention Institute Health Initiative

Ethel Maciel

Ethel Maciel

Brazilian Ministry of Health

Secretary of Health and Environment Surveillance

Juliette Morgan

Juliette Morgan

US Centers for Disease Control and Prevention (CDC)

South America Regional Director

Moderated by

Manoel Barral

Manoel Barral

Fiocruz

CIDACs Senior Researcher

Health

Special session: Challenges in building health surveillance systems

Share this session

13 February 2023, 16:30 - 17:45 BRT (Rio de Janeiro)

13 February 2023, 20:30 - 21:45 CET (Brussels)

13 February 2023, 20:30 - 21:45 WAT (Nigeria)

13 February 2023, 21:30 - 22:45 SAST (Cape Town)

13 February 2023, 14:30 - 15:45 EST (New York)

13 February 2023, 04:30 - 05:45 KST (Seoul)

13 February 2023, 03:30 - 04:45 CST (Beijing)

13 February 2023, 01:00 - 02:15 IST (New Delhi)

13 February 2023, 23:30 - 00:45 GST (Dubai)

Room Estácio & online

The Covid-19 pandemic demonstrated an urgent need for effective international health surveillance systems. At the moment, most health surveillance systems only operate locally or nationally. An integrated and multi-disciplinary surveillance system, focused on data sharing between countries and a global intelligence network for disease control, will be an essential first step to preparing and responding to new outbreaks.

Community-based citizen science can make substantial contributions to building effective health surveillance systems. Community members can provide valuable updated information that helps identify problems, prioritize local solutions, and mobilize support and advocacy. Empowering communities through access to information and training is an important step toward this goal.

Creating a global surveillance system is highly complex. On the one hand, it must incorporate environmental and animal components into health assessment – the One Health approach. This includes multi-disciplinary efforts to understand the interactions between the oceans, air, freshwater, biodiversity, climate, and many other factors that influence human health and well-being.

On the other hand, there are tricky administrative and procedural concerns that need to be considered. The launch of the World Health Organization (WHO) Hub for Pandemic and Epidemic Intelligence was a good start. Among other important questions, the Hub aims to address issues such as how to foster a trustful global network of collaboration; how to ensure technology transfer and development in low-income countries, how to establish continuous technical guidance and training between countries, and how to standardize and interpret data collection from different sources.

The speakers will discuss the challenges and potential solutions to developing local and global health surveillance systems.

Oliver Morgan

Oliver Morgan

World Health Organization

Director Health Emergency Information and Risk Assessment

John Haynes

John Haynes

Applied Sciences Program of the NASA Earth Science Division

Program Manager for Health and Air Quality Applications

Ana Bento

Ana Bento

The Rockefeller Foundation

Director of Science, Pandemic Prevention Institute Health Initiative

Ethel Maciel

Ethel Maciel

Brazilian Ministry of Health

Secretary of Health and Environment Surveillance

Juliette Morgan

Juliette Morgan

US Centers for Disease Control and Prevention (CDC)

South America Regional Director

Moderated by

Manoel Barral

Manoel Barral

Fiocruz

CIDACs Senior Researcher

Health

Special session: Challenges in building health surveillance systems

Share this session

13 February 2023, 16:30 - 17:45 BRT (Rio de Janeiro)

13 February 2023, 20:30 - 21:45 CET (Brussels)

13 February 2023, 20:30 - 21:45 WAT (Nigeria)

13 February 2023, 21:30 - 22:45 SAST (Cape Town)

13 February 2023, 14:30 - 15:45 EST (New York)

13 February 2023, 04:30 - 05:45 KST (Seoul)

13 February 2023, 03:30 - 04:45 CST (Beijing)

13 February 2023, 01:00 - 02:15 IST (New Delhi)

13 February 2023, 23:30 - 00:45 GST (Dubai)

Room Estácio & online

The Covid-19 pandemic demonstrated an urgent need for effective international health surveillance systems. At the moment, most health surveillance systems only operate locally or nationally. An integrated and multi-disciplinary surveillance system, focused on data sharing between countries and a global intelligence network for disease control, will be an essential first step to preparing and responding to new outbreaks.

Community-based citizen science can make substantial contributions to building effective health surveillance systems. Community members can provide valuable updated information that helps identify problems, prioritize local solutions, and mobilize support and advocacy. Empowering communities through access to information and training is an important step toward this goal.

Creating a global surveillance system is highly complex. On the one hand, it must incorporate environmental and animal components into health assessment – the One Health approach. This includes multi-disciplinary efforts to understand the interactions between the oceans, air, freshwater, biodiversity, climate, and many other factors that influence human health and well-being.

On the other hand, there are tricky administrative and procedural concerns that need to be considered. The launch of the World Health Organization (WHO) Hub for Pandemic and Epidemic Intelligence was a good start. Among other important questions, the Hub aims to address issues such as how to foster a trustful global network of collaboration; how to ensure technology transfer and development in low-income countries, how to establish continuous technical guidance and training between countries, and how to standardize and interpret data collection from different sources.

The speakers will discuss the challenges and potential solutions to developing local and global health surveillance systems.

Oliver Morgan

Oliver Morgan

World Health Organization

Director Health Emergency Information and Risk Assessment

John Haynes

John Haynes

Applied Sciences Program of the NASA Earth Science Division

Program Manager for Health and Air Quality Applications

Ana Bento

Ana Bento

The Rockefeller Foundation

Director of Science, Pandemic Prevention Institute Health Initiative

Ethel Maciel

Ethel Maciel

Brazilian Ministry of Health

Secretary of Health and Environment Surveillance

Juliette Morgan

Juliette Morgan

US Centers for Disease Control and Prevention (CDC)

South America Regional Director

Moderated by

Manoel Barral

Manoel Barral

Fiocruz

CIDACs Senior Researcher

14 February 2023

09:00
13:00
13:00
14:00
07:00
21:00
20:00
17:30
16:00
Vaccines and immunization: Challenges and perspectives for local manufacturing

Health

×

Health

Vaccines and immunization: Challenges and perspectives for local manufacturing

Share this session

14 February 2023, 09:00 - 16:15 BRT (Rio de Janeiro)

14 February 2023, 13:00 - 20:15 CET (Brussels)

14 February 2023, 13:00 - 20:15 WAT (Nigeria)

14 February 2023, 14:00 - 21:15 SAST (Cape Town)

14 February 2023, 07:00 - 14:15 EST (New York)

14 February 2023, 21:00 - 04:15 KST (Seoul)

14 February 2023, 20:00 - 03:15 CST (Beijing)

14 February 2023, 17:30 - 00:45 IST (New Delhi)

14 February 2023, 16:00 - 23:15 GST (Dubai)

Room Flamengo & online

The COVID-19 pandemic highlighted the huge inequities in access to vaccines and the gap in the level of immunization between developed and developing countries and especially in the least developed countries. These disparities made global efforts to tackle the pandemic harder. They led to more hospitalizations and deaths, and exacerbated the impacts of long covid. Economies were also unevenly impacted as different countries emerged from the worst of the pandemic at different rates. These consequences were felt far more acutely in the most vulnerable countries.

The pandemic also exposed and exaggerated the imbalance in access to technology and the inequitable terms related to technology transfer agreements. The dependency on critical health goods and consumables manufactured by a few countries became even more evident, especially when the pandemic started to impact the supply chain and restrict the flow of goods around the world. All of these issues point to the urgent need for greater international collaboration and unity so the world is better prepared for the next major health emergency. This starts by addressing local health needs and ensuring that there is equal access to immunization and vaccines.

During this event, the first panel will address the funding mechanisms that are needed to accelerate vaccine innovation. The second panel will highlight some of the regional experiences of creating skills for local production and investment in the development and introduction of new vaccines to support immunization programs. They will also express their ideas about how to and address public health emergencies.

Keynote speech: Vaccine for all - Technology, manufacturing immunization uptake

James  Fitzgerald

James Fitzgerald

PAHO/WHO

Director, Health Systems and Services

Session 1: Immunization challenges in Brazil - Technology, manufacturing & access

Ethel Maciel

Ethel Maciel

Brazilian Ministry of Health

Secretary of Health and Environment Surveillance

Hugo G.  da Silva

Hugo G. da Silva

AstraZeneca

Global Head of Vaccines

Júlia  Spinardi

Júlia Spinardi

Pfizer

Medical and Scientific Affairs Senior Director

Cristiano G. Pereira

Cristiano G. Pereira

Butantan Institute

Innovation Tech Licensing Manager

Mauricio Zuma

Mauricio Zuma

Bio-Manguinhos

CEO

Moderated by

Mariangela  Simão

Mariangela Simão

Todos pela Saúde Institute

Executive Director

Coffee break & networking

Session 2: Vaccine manufacturing in developing countries

Carla  Vizzotti

Carla Vizzotti

Argentina

Health Minister

Nicolo Gligo

Nicolo Gligo

Economic Commission for Latin America and the Caribbean (ECLAC)

Economic Affairs Officer

Moderated by

Tiago  Rocca

Tiago Rocca

Developing Countries Vaccine Manufacturers (DCVMN)

Deputy Chair - Board of Members

Lav Agarwal

Lav Agarwal

Government of India

Additional Secretary, Ministry of Health & Family Welfare

Brunch & networking

Keynote speech: Vaccine R&D for emerging and reemerging diseases - Current and next generation technologies

Karin Bok

Karin Bok

National Institute of Allergy and Infectious Diseases (NIAID), Vaccine Research Center

Deputy Director (Acting), Director of Pandemic Preparedness and Emergency Response

Session 3: Vaccine R&D mechanisms for accelerating innovation

William  Hall

William Hall

Wellcome Trust

Head of Global Government Relations

Anand  Ekambaram

Anand Ekambaram

CEPI

Executive Director Manufacturing and Supply Chain Management

Chaired by

Rachel  Chikwamba

Rachel Chikwamba

CSIR

Group Executive: Advanced Chemistry and Life Sciences

Health

Vaccines and immunization: Challenges and perspectives for local manufacturing

Share this session

14 February 2023, 09:00 - 16:15 BRT (Rio de Janeiro)

14 February 2023, 13:00 - 20:15 CET (Brussels)

14 February 2023, 13:00 - 20:15 WAT (Nigeria)

14 February 2023, 14:00 - 21:15 SAST (Cape Town)

14 February 2023, 07:00 - 14:15 EST (New York)

14 February 2023, 21:00 - 04:15 KST (Seoul)

14 February 2023, 20:00 - 03:15 CST (Beijing)

14 February 2023, 17:30 - 00:45 IST (New Delhi)

14 February 2023, 16:00 - 23:15 GST (Dubai)

Room Flamengo & online

The COVID-19 pandemic highlighted the huge inequities in access to vaccines and the gap in the level of immunization between developed and developing countries and especially in the least developed countries. These disparities made global efforts to tackle the pandemic harder. They led to more hospitalizations and deaths, and exacerbated the impacts of long covid. Economies were also unevenly impacted as different countries emerged from the worst of the pandemic at different rates. These consequences were felt far more acutely in the most vulnerable countries.

The pandemic also exposed and exaggerated the imbalance in access to technology and the inequitable terms related to technology transfer agreements. The dependency on critical health goods and consumables manufactured by a few countries became even more evident, especially when the pandemic started to impact the supply chain and restrict the flow of goods around the world. All of these issues point to the urgent need for greater international collaboration and unity so the world is better prepared for the next major health emergency. This starts by addressing local health needs and ensuring that there is equal access to immunization and vaccines.

During this event, the first panel will address the funding mechanisms that are needed to accelerate vaccine innovation. The second panel will highlight some of the regional experiences of creating skills for local production and investment in the development and introduction of new vaccines to support immunization programs. They will also express their ideas about how to and address public health emergencies.

Keynote speech: Vaccine for all - Technology, manufacturing immunization uptake

James  Fitzgerald

James Fitzgerald

PAHO/WHO

Director, Health Systems and Services

Session 1: Immunization challenges in Brazil - Technology, manufacturing & access

Ethel Maciel

Ethel Maciel

Brazilian Ministry of Health

Secretary of Health and Environment Surveillance

Hugo G.  da Silva

Hugo G. da Silva

AstraZeneca

Global Head of Vaccines

Júlia  Spinardi

Júlia Spinardi

Pfizer

Medical and Scientific Affairs Senior Director

Cristiano G. Pereira

Cristiano G. Pereira

Butantan Institute

Innovation Tech Licensing Manager

Mauricio Zuma

Mauricio Zuma

Bio-Manguinhos

CEO

Moderated by

Mariangela  Simão

Mariangela Simão

Todos pela Saúde Institute

Executive Director

Coffee break & networking

Session 2: Vaccine manufacturing in developing countries

Carla  Vizzotti

Carla Vizzotti

Argentina

Health Minister

Nicolo Gligo

Nicolo Gligo

Economic Commission for Latin America and the Caribbean (ECLAC)

Economic Affairs Officer

Moderated by

Tiago  Rocca

Tiago Rocca

Developing Countries Vaccine Manufacturers (DCVMN)

Deputy Chair - Board of Members

Lav Agarwal

Lav Agarwal

Government of India

Additional Secretary, Ministry of Health & Family Welfare

Brunch & networking

Keynote speech: Vaccine R&D for emerging and reemerging diseases - Current and next generation technologies

Karin Bok

Karin Bok

National Institute of Allergy and Infectious Diseases (NIAID), Vaccine Research Center

Deputy Director (Acting), Director of Pandemic Preparedness and Emergency Response

Session 3: Vaccine R&D mechanisms for accelerating innovation

William  Hall

William Hall

Wellcome Trust

Head of Global Government Relations

Anand  Ekambaram

Anand Ekambaram

CEPI

Executive Director Manufacturing and Supply Chain Management

Chaired by

Rachel  Chikwamba

Rachel Chikwamba

CSIR

Group Executive: Advanced Chemistry and Life Sciences

Health

Vaccines and immunization: Challenges and perspectives for local manufacturing

Share this session

14 February 2023, 09:00 - 16:15 BRT (Rio de Janeiro)

14 February 2023, 13:00 - 20:15 CET (Brussels)

14 February 2023, 13:00 - 20:15 WAT (Nigeria)

14 February 2023, 14:00 - 21:15 SAST (Cape Town)

14 February 2023, 07:00 - 14:15 EST (New York)

14 February 2023, 21:00 - 04:15 KST (Seoul)

14 February 2023, 20:00 - 03:15 CST (Beijing)

14 February 2023, 17:30 - 00:45 IST (New Delhi)

14 February 2023, 16:00 - 23:15 GST (Dubai)

Room Flamengo & online

The COVID-19 pandemic highlighted the huge inequities in access to vaccines and the gap in the level of immunization between developed and developing countries and especially in the least developed countries. These disparities made global efforts to tackle the pandemic harder. They led to more hospitalizations and deaths, and exacerbated the impacts of long covid. Economies were also unevenly impacted as different countries emerged from the worst of the pandemic at different rates. These consequences were felt far more acutely in the most vulnerable countries.

The pandemic also exposed and exaggerated the imbalance in access to technology and the inequitable terms related to technology transfer agreements. The dependency on critical health goods and consumables manufactured by a few countries became even more evident, especially when the pandemic started to impact the supply chain and restrict the flow of goods around the world. All of these issues point to the urgent need for greater international collaboration and unity so the world is better prepared for the next major health emergency. This starts by addressing local health needs and ensuring that there is equal access to immunization and vaccines.

During this event, the first panel will address the funding mechanisms that are needed to accelerate vaccine innovation. The second panel will highlight some of the regional experiences of creating skills for local production and investment in the development and introduction of new vaccines to support immunization programs. They will also express their ideas about how to and address public health emergencies.

Keynote speech: Vaccine for all - Technology, manufacturing immunization uptake

James  Fitzgerald

James Fitzgerald

PAHO/WHO

Director, Health Systems and Services

Session 1: Immunization challenges in Brazil - Technology, manufacturing & access

Ethel Maciel

Ethel Maciel

Brazilian Ministry of Health

Secretary of Health and Environment Surveillance

Hugo G.  da Silva

Hugo G. da Silva

AstraZeneca

Global Head of Vaccines

Júlia  Spinardi

Júlia Spinardi

Pfizer

Medical and Scientific Affairs Senior Director

Cristiano G. Pereira

Cristiano G. Pereira

Butantan Institute

Innovation Tech Licensing Manager

Mauricio Zuma

Mauricio Zuma

Bio-Manguinhos

CEO

Moderated by

Mariangela  Simão

Mariangela Simão

Todos pela Saúde Institute

Executive Director

Coffee break & networking

Session 2: Vaccine manufacturing in developing countries

Carla  Vizzotti

Carla Vizzotti

Argentina

Health Minister

Nicolo Gligo

Nicolo Gligo

Economic Commission for Latin America and the Caribbean (ECLAC)

Economic Affairs Officer

Moderated by

Tiago  Rocca

Tiago Rocca

Developing Countries Vaccine Manufacturers (DCVMN)

Deputy Chair - Board of Members

Lav Agarwal

Lav Agarwal

Government of India

Additional Secretary, Ministry of Health & Family Welfare

Brunch & networking

Keynote speech: Vaccine R&D for emerging and reemerging diseases - Current and next generation technologies

Karin Bok

Karin Bok

National Institute of Allergy and Infectious Diseases (NIAID), Vaccine Research Center

Deputy Director (Acting), Director of Pandemic Preparedness and Emergency Response

Session 3: Vaccine R&D mechanisms for accelerating innovation

William  Hall

William Hall

Wellcome Trust

Head of Global Government Relations

Anand  Ekambaram

Anand Ekambaram

CEPI

Executive Director Manufacturing and Supply Chain Management

Chaired by

Rachel  Chikwamba

Rachel Chikwamba

CSIR

Group Executive: Advanced Chemistry and Life Sciences

Health

Vaccines and immunization: Challenges and perspectives for local manufacturing

Share this session

14 February 2023, 09:00 - 16:15 BRT (Rio de Janeiro)

14 February 2023, 13:00 - 20:15 CET (Brussels)

14 February 2023, 13:00 - 20:15 WAT (Nigeria)

14 February 2023, 14:00 - 21:15 SAST (Cape Town)

14 February 2023, 07:00 - 14:15 EST (New York)

14 February 2023, 21:00 - 04:15 KST (Seoul)

14 February 2023, 20:00 - 03:15 CST (Beijing)

14 February 2023, 17:30 - 00:45 IST (New Delhi)

14 February 2023, 16:00 - 23:15 GST (Dubai)

Room Flamengo & online

The COVID-19 pandemic highlighted the huge inequities in access to vaccines and the gap in the level of immunization between developed and developing countries and especially in the least developed countries. These disparities made global efforts to tackle the pandemic harder. They led to more hospitalizations and deaths, and exacerbated the impacts of long covid. Economies were also unevenly impacted as different countries emerged from the worst of the pandemic at different rates. These consequences were felt far more acutely in the most vulnerable countries.

The pandemic also exposed and exaggerated the imbalance in access to technology and the inequitable terms related to technology transfer agreements. The dependency on critical health goods and consumables manufactured by a few countries became even more evident, especially when the pandemic started to impact the supply chain and restrict the flow of goods around the world. All of these issues point to the urgent need for greater international collaboration and unity so the world is better prepared for the next major health emergency. This starts by addressing local health needs and ensuring that there is equal access to immunization and vaccines.

During this event, the first panel will address the funding mechanisms that are needed to accelerate vaccine innovation. The second panel will highlight some of the regional experiences of creating skills for local production and investment in the development and introduction of new vaccines to support immunization programs. They will also express their ideas about how to and address public health emergencies.

Keynote speech: Vaccine for all - Technology, manufacturing immunization uptake

James  Fitzgerald

James Fitzgerald

PAHO/WHO

Director, Health Systems and Services

Session 1: Immunization challenges in Brazil - Technology, manufacturing & access

Ethel Maciel

Ethel Maciel

Brazilian Ministry of Health

Secretary of Health and Environment Surveillance

Hugo G.  da Silva

Hugo G. da Silva

AstraZeneca

Global Head of Vaccines

Júlia  Spinardi

Júlia Spinardi

Pfizer

Medical and Scientific Affairs Senior Director

Cristiano G. Pereira

Cristiano G. Pereira

Butantan Institute

Innovation Tech Licensing Manager

Mauricio Zuma

Mauricio Zuma

Bio-Manguinhos

CEO

Moderated by

Mariangela  Simão

Mariangela Simão

Todos pela Saúde Institute

Executive Director

Coffee break & networking

Session 2: Vaccine manufacturing in developing countries

Carla  Vizzotti

Carla Vizzotti

Argentina

Health Minister

Nicolo Gligo

Nicolo Gligo

Economic Commission for Latin America and the Caribbean (ECLAC)

Economic Affairs Officer

Moderated by

Tiago  Rocca

Tiago Rocca

Developing Countries Vaccine Manufacturers (DCVMN)

Deputy Chair - Board of Members

Lav Agarwal

Lav Agarwal

Government of India

Additional Secretary, Ministry of Health & Family Welfare

Brunch & networking

Keynote speech: Vaccine R&D for emerging and reemerging diseases - Current and next generation technologies

Karin Bok

Karin Bok

National Institute of Allergy and Infectious Diseases (NIAID), Vaccine Research Center

Deputy Director (Acting), Director of Pandemic Preparedness and Emergency Response

Session 3: Vaccine R&D mechanisms for accelerating innovation

William  Hall

William Hall

Wellcome Trust

Head of Global Government Relations

Anand  Ekambaram

Anand Ekambaram

CEPI

Executive Director Manufacturing and Supply Chain Management

Chaired by

Rachel  Chikwamba

Rachel Chikwamba

CSIR

Group Executive: Advanced Chemistry and Life Sciences

Health

Vaccines and immunization: Challenges and perspectives for local manufacturing

Share this session

14 February 2023, 09:00 - 16:15 BRT (Rio de Janeiro)

14 February 2023, 13:00 - 20:15 CET (Brussels)

14 February 2023, 13:00 - 20:15 WAT (Nigeria)

14 February 2023, 14:00 - 21:15 SAST (Cape Town)

14 February 2023, 07:00 - 14:15 EST (New York)

14 February 2023, 21:00 - 04:15 KST (Seoul)

14 February 2023, 20:00 - 03:15 CST (Beijing)

14 February 2023, 17:30 - 00:45 IST (New Delhi)

14 February 2023, 16:00 - 23:15 GST (Dubai)

Room Flamengo & online

The COVID-19 pandemic highlighted the huge inequities in access to vaccines and the gap in the level of immunization between developed and developing countries and especially in the least developed countries. These disparities made global efforts to tackle the pandemic harder. They led to more hospitalizations and deaths, and exacerbated the impacts of long covid. Economies were also unevenly impacted as different countries emerged from the worst of the pandemic at different rates. These consequences were felt far more acutely in the most vulnerable countries.

The pandemic also exposed and exaggerated the imbalance in access to technology and the inequitable terms related to technology transfer agreements. The dependency on critical health goods and consumables manufactured by a few countries became even more evident, especially when the pandemic started to impact the supply chain and restrict the flow of goods around the world. All of these issues point to the urgent need for greater international collaboration and unity so the world is better prepared for the next major health emergency. This starts by addressing local health needs and ensuring that there is equal access to immunization and vaccines.

During this event, the first panel will address the funding mechanisms that are needed to accelerate vaccine innovation. The second panel will highlight some of the regional experiences of creating skills for local production and investment in the development and introduction of new vaccines to support immunization programs. They will also express their ideas about how to and address public health emergencies.

Keynote speech: Vaccine for all - Technology, manufacturing immunization uptake

James  Fitzgerald

James Fitzgerald

PAHO/WHO

Director, Health Systems and Services

Session 1: Immunization challenges in Brazil - Technology, manufacturing & access

Ethel Maciel

Ethel Maciel

Brazilian Ministry of Health

Secretary of Health and Environment Surveillance

Hugo G.  da Silva

Hugo G. da Silva

AstraZeneca

Global Head of Vaccines

Júlia  Spinardi

Júlia Spinardi

Pfizer

Medical and Scientific Affairs Senior Director

Cristiano G. Pereira

Cristiano G. Pereira

Butantan Institute

Innovation Tech Licensing Manager

Mauricio Zuma

Mauricio Zuma

Bio-Manguinhos

CEO

Moderated by

Mariangela  Simão

Mariangela Simão

Todos pela Saúde Institute

Executive Director

Coffee break & networking

Session 2: Vaccine manufacturing in developing countries

Carla  Vizzotti

Carla Vizzotti

Argentina

Health Minister

Nicolo Gligo

Nicolo Gligo

Economic Commission for Latin America and the Caribbean (ECLAC)

Economic Affairs Officer

Moderated by

Tiago  Rocca

Tiago Rocca

Developing Countries Vaccine Manufacturers (DCVMN)

Deputy Chair - Board of Members

Lav Agarwal

Lav Agarwal

Government of India

Additional Secretary, Ministry of Health & Family Welfare

Brunch & networking

Keynote speech: Vaccine R&D for emerging and reemerging diseases - Current and next generation technologies

Karin Bok

Karin Bok

National Institute of Allergy and Infectious Diseases (NIAID), Vaccine Research Center

Deputy Director (Acting), Director of Pandemic Preparedness and Emergency Response

Session 3: Vaccine R&D mechanisms for accelerating innovation

William  Hall

William Hall

Wellcome Trust

Head of Global Government Relations

Anand  Ekambaram

Anand Ekambaram

CEPI

Executive Director Manufacturing and Supply Chain Management

Chaired by

Rachel  Chikwamba

Rachel Chikwamba

CSIR

Group Executive: Advanced Chemistry and Life Sciences

Health

Vaccines and immunization: Challenges and perspectives for local manufacturing

Share this session

14 February 2023, 09:00 - 16:15 BRT (Rio de Janeiro)

14 February 2023, 13:00 - 20:15 CET (Brussels)

14 February 2023, 13:00 - 20:15 WAT (Nigeria)

14 February 2023, 14:00 - 21:15 SAST (Cape Town)

14 February 2023, 07:00 - 14:15 EST (New York)

14 February 2023, 21:00 - 04:15 KST (Seoul)

14 February 2023, 20:00 - 03:15 CST (Beijing)

14 February 2023, 17:30 - 00:45 IST (New Delhi)

14 February 2023, 16:00 - 23:15 GST (Dubai)

Room Flamengo & online

The COVID-19 pandemic highlighted the huge inequities in access to vaccines and the gap in the level of immunization between developed and developing countries and especially in the least developed countries. These disparities made global efforts to tackle the pandemic harder. They led to more hospitalizations and deaths, and exacerbated the impacts of long covid. Economies were also unevenly impacted as different countries emerged from the worst of the pandemic at different rates. These consequences were felt far more acutely in the most vulnerable countries.

The pandemic also exposed and exaggerated the imbalance in access to technology and the inequitable terms related to technology transfer agreements. The dependency on critical health goods and consumables manufactured by a few countries became even more evident, especially when the pandemic started to impact the supply chain and restrict the flow of goods around the world. All of these issues point to the urgent need for greater international collaboration and unity so the world is better prepared for the next major health emergency. This starts by addressing local health needs and ensuring that there is equal access to immunization and vaccines.

During this event, the first panel will address the funding mechanisms that are needed to accelerate vaccine innovation. The second panel will highlight some of the regional experiences of creating skills for local production and investment in the development and introduction of new vaccines to support immunization programs. They will also express their ideas about how to and address public health emergencies.

Keynote speech: Vaccine for all - Technology, manufacturing immunization uptake

James  Fitzgerald

James Fitzgerald

PAHO/WHO

Director, Health Systems and Services

Session 1: Immunization challenges in Brazil - Technology, manufacturing & access

Ethel Maciel

Ethel Maciel

Brazilian Ministry of Health

Secretary of Health and Environment Surveillance

Hugo G.  da Silva

Hugo G. da Silva

AstraZeneca

Global Head of Vaccines

Júlia  Spinardi

Júlia Spinardi

Pfizer

Medical and Scientific Affairs Senior Director

Cristiano G. Pereira

Cristiano G. Pereira

Butantan Institute

Innovation Tech Licensing Manager

Mauricio Zuma

Mauricio Zuma

Bio-Manguinhos

CEO

Moderated by

Mariangela  Simão

Mariangela Simão

Todos pela Saúde Institute

Executive Director

Coffee break & networking

Session 2: Vaccine manufacturing in developing countries

Carla  Vizzotti

Carla Vizzotti

Argentina

Health Minister

Nicolo Gligo

Nicolo Gligo

Economic Commission for Latin America and the Caribbean (ECLAC)

Economic Affairs Officer

Moderated by

Tiago  Rocca

Tiago Rocca

Developing Countries Vaccine Manufacturers (DCVMN)

Deputy Chair - Board of Members

Lav Agarwal

Lav Agarwal

Government of India

Additional Secretary, Ministry of Health & Family Welfare

Brunch & networking

Keynote speech: Vaccine R&D for emerging and reemerging diseases - Current and next generation technologies

Karin Bok

Karin Bok

National Institute of Allergy and Infectious Diseases (NIAID), Vaccine Research Center

Deputy Director (Acting), Director of Pandemic Preparedness and Emergency Response

Session 3: Vaccine R&D mechanisms for accelerating innovation

William  Hall

William Hall

Wellcome Trust

Head of Global Government Relations

Anand  Ekambaram

Anand Ekambaram

CEPI

Executive Director Manufacturing and Supply Chain Management

Chaired by

Rachel  Chikwamba

Rachel Chikwamba

CSIR

Group Executive: Advanced Chemistry and Life Sciences

Health

Vaccines and immunization: Challenges and perspectives for local manufacturing

Share this session

14 February 2023, 09:00 - 16:15 BRT (Rio de Janeiro)

14 February 2023, 13:00 - 20:15 CET (Brussels)

14 February 2023, 13:00 - 20:15 WAT (Nigeria)

14 February 2023, 14:00 - 21:15 SAST (Cape Town)

14 February 2023, 07:00 - 14:15 EST (New York)

14 February 2023, 21:00 - 04:15 KST (Seoul)

14 February 2023, 20:00 - 03:15 CST (Beijing)

14 February 2023, 17:30 - 00:45 IST (New Delhi)

14 February 2023, 16:00 - 23:15 GST (Dubai)

Room Flamengo & online

The COVID-19 pandemic highlighted the huge inequities in access to vaccines and the gap in the level of immunization between developed and developing countries and especially in the least developed countries. These disparities made global efforts to tackle the pandemic harder. They led to more hospitalizations and deaths, and exacerbated the impacts of long covid. Economies were also unevenly impacted as different countries emerged from the worst of the pandemic at different rates. These consequences were felt far more acutely in the most vulnerable countries.

The pandemic also exposed and exaggerated the imbalance in access to technology and the inequitable terms related to technology transfer agreements. The dependency on critical health goods and consumables manufactured by a few countries became even more evident, especially when the pandemic started to impact the supply chain and restrict the flow of goods around the world. All of these issues point to the urgent need for greater international collaboration and unity so the world is better prepared for the next major health emergency. This starts by addressing local health needs and ensuring that there is equal access to immunization and vaccines.

During this event, the first panel will address the funding mechanisms that are needed to accelerate vaccine innovation. The second panel will highlight some of the regional experiences of creating skills for local production and investment in the development and introduction of new vaccines to support immunization programs. They will also express their ideas about how to and address public health emergencies.

Keynote speech: Vaccine for all - Technology, manufacturing immunization uptake

James  Fitzgerald

James Fitzgerald

PAHO/WHO

Director, Health Systems and Services

Session 1: Immunization challenges in Brazil - Technology, manufacturing & access

Ethel Maciel

Ethel Maciel

Brazilian Ministry of Health

Secretary of Health and Environment Surveillance

Hugo G.  da Silva

Hugo G. da Silva

AstraZeneca

Global Head of Vaccines

Júlia  Spinardi

Júlia Spinardi

Pfizer

Medical and Scientific Affairs Senior Director

Cristiano G. Pereira

Cristiano G. Pereira

Butantan Institute

Innovation Tech Licensing Manager

Mauricio Zuma

Mauricio Zuma

Bio-Manguinhos

CEO

Moderated by

Mariangela  Simão

Mariangela Simão

Todos pela Saúde Institute

Executive Director

Coffee break & networking

Session 2: Vaccine manufacturing in developing countries

Carla  Vizzotti

Carla Vizzotti

Argentina

Health Minister

Nicolo Gligo

Nicolo Gligo

Economic Commission for Latin America and the Caribbean (ECLAC)

Economic Affairs Officer

Moderated by

Tiago  Rocca

Tiago Rocca

Developing Countries Vaccine Manufacturers (DCVMN)

Deputy Chair - Board of Members

Lav Agarwal

Lav Agarwal

Government of India

Additional Secretary, Ministry of Health & Family Welfare

Brunch & networking

Keynote speech: Vaccine R&D for emerging and reemerging diseases - Current and next generation technologies

Karin Bok

Karin Bok

National Institute of Allergy and Infectious Diseases (NIAID), Vaccine Research Center

Deputy Director (Acting), Director of Pandemic Preparedness and Emergency Response

Session 3: Vaccine R&D mechanisms for accelerating innovation

William  Hall

William Hall

Wellcome Trust

Head of Global Government Relations

Anand  Ekambaram

Anand Ekambaram

CEPI

Executive Director Manufacturing and Supply Chain Management

Chaired by

Rachel  Chikwamba

Rachel Chikwamba

CSIR

Group Executive: Advanced Chemistry and Life Sciences

Health

Vaccines and immunization: Challenges and perspectives for local manufacturing

Share this session

14 February 2023, 09:00 - 16:15 BRT (Rio de Janeiro)

14 February 2023, 13:00 - 20:15 CET (Brussels)

14 February 2023, 13:00 - 20:15 WAT (Nigeria)

14 February 2023, 14:00 - 21:15 SAST (Cape Town)

14 February 2023, 07:00 - 14:15 EST (New York)

14 February 2023, 21:00 - 04:15 KST (Seoul)

14 February 2023, 20:00 - 03:15 CST (Beijing)

14 February 2023, 17:30 - 00:45 IST (New Delhi)

14 February 2023, 16:00 - 23:15 GST (Dubai)

Room Flamengo & online

The COVID-19 pandemic highlighted the huge inequities in access to vaccines and the gap in the level of immunization between developed and developing countries and especially in the least developed countries. These disparities made global efforts to tackle the pandemic harder. They led to more hospitalizations and deaths, and exacerbated the impacts of long covid. Economies were also unevenly impacted as different countries emerged from the worst of the pandemic at different rates. These consequences were felt far more acutely in the most vulnerable countries.

The pandemic also exposed and exaggerated the imbalance in access to technology and the inequitable terms related to technology transfer agreements. The dependency on critical health goods and consumables manufactured by a few countries became even more evident, especially when the pandemic started to impact the supply chain and restrict the flow of goods around the world. All of these issues point to the urgent need for greater international collaboration and unity so the world is better prepared for the next major health emergency. This starts by addressing local health needs and ensuring that there is equal access to immunization and vaccines.

During this event, the first panel will address the funding mechanisms that are needed to accelerate vaccine innovation. The second panel will highlight some of the regional experiences of creating skills for local production and investment in the development and introduction of new vaccines to support immunization programs. They will also express their ideas about how to and address public health emergencies.

Keynote speech: Vaccine for all - Technology, manufacturing immunization uptake

James  Fitzgerald

James Fitzgerald

PAHO/WHO

Director, Health Systems and Services

Session 1: Immunization challenges in Brazil - Technology, manufacturing & access

Ethel Maciel

Ethel Maciel

Brazilian Ministry of Health

Secretary of Health and Environment Surveillance

Hugo G.  da Silva

Hugo G. da Silva

AstraZeneca

Global Head of Vaccines

Júlia  Spinardi

Júlia Spinardi

Pfizer

Medical and Scientific Affairs Senior Director

Cristiano G. Pereira

Cristiano G. Pereira

Butantan Institute

Innovation Tech Licensing Manager

Mauricio Zuma

Mauricio Zuma

Bio-Manguinhos

CEO

Moderated by

Mariangela  Simão

Mariangela Simão

Todos pela Saúde Institute

Executive Director

Coffee break & networking

Session 2: Vaccine manufacturing in developing countries

Carla  Vizzotti

Carla Vizzotti

Argentina

Health Minister

Nicolo Gligo

Nicolo Gligo

Economic Commission for Latin America and the Caribbean (ECLAC)

Economic Affairs Officer

Moderated by

Tiago  Rocca

Tiago Rocca

Developing Countries Vaccine Manufacturers (DCVMN)

Deputy Chair - Board of Members

Lav Agarwal

Lav Agarwal

Government of India

Additional Secretary, Ministry of Health & Family Welfare

Brunch & networking

Keynote speech: Vaccine R&D for emerging and reemerging diseases - Current and next generation technologies

Karin Bok

Karin Bok

National Institute of Allergy and Infectious Diseases (NIAID), Vaccine Research Center

Deputy Director (Acting), Director of Pandemic Preparedness and Emergency Response

Session 3: Vaccine R&D mechanisms for accelerating innovation

William  Hall

William Hall

Wellcome Trust

Head of Global Government Relations

Anand  Ekambaram

Anand Ekambaram

CEPI

Executive Director Manufacturing and Supply Chain Management

Chaired by

Rachel  Chikwamba

Rachel Chikwamba

CSIR

Group Executive: Advanced Chemistry and Life Sciences

Health

Vaccines and immunization: Challenges and perspectives for local manufacturing

Share this session

14 February 2023, 09:00 - 16:15 BRT (Rio de Janeiro)

14 February 2023, 13:00 - 20:15 CET (Brussels)

14 February 2023, 13:00 - 20:15 WAT (Nigeria)

14 February 2023, 14:00 - 21:15 SAST (Cape Town)

14 February 2023, 07:00 - 14:15 EST (New York)

14 February 2023, 21:00 - 04:15 KST (Seoul)

14 February 2023, 20:00 - 03:15 CST (Beijing)

14 February 2023, 17:30 - 00:45 IST (New Delhi)

14 February 2023, 16:00 - 23:15 GST (Dubai)

Room Flamengo & online

The COVID-19 pandemic highlighted the huge inequities in access to vaccines and the gap in the level of immunization between developed and developing countries and especially in the least developed countries. These disparities made global efforts to tackle the pandemic harder. They led to more hospitalizations and deaths, and exacerbated the impacts of long covid. Economies were also unevenly impacted as different countries emerged from the worst of the pandemic at different rates. These consequences were felt far more acutely in the most vulnerable countries.

The pandemic also exposed and exaggerated the imbalance in access to technology and the inequitable terms related to technology transfer agreements. The dependency on critical health goods and consumables manufactured by a few countries became even more evident, especially when the pandemic started to impact the supply chain and restrict the flow of goods around the world. All of these issues point to the urgent need for greater international collaboration and unity so the world is better prepared for the next major health emergency. This starts by addressing local health needs and ensuring that there is equal access to immunization and vaccines.

During this event, the first panel will address the funding mechanisms that are needed to accelerate vaccine innovation. The second panel will highlight some of the regional experiences of creating skills for local production and investment in the development and introduction of new vaccines to support immunization programs. They will also express their ideas about how to and address public health emergencies.

Keynote speech: Vaccine for all - Technology, manufacturing immunization uptake

James  Fitzgerald

James Fitzgerald

PAHO/WHO

Director, Health Systems and Services

Session 1: Immunization challenges in Brazil - Technology, manufacturing & access

Ethel Maciel

Ethel Maciel

Brazilian Ministry of Health

Secretary of Health and Environment Surveillance

Hugo G.  da Silva

Hugo G. da Silva

AstraZeneca

Global Head of Vaccines

Júlia  Spinardi

Júlia Spinardi

Pfizer

Medical and Scientific Affairs Senior Director

Cristiano G. Pereira

Cristiano G. Pereira

Butantan Institute

Innovation Tech Licensing Manager

Mauricio Zuma

Mauricio Zuma

Bio-Manguinhos

CEO

Moderated by

Mariangela  Simão

Mariangela Simão

Todos pela Saúde Institute

Executive Director

Coffee break & networking

Session 2: Vaccine manufacturing in developing countries

Carla  Vizzotti

Carla Vizzotti

Argentina

Health Minister

Nicolo Gligo

Nicolo Gligo

Economic Commission for Latin America and the Caribbean (ECLAC)

Economic Affairs Officer

Moderated by

Tiago  Rocca

Tiago Rocca

Developing Countries Vaccine Manufacturers (DCVMN)

Deputy Chair - Board of Members

Lav Agarwal

Lav Agarwal

Government of India

Additional Secretary, Ministry of Health & Family Welfare

Brunch & networking

Keynote speech: Vaccine R&D for emerging and reemerging diseases - Current and next generation technologies

Karin Bok

Karin Bok

National Institute of Allergy and Infectious Diseases (NIAID), Vaccine Research Center

Deputy Director (Acting), Director of Pandemic Preparedness and Emergency Response

Session 3: Vaccine R&D mechanisms for accelerating innovation

William  Hall

William Hall

Wellcome Trust

Head of Global Government Relations

Anand  Ekambaram

Anand Ekambaram

CEPI

Executive Director Manufacturing and Supply Chain Management

Chaired by

Rachel  Chikwamba

Rachel Chikwamba

CSIR

Group Executive: Advanced Chemistry and Life Sciences

13:30
17:30
17:30
18:30
11:30
01:30
00:30
22:00
20:30
Special session: Alert-early warning system for outbreaks with pandemic potential (AESOP)

Health

×

Health

Special session: Alert-early warning system for outbreaks with pandemic potential (AESOP)

Share this session

14 February 2023, 13:30 - 14:45 BRT (Rio de Janeiro)

14 February 2023, 17:30 - 18:45 CET (Brussels)

14 February 2023, 17:30 - 18:45 WAT (Nigeria)

14 February 2023, 18:30 - 19:45 SAST (Cape Town)

14 February 2023, 11:30 - 12:45 EST (New York)

14 February 2023, 01:30 - 02:45 KST (Seoul)

14 February 2023, 00:30 - 01:45 CST (Beijing)

14 February 2023, 22:00 - 23:15 IST (New Delhi)

14 February 2023, 20:30 - 21:45 GST (Dubai)

Room Estácio & online

The Center for Data and Knowledge Integration for Health (CIDACS) of the Oswaldo Cruz Foundation (Fiocruz) and The Rockefeller Foundation are co-hosting this session to share the co-creation journey and future stages of their joint initiative – the launch of the Alert-Early Warning System for Outbreaks of Pandemic Potential (AESOP) in Brazil.

There are already numerous predictive modeling tools designed to forecast disease emergence and inform public health decision-making. Most of these models rely on a few basic data inputs and are limited in scope and scale. The cutting-edge AESOP tool integrates far more data points and combines infectious disease surveillance data streams and non-health data such as climate change, habitat destruction, and socio-demographics. It is also envisioned that AESOP will become an advanced and predictive modeling tool using AI/machine learning supported by a federated network system research centers, local to national public health entities, and relevant governmental and non-governmental organizations.

There has been significant progress with AESOP since its launch in June 2022. This session will focus on the following:

  • celebrating the Fiocruz-Rockefeller Foundation co-creation journey in the development of AESOP;
  • highlighting the vision for AESOP and its use in early-warning outbreak surveillance and detection;
  • sharing insights into AESOP’s cutting-edge innovation and its development stages;
  • showcasing progress to-date and AESOP’s emerging dashboard and system;
  • exploring AESOP’s potential benefits to the surveillance ecosystem.

Manoel Barral

Manoel Barral

Fiocruz

CIDACs Senior Researcher

Pablo Ivan Pereira Ramos

Pablo Ivan Pereira Ramos

Fiocruz

CIDACs Associate Researcher

Izabel Marcilio

Izabel Marcilio

Fiocruz

CIDACS Epidemiologist

Kay van der Horst

Kay van der Horst

Global Networks & Partnerships

The Rockefeller Foundation Managing Director

Ana Bento

Ana Bento

The Rockefeller Foundation

Director of Science, Pandemic Prevention Institute Health Initiative

Robel Kassa

Robel Kassa

The Rockefeller Foundation

Director of Data Engineering

Health

Special session: Alert-early warning system for outbreaks with pandemic potential (AESOP)

Share this session

14 February 2023, 13:30 - 14:45 BRT (Rio de Janeiro)

14 February 2023, 17:30 - 18:45 CET (Brussels)

14 February 2023, 17:30 - 18:45 WAT (Nigeria)

14 February 2023, 18:30 - 19:45 SAST (Cape Town)

14 February 2023, 11:30 - 12:45 EST (New York)

14 February 2023, 01:30 - 02:45 KST (Seoul)

14 February 2023, 00:30 - 01:45 CST (Beijing)

14 February 2023, 22:00 - 23:15 IST (New Delhi)

14 February 2023, 20:30 - 21:45 GST (Dubai)

Room Estácio & online

The Center for Data and Knowledge Integration for Health (CIDACS) of the Oswaldo Cruz Foundation (Fiocruz) and The Rockefeller Foundation are co-hosting this session to share the co-creation journey and future stages of their joint initiative – the launch of the Alert-Early Warning System for Outbreaks of Pandemic Potential (AESOP) in Brazil.

There are already numerous predictive modeling tools designed to forecast disease emergence and inform public health decision-making. Most of these models rely on a few basic data inputs and are limited in scope and scale. The cutting-edge AESOP tool integrates far more data points and combines infectious disease surveillance data streams and non-health data such as climate change, habitat destruction, and socio-demographics. It is also envisioned that AESOP will become an advanced and predictive modeling tool using AI/machine learning supported by a federated network system research centers, local to national public health entities, and relevant governmental and non-governmental organizations.

There has been significant progress with AESOP since its launch in June 2022. This session will focus on the following:

  • celebrating the Fiocruz-Rockefeller Foundation co-creation journey in the development of AESOP;
  • highlighting the vision for AESOP and its use in early-warning outbreak surveillance and detection;
  • sharing insights into AESOP’s cutting-edge innovation and its development stages;
  • showcasing progress to-date and AESOP’s emerging dashboard and system;
  • exploring AESOP’s potential benefits to the surveillance ecosystem.

Manoel Barral

Manoel Barral

Fiocruz

CIDACs Senior Researcher

Pablo Ivan Pereira Ramos

Pablo Ivan Pereira Ramos

Fiocruz

CIDACs Associate Researcher

Izabel Marcilio

Izabel Marcilio

Fiocruz

CIDACS Epidemiologist

Kay van der Horst

Kay van der Horst

Global Networks & Partnerships

The Rockefeller Foundation Managing Director

Ana Bento

Ana Bento

The Rockefeller Foundation

Director of Science, Pandemic Prevention Institute Health Initiative

Robel Kassa

Robel Kassa

The Rockefeller Foundation

Director of Data Engineering

Health

Special session: Alert-early warning system for outbreaks with pandemic potential (AESOP)

Share this session

14 February 2023, 13:30 - 14:45 BRT (Rio de Janeiro)

14 February 2023, 17:30 - 18:45 CET (Brussels)

14 February 2023, 17:30 - 18:45 WAT (Nigeria)

14 February 2023, 18:30 - 19:45 SAST (Cape Town)

14 February 2023, 11:30 - 12:45 EST (New York)

14 February 2023, 01:30 - 02:45 KST (Seoul)

14 February 2023, 00:30 - 01:45 CST (Beijing)

14 February 2023, 22:00 - 23:15 IST (New Delhi)

14 February 2023, 20:30 - 21:45 GST (Dubai)

Room Estácio & online

The Center for Data and Knowledge Integration for Health (CIDACS) of the Oswaldo Cruz Foundation (Fiocruz) and The Rockefeller Foundation are co-hosting this session to share the co-creation journey and future stages of their joint initiative – the launch of the Alert-Early Warning System for Outbreaks of Pandemic Potential (AESOP) in Brazil.

There are already numerous predictive modeling tools designed to forecast disease emergence and inform public health decision-making. Most of these models rely on a few basic data inputs and are limited in scope and scale. The cutting-edge AESOP tool integrates far more data points and combines infectious disease surveillance data streams and non-health data such as climate change, habitat destruction, and socio-demographics. It is also envisioned that AESOP will become an advanced and predictive modeling tool using AI/machine learning supported by a federated network system research centers, local to national public health entities, and relevant governmental and non-governmental organizations.

There has been significant progress with AESOP since its launch in June 2022. This session will focus on the following:

  • celebrating the Fiocruz-Rockefeller Foundation co-creation journey in the development of AESOP;
  • highlighting the vision for AESOP and its use in early-warning outbreak surveillance and detection;
  • sharing insights into AESOP’s cutting-edge innovation and its development stages;
  • showcasing progress to-date and AESOP’s emerging dashboard and system;
  • exploring AESOP’s potential benefits to the surveillance ecosystem.

Manoel Barral

Manoel Barral

Fiocruz

CIDACs Senior Researcher

Pablo Ivan Pereira Ramos

Pablo Ivan Pereira Ramos

Fiocruz

CIDACs Associate Researcher

Izabel Marcilio

Izabel Marcilio

Fiocruz

CIDACS Epidemiologist

Kay van der Horst

Kay van der Horst

Global Networks & Partnerships

The Rockefeller Foundation Managing Director

Ana Bento

Ana Bento

The Rockefeller Foundation

Director of Science, Pandemic Prevention Institute Health Initiative

Robel Kassa

Robel Kassa

The Rockefeller Foundation

Director of Data Engineering

Health

Special session: Alert-early warning system for outbreaks with pandemic potential (AESOP)

Share this session

14 February 2023, 13:30 - 14:45 BRT (Rio de Janeiro)

14 February 2023, 17:30 - 18:45 CET (Brussels)

14 February 2023, 17:30 - 18:45 WAT (Nigeria)

14 February 2023, 18:30 - 19:45 SAST (Cape Town)

14 February 2023, 11:30 - 12:45 EST (New York)

14 February 2023, 01:30 - 02:45 KST (Seoul)

14 February 2023, 00:30 - 01:45 CST (Beijing)

14 February 2023, 22:00 - 23:15 IST (New Delhi)

14 February 2023, 20:30 - 21:45 GST (Dubai)

Room Estácio & online

The Center for Data and Knowledge Integration for Health (CIDACS) of the Oswaldo Cruz Foundation (Fiocruz) and The Rockefeller Foundation are co-hosting this session to share the co-creation journey and future stages of their joint initiative – the launch of the Alert-Early Warning System for Outbreaks of Pandemic Potential (AESOP) in Brazil.

There are already numerous predictive modeling tools designed to forecast disease emergence and inform public health decision-making. Most of these models rely on a few basic data inputs and are limited in scope and scale. The cutting-edge AESOP tool integrates far more data points and combines infectious disease surveillance data streams and non-health data such as climate change, habitat destruction, and socio-demographics. It is also envisioned that AESOP will become an advanced and predictive modeling tool using AI/machine learning supported by a federated network system research centers, local to national public health entities, and relevant governmental and non-governmental organizations.

There has been significant progress with AESOP since its launch in June 2022. This session will focus on the following:

  • celebrating the Fiocruz-Rockefeller Foundation co-creation journey in the development of AESOP;
  • highlighting the vision for AESOP and its use in early-warning outbreak surveillance and detection;
  • sharing insights into AESOP’s cutting-edge innovation and its development stages;
  • showcasing progress to-date and AESOP’s emerging dashboard and system;
  • exploring AESOP’s potential benefits to the surveillance ecosystem.

Manoel Barral

Manoel Barral

Fiocruz

CIDACs Senior Researcher

Pablo Ivan Pereira Ramos

Pablo Ivan Pereira Ramos

Fiocruz

CIDACs Associate Researcher

Izabel Marcilio

Izabel Marcilio

Fiocruz

CIDACS Epidemiologist

Kay van der Horst

Kay van der Horst

Global Networks & Partnerships

The Rockefeller Foundation Managing Director

Ana Bento

Ana Bento

The Rockefeller Foundation

Director of Science, Pandemic Prevention Institute Health Initiative

Robel Kassa

Robel Kassa

The Rockefeller Foundation

Director of Data Engineering

Health

Special session: Alert-early warning system for outbreaks with pandemic potential (AESOP)

Share this session

14 February 2023, 13:30 - 14:45 BRT (Rio de Janeiro)

14 February 2023, 17:30 - 18:45 CET (Brussels)

14 February 2023, 17:30 - 18:45 WAT (Nigeria)

14 February 2023, 18:30 - 19:45 SAST (Cape Town)

14 February 2023, 11:30 - 12:45 EST (New York)

14 February 2023, 01:30 - 02:45 KST (Seoul)

14 February 2023, 00:30 - 01:45 CST (Beijing)

14 February 2023, 22:00 - 23:15 IST (New Delhi)

14 February 2023, 20:30 - 21:45 GST (Dubai)

Room Estácio & online

The Center for Data and Knowledge Integration for Health (CIDACS) of the Oswaldo Cruz Foundation (Fiocruz) and The Rockefeller Foundation are co-hosting this session to share the co-creation journey and future stages of their joint initiative – the launch of the Alert-Early Warning System for Outbreaks of Pandemic Potential (AESOP) in Brazil.

There are already numerous predictive modeling tools designed to forecast disease emergence and inform public health decision-making. Most of these models rely on a few basic data inputs and are limited in scope and scale. The cutting-edge AESOP tool integrates far more data points and combines infectious disease surveillance data streams and non-health data such as climate change, habitat destruction, and socio-demographics. It is also envisioned that AESOP will become an advanced and predictive modeling tool using AI/machine learning supported by a federated network system research centers, local to national public health entities, and relevant governmental and non-governmental organizations.

There has been significant progress with AESOP since its launch in June 2022. This session will focus on the following:

  • celebrating the Fiocruz-Rockefeller Foundation co-creation journey in the development of AESOP;
  • highlighting the vision for AESOP and its use in early-warning outbreak surveillance and detection;
  • sharing insights into AESOP’s cutting-edge innovation and its development stages;
  • showcasing progress to-date and AESOP’s emerging dashboard and system;
  • exploring AESOP’s potential benefits to the surveillance ecosystem.

Manoel Barral

Manoel Barral

Fiocruz

CIDACs Senior Researcher

Pablo Ivan Pereira Ramos

Pablo Ivan Pereira Ramos

Fiocruz

CIDACs Associate Researcher

Izabel Marcilio

Izabel Marcilio

Fiocruz

CIDACS Epidemiologist

Kay van der Horst

Kay van der Horst

Global Networks & Partnerships

The Rockefeller Foundation Managing Director

Ana Bento

Ana Bento

The Rockefeller Foundation

Director of Science, Pandemic Prevention Institute Health Initiative

Robel Kassa

Robel Kassa

The Rockefeller Foundation

Director of Data Engineering

Health

Special session: Alert-early warning system for outbreaks with pandemic potential (AESOP)

Share this session

14 February 2023, 13:30 - 14:45 BRT (Rio de Janeiro)

14 February 2023, 17:30 - 18:45 CET (Brussels)

14 February 2023, 17:30 - 18:45 WAT (Nigeria)

14 February 2023, 18:30 - 19:45 SAST (Cape Town)

14 February 2023, 11:30 - 12:45 EST (New York)

14 February 2023, 01:30 - 02:45 KST (Seoul)

14 February 2023, 00:30 - 01:45 CST (Beijing)

14 February 2023, 22:00 - 23:15 IST (New Delhi)

14 February 2023, 20:30 - 21:45 GST (Dubai)

Room Estácio & online

The Center for Data and Knowledge Integration for Health (CIDACS) of the Oswaldo Cruz Foundation (Fiocruz) and The Rockefeller Foundation are co-hosting this session to share the co-creation journey and future stages of their joint initiative – the launch of the Alert-Early Warning System for Outbreaks of Pandemic Potential (AESOP) in Brazil.

There are already numerous predictive modeling tools designed to forecast disease emergence and inform public health decision-making. Most of these models rely on a few basic data inputs and are limited in scope and scale. The cutting-edge AESOP tool integrates far more data points and combines infectious disease surveillance data streams and non-health data such as climate change, habitat destruction, and socio-demographics. It is also envisioned that AESOP will become an advanced and predictive modeling tool using AI/machine learning supported by a federated network system research centers, local to national public health entities, and relevant governmental and non-governmental organizations.

There has been significant progress with AESOP since its launch in June 2022. This session will focus on the following:

  • celebrating the Fiocruz-Rockefeller Foundation co-creation journey in the development of AESOP;
  • highlighting the vision for AESOP and its use in early-warning outbreak surveillance and detection;
  • sharing insights into AESOP’s cutting-edge innovation and its development stages;
  • showcasing progress to-date and AESOP’s emerging dashboard and system;
  • exploring AESOP’s potential benefits to the surveillance ecosystem.

Manoel Barral

Manoel Barral

Fiocruz

CIDACs Senior Researcher

Pablo Ivan Pereira Ramos

Pablo Ivan Pereira Ramos

Fiocruz

CIDACs Associate Researcher

Izabel Marcilio

Izabel Marcilio

Fiocruz

CIDACS Epidemiologist

Kay van der Horst

Kay van der Horst

Global Networks & Partnerships

The Rockefeller Foundation Managing Director

Ana Bento

Ana Bento

The Rockefeller Foundation

Director of Science, Pandemic Prevention Institute Health Initiative

Robel Kassa

Robel Kassa

The Rockefeller Foundation

Director of Data Engineering

Health

Special session: Alert-early warning system for outbreaks with pandemic potential (AESOP)

Share this session

14 February 2023, 13:30 - 14:45 BRT (Rio de Janeiro)

14 February 2023, 17:30 - 18:45 CET (Brussels)

14 February 2023, 17:30 - 18:45 WAT (Nigeria)

14 February 2023, 18:30 - 19:45 SAST (Cape Town)

14 February 2023, 11:30 - 12:45 EST (New York)

14 February 2023, 01:30 - 02:45 KST (Seoul)

14 February 2023, 00:30 - 01:45 CST (Beijing)

14 February 2023, 22:00 - 23:15 IST (New Delhi)

14 February 2023, 20:30 - 21:45 GST (Dubai)

Room Estácio & online

The Center for Data and Knowledge Integration for Health (CIDACS) of the Oswaldo Cruz Foundation (Fiocruz) and The Rockefeller Foundation are co-hosting this session to share the co-creation journey and future stages of their joint initiative – the launch of the Alert-Early Warning System for Outbreaks of Pandemic Potential (AESOP) in Brazil.

There are already numerous predictive modeling tools designed to forecast disease emergence and inform public health decision-making. Most of these models rely on a few basic data inputs and are limited in scope and scale. The cutting-edge AESOP tool integrates far more data points and combines infectious disease surveillance data streams and non-health data such as climate change, habitat destruction, and socio-demographics. It is also envisioned that AESOP will become an advanced and predictive modeling tool using AI/machine learning supported by a federated network system research centers, local to national public health entities, and relevant governmental and non-governmental organizations.

There has been significant progress with AESOP since its launch in June 2022. This session will focus on the following:

  • celebrating the Fiocruz-Rockefeller Foundation co-creation journey in the development of AESOP;
  • highlighting the vision for AESOP and its use in early-warning outbreak surveillance and detection;
  • sharing insights into AESOP’s cutting-edge innovation and its development stages;
  • showcasing progress to-date and AESOP’s emerging dashboard and system;
  • exploring AESOP’s potential benefits to the surveillance ecosystem.

Manoel Barral

Manoel Barral

Fiocruz

CIDACs Senior Researcher

Pablo Ivan Pereira Ramos

Pablo Ivan Pereira Ramos

Fiocruz

CIDACs Associate Researcher

Izabel Marcilio

Izabel Marcilio

Fiocruz

CIDACS Epidemiologist

Kay van der Horst

Kay van der Horst

Global Networks & Partnerships

The Rockefeller Foundation Managing Director

Ana Bento

Ana Bento

The Rockefeller Foundation

Director of Science, Pandemic Prevention Institute Health Initiative

Robel Kassa

Robel Kassa

The Rockefeller Foundation

Director of Data Engineering

Health

Special session: Alert-early warning system for outbreaks with pandemic potential (AESOP)

Share this session

14 February 2023, 13:30 - 14:45 BRT (Rio de Janeiro)

14 February 2023, 17:30 - 18:45 CET (Brussels)

14 February 2023, 17:30 - 18:45 WAT (Nigeria)

14 February 2023, 18:30 - 19:45 SAST (Cape Town)

14 February 2023, 11:30 - 12:45 EST (New York)

14 February 2023, 01:30 - 02:45 KST (Seoul)

14 February 2023, 00:30 - 01:45 CST (Beijing)

14 February 2023, 22:00 - 23:15 IST (New Delhi)

14 February 2023, 20:30 - 21:45 GST (Dubai)

Room Estácio & online

The Center for Data and Knowledge Integration for Health (CIDACS) of the Oswaldo Cruz Foundation (Fiocruz) and The Rockefeller Foundation are co-hosting this session to share the co-creation journey and future stages of their joint initiative – the launch of the Alert-Early Warning System for Outbreaks of Pandemic Potential (AESOP) in Brazil.

There are already numerous predictive modeling tools designed to forecast disease emergence and inform public health decision-making. Most of these models rely on a few basic data inputs and are limited in scope and scale. The cutting-edge AESOP tool integrates far more data points and combines infectious disease surveillance data streams and non-health data such as climate change, habitat destruction, and socio-demographics. It is also envisioned that AESOP will become an advanced and predictive modeling tool using AI/machine learning supported by a federated network system research centers, local to national public health entities, and relevant governmental and non-governmental organizations.

There has been significant progress with AESOP since its launch in June 2022. This session will focus on the following:

  • celebrating the Fiocruz-Rockefeller Foundation co-creation journey in the development of AESOP;
  • highlighting the vision for AESOP and its use in early-warning outbreak surveillance and detection;
  • sharing insights into AESOP’s cutting-edge innovation and its development stages;
  • showcasing progress to-date and AESOP’s emerging dashboard and system;
  • exploring AESOP’s potential benefits to the surveillance ecosystem.

Manoel Barral

Manoel Barral

Fiocruz

CIDACs Senior Researcher

Pablo Ivan Pereira Ramos

Pablo Ivan Pereira Ramos

Fiocruz

CIDACs Associate Researcher

Izabel Marcilio

Izabel Marcilio

Fiocruz

CIDACS Epidemiologist

Kay van der Horst

Kay van der Horst

Global Networks & Partnerships

The Rockefeller Foundation Managing Director

Ana Bento

Ana Bento

The Rockefeller Foundation

Director of Science, Pandemic Prevention Institute Health Initiative

Robel Kassa

Robel Kassa

The Rockefeller Foundation

Director of Data Engineering

Health

Special session: Alert-early warning system for outbreaks with pandemic potential (AESOP)

Share this session

14 February 2023, 13:30 - 14:45 BRT (Rio de Janeiro)

14 February 2023, 17:30 - 18:45 CET (Brussels)

14 February 2023, 17:30 - 18:45 WAT (Nigeria)

14 February 2023, 18:30 - 19:45 SAST (Cape Town)

14 February 2023, 11:30 - 12:45 EST (New York)

14 February 2023, 01:30 - 02:45 KST (Seoul)

14 February 2023, 00:30 - 01:45 CST (Beijing)

14 February 2023, 22:00 - 23:15 IST (New Delhi)

14 February 2023, 20:30 - 21:45 GST (Dubai)

Room Estácio & online

The Center for Data and Knowledge Integration for Health (CIDACS) of the Oswaldo Cruz Foundation (Fiocruz) and The Rockefeller Foundation are co-hosting this session to share the co-creation journey and future stages of their joint initiative – the launch of the Alert-Early Warning System for Outbreaks of Pandemic Potential (AESOP) in Brazil.

There are already numerous predictive modeling tools designed to forecast disease emergence and inform public health decision-making. Most of these models rely on a few basic data inputs and are limited in scope and scale. The cutting-edge AESOP tool integrates far more data points and combines infectious disease surveillance data streams and non-health data such as climate change, habitat destruction, and socio-demographics. It is also envisioned that AESOP will become an advanced and predictive modeling tool using AI/machine learning supported by a federated network system research centers, local to national public health entities, and relevant governmental and non-governmental organizations.

There has been significant progress with AESOP since its launch in June 2022. This session will focus on the following:

  • celebrating the Fiocruz-Rockefeller Foundation co-creation journey in the development of AESOP;
  • highlighting the vision for AESOP and its use in early-warning outbreak surveillance and detection;
  • sharing insights into AESOP’s cutting-edge innovation and its development stages;
  • showcasing progress to-date and AESOP’s emerging dashboard and system;
  • exploring AESOP’s potential benefits to the surveillance ecosystem.

Manoel Barral

Manoel Barral

Fiocruz

CIDACs Senior Researcher

Pablo Ivan Pereira Ramos

Pablo Ivan Pereira Ramos

Fiocruz

CIDACs Associate Researcher

Izabel Marcilio

Izabel Marcilio

Fiocruz

CIDACS Epidemiologist

Kay van der Horst

Kay van der Horst

Global Networks & Partnerships

The Rockefeller Foundation Managing Director

Ana Bento

Ana Bento

The Rockefeller Foundation

Director of Science, Pandemic Prevention Institute Health Initiative

Robel Kassa

Robel Kassa

The Rockefeller Foundation

Director of Data Engineering

15:00
19:00
19:00
20:00
13:00
03:00
02:00
23:30
22:00
Deep dive session: Preparedness and response to health emergencies – The role of cities

Health

×

Health

Deep dive session: Preparedness and response to health emergencies – The role of cities

Share this session

14 February 2023, 15:00 - 16:15 BRT (Rio de Janeiro)

14 February 2023, 19:00 - 20:15 CET (Brussels)

14 February 2023, 19:00 - 20:15 WAT (Nigeria)

14 February 2023, 20:00 - 21:15 SAST (Cape Town)

14 February 2023, 13:00 - 14:15 EST (New York)

14 February 2023, 03:00 - 04:15 KST (Seoul)

14 February 2023, 02:00 - 03:15 CST (Beijing)

14 February 2023, 23:30 - 00:45 IST (New Delhi)

14 February 2023, 22:00 - 23:15 GST (Dubai)

Room Estácio & online

History has shown that a variety of hazards can affect health and well-being. These include natural disasters, chemical, radiological, physical, and biological hazards such as epidemics, pandemics, emerging infectious diseases (EIDs) and bioterrorism. Environmental hazards, particularly those exacerbated by the climate emergency, are also on the rise. The huge cost of these hazards and health emergencies on people and economies illustrate why preparedness to face such threats at all levels (local, regional, national, and international) is so vital.

Urban areas have unique vulnerabilities that make them more prone to the impacts of health emergencies. This is a concern as more than 50% of the world’s population live in urban areas, and scientists calculate that this will increase to 70% by 2050. This means that preparedness for health emergencies in cities is especially important.

During this session the speakers will explore the capacities that make local actors essential in mitigating health hazards. They will also debate what constitutes preparedness and the role different stakeholders can play in this process.

Roberto Lucchini

Roberto Lucchini (TBC)

Florida International University

Professor of Environmental Health Sciences

Daniel Buss

Daniel Buss

Pan American Health Organization (PAHO)

Unit Chief Climate Change and Environmental Determinants of Health (CDE-CE)

Elizabet Diago

Elizabet Diago

ISGlobal

Preparedness Program Manager

Hafeez  Rehman

Hafeez Rehman

VITO Arabia Science and Technology LLC

CEO

Elis Borde

Elis Borde

Federal University of Minas Gerais

Professor

Moderated by

Clara Marín

Clara Marín

ISGlobal

Policy Program Officer

Health

Deep dive session: Preparedness and response to health emergencies – The role of cities

Share this session

14 February 2023, 15:00 - 16:15 BRT (Rio de Janeiro)

14 February 2023, 19:00 - 20:15 CET (Brussels)

14 February 2023, 19:00 - 20:15 WAT (Nigeria)

14 February 2023, 20:00 - 21:15 SAST (Cape Town)

14 February 2023, 13:00 - 14:15 EST (New York)

14 February 2023, 03:00 - 04:15 KST (Seoul)

14 February 2023, 02:00 - 03:15 CST (Beijing)

14 February 2023, 23:30 - 00:45 IST (New Delhi)

14 February 2023, 22:00 - 23:15 GST (Dubai)

Room Estácio & online

History has shown that a variety of hazards can affect health and well-being. These include natural disasters, chemical, radiological, physical, and biological hazards such as epidemics, pandemics, emerging infectious diseases (EIDs) and bioterrorism. Environmental hazards, particularly those exacerbated by the climate emergency, are also on the rise. The huge cost of these hazards and health emergencies on people and economies illustrate why preparedness to face such threats at all levels (local, regional, national, and international) is so vital.

Urban areas have unique vulnerabilities that make them more prone to the impacts of health emergencies. This is a concern as more than 50% of the world’s population live in urban areas, and scientists calculate that this will increase to 70% by 2050. This means that preparedness for health emergencies in cities is especially important.

During this session the speakers will explore the capacities that make local actors essential in mitigating health hazards. They will also debate what constitutes preparedness and the role different stakeholders can play in this process.

Roberto Lucchini

Roberto Lucchini (TBC)

Florida International University

Professor of Environmental Health Sciences

Daniel Buss

Daniel Buss

Pan American Health Organization (PAHO)

Unit Chief Climate Change and Environmental Determinants of Health (CDE-CE)

Elizabet Diago

Elizabet Diago

ISGlobal

Preparedness Program Manager

Hafeez  Rehman

Hafeez Rehman

VITO Arabia Science and Technology LLC

CEO

Elis Borde

Elis Borde

Federal University of Minas Gerais

Professor

Moderated by

Clara Marín

Clara Marín

ISGlobal

Policy Program Officer

Health

Deep dive session: Preparedness and response to health emergencies – The role of cities

Share this session

14 February 2023, 15:00 - 16:15 BRT (Rio de Janeiro)

14 February 2023, 19:00 - 20:15 CET (Brussels)

14 February 2023, 19:00 - 20:15 WAT (Nigeria)

14 February 2023, 20:00 - 21:15 SAST (Cape Town)

14 February 2023, 13:00 - 14:15 EST (New York)

14 February 2023, 03:00 - 04:15 KST (Seoul)

14 February 2023, 02:00 - 03:15 CST (Beijing)

14 February 2023, 23:30 - 00:45 IST (New Delhi)

14 February 2023, 22:00 - 23:15 GST (Dubai)

Room Estácio & online

History has shown that a variety of hazards can affect health and well-being. These include natural disasters, chemical, radiological, physical, and biological hazards such as epidemics, pandemics, emerging infectious diseases (EIDs) and bioterrorism. Environmental hazards, particularly those exacerbated by the climate emergency, are also on the rise. The huge cost of these hazards and health emergencies on people and economies illustrate why preparedness to face such threats at all levels (local, regional, national, and international) is so vital.

Urban areas have unique vulnerabilities that make them more prone to the impacts of health emergencies. This is a concern as more than 50% of the world’s population live in urban areas, and scientists calculate that this will increase to 70% by 2050. This means that preparedness for health emergencies in cities is especially important.

During this session the speakers will explore the capacities that make local actors essential in mitigating health hazards. They will also debate what constitutes preparedness and the role different stakeholders can play in this process.

Roberto Lucchini

Roberto Lucchini (TBC)

Florida International University

Professor of Environmental Health Sciences

Daniel Buss

Daniel Buss

Pan American Health Organization (PAHO)

Unit Chief Climate Change and Environmental Determinants of Health (CDE-CE)

Elizabet Diago

Elizabet Diago

ISGlobal

Preparedness Program Manager

Hafeez  Rehman

Hafeez Rehman

VITO Arabia Science and Technology LLC

CEO

Elis Borde

Elis Borde

Federal University of Minas Gerais

Professor

Moderated by

Clara Marín

Clara Marín

ISGlobal

Policy Program Officer

Health

Deep dive session: Preparedness and response to health emergencies – The role of cities

Share this session

14 February 2023, 15:00 - 16:15 BRT (Rio de Janeiro)

14 February 2023, 19:00 - 20:15 CET (Brussels)

14 February 2023, 19:00 - 20:15 WAT (Nigeria)

14 February 2023, 20:00 - 21:15 SAST (Cape Town)

14 February 2023, 13:00 - 14:15 EST (New York)

14 February 2023, 03:00 - 04:15 KST (Seoul)

14 February 2023, 02:00 - 03:15 CST (Beijing)

14 February 2023, 23:30 - 00:45 IST (New Delhi)

14 February 2023, 22:00 - 23:15 GST (Dubai)

Room Estácio & online

History has shown that a variety of hazards can affect health and well-being. These include natural disasters, chemical, radiological, physical, and biological hazards such as epidemics, pandemics, emerging infectious diseases (EIDs) and bioterrorism. Environmental hazards, particularly those exacerbated by the climate emergency, are also on the rise. The huge cost of these hazards and health emergencies on people and economies illustrate why preparedness to face such threats at all levels (local, regional, national, and international) is so vital.

Urban areas have unique vulnerabilities that make them more prone to the impacts of health emergencies. This is a concern as more than 50% of the world’s population live in urban areas, and scientists calculate that this will increase to 70% by 2050. This means that preparedness for health emergencies in cities is especially important.

During this session the speakers will explore the capacities that make local actors essential in mitigating health hazards. They will also debate what constitutes preparedness and the role different stakeholders can play in this process.

Roberto Lucchini

Roberto Lucchini (TBC)

Florida International University

Professor of Environmental Health Sciences

Daniel Buss

Daniel Buss

Pan American Health Organization (PAHO)

Unit Chief Climate Change and Environmental Determinants of Health (CDE-CE)

Elizabet Diago

Elizabet Diago

ISGlobal

Preparedness Program Manager

Hafeez  Rehman

Hafeez Rehman

VITO Arabia Science and Technology LLC

CEO

Elis Borde

Elis Borde

Federal University of Minas Gerais

Professor

Moderated by

Clara Marín

Clara Marín

ISGlobal

Policy Program Officer

Health

Deep dive session: Preparedness and response to health emergencies – The role of cities

Share this session

14 February 2023, 15:00 - 16:15 BRT (Rio de Janeiro)

14 February 2023, 19:00 - 20:15 CET (Brussels)

14 February 2023, 19:00 - 20:15 WAT (Nigeria)

14 February 2023, 20:00 - 21:15 SAST (Cape Town)

14 February 2023, 13:00 - 14:15 EST (New York)

14 February 2023, 03:00 - 04:15 KST (Seoul)

14 February 2023, 02:00 - 03:15 CST (Beijing)

14 February 2023, 23:30 - 00:45 IST (New Delhi)

14 February 2023, 22:00 - 23:15 GST (Dubai)

Room Estácio & online

History has shown that a variety of hazards can affect health and well-being. These include natural disasters, chemical, radiological, physical, and biological hazards such as epidemics, pandemics, emerging infectious diseases (EIDs) and bioterrorism. Environmental hazards, particularly those exacerbated by the climate emergency, are also on the rise. The huge cost of these hazards and health emergencies on people and economies illustrate why preparedness to face such threats at all levels (local, regional, national, and international) is so vital.

Urban areas have unique vulnerabilities that make them more prone to the impacts of health emergencies. This is a concern as more than 50% of the world’s population live in urban areas, and scientists calculate that this will increase to 70% by 2050. This means that preparedness for health emergencies in cities is especially important.

During this session the speakers will explore the capacities that make local actors essential in mitigating health hazards. They will also debate what constitutes preparedness and the role different stakeholders can play in this process.

Roberto Lucchini

Roberto Lucchini (TBC)

Florida International University

Professor of Environmental Health Sciences

Daniel Buss

Daniel Buss

Pan American Health Organization (PAHO)

Unit Chief Climate Change and Environmental Determinants of Health (CDE-CE)

Elizabet Diago

Elizabet Diago

ISGlobal

Preparedness Program Manager

Hafeez  Rehman

Hafeez Rehman

VITO Arabia Science and Technology LLC

CEO

Elis Borde

Elis Borde

Federal University of Minas Gerais

Professor

Moderated by

Clara Marín

Clara Marín

ISGlobal

Policy Program Officer

Health

Deep dive session: Preparedness and response to health emergencies – The role of cities

Share this session

14 February 2023, 15:00 - 16:15 BRT (Rio de Janeiro)

14 February 2023, 19:00 - 20:15 CET (Brussels)

14 February 2023, 19:00 - 20:15 WAT (Nigeria)

14 February 2023, 20:00 - 21:15 SAST (Cape Town)

14 February 2023, 13:00 - 14:15 EST (New York)

14 February 2023, 03:00 - 04:15 KST (Seoul)

14 February 2023, 02:00 - 03:15 CST (Beijing)

14 February 2023, 23:30 - 00:45 IST (New Delhi)

14 February 2023, 22:00 - 23:15 GST (Dubai)

Room Estácio & online

History has shown that a variety of hazards can affect health and well-being. These include natural disasters, chemical, radiological, physical, and biological hazards such as epidemics, pandemics, emerging infectious diseases (EIDs) and bioterrorism. Environmental hazards, particularly those exacerbated by the climate emergency, are also on the rise. The huge cost of these hazards and health emergencies on people and economies illustrate why preparedness to face such threats at all levels (local, regional, national, and international) is so vital.

Urban areas have unique vulnerabilities that make them more prone to the impacts of health emergencies. This is a concern as more than 50% of the world’s population live in urban areas, and scientists calculate that this will increase to 70% by 2050. This means that preparedness for health emergencies in cities is especially important.

During this session the speakers will explore the capacities that make local actors essential in mitigating health hazards. They will also debate what constitutes preparedness and the role different stakeholders can play in this process.

Roberto Lucchini

Roberto Lucchini (TBC)

Florida International University

Professor of Environmental Health Sciences

Daniel Buss

Daniel Buss

Pan American Health Organization (PAHO)

Unit Chief Climate Change and Environmental Determinants of Health (CDE-CE)

Elizabet Diago

Elizabet Diago

ISGlobal

Preparedness Program Manager

Hafeez  Rehman

Hafeez Rehman

VITO Arabia Science and Technology LLC

CEO

Elis Borde

Elis Borde

Federal University of Minas Gerais

Professor

Moderated by

Clara Marín

Clara Marín

ISGlobal

Policy Program Officer

Health

Deep dive session: Preparedness and response to health emergencies – The role of cities

Share this session

14 February 2023, 15:00 - 16:15 BRT (Rio de Janeiro)

14 February 2023, 19:00 - 20:15 CET (Brussels)

14 February 2023, 19:00 - 20:15 WAT (Nigeria)

14 February 2023, 20:00 - 21:15 SAST (Cape Town)

14 February 2023, 13:00 - 14:15 EST (New York)

14 February 2023, 03:00 - 04:15 KST (Seoul)

14 February 2023, 02:00 - 03:15 CST (Beijing)

14 February 2023, 23:30 - 00:45 IST (New Delhi)

14 February 2023, 22:00 - 23:15 GST (Dubai)

Room Estácio & online

History has shown that a variety of hazards can affect health and well-being. These include natural disasters, chemical, radiological, physical, and biological hazards such as epidemics, pandemics, emerging infectious diseases (EIDs) and bioterrorism. Environmental hazards, particularly those exacerbated by the climate emergency, are also on the rise. The huge cost of these hazards and health emergencies on people and economies illustrate why preparedness to face such threats at all levels (local, regional, national, and international) is so vital.

Urban areas have unique vulnerabilities that make them more prone to the impacts of health emergencies. This is a concern as more than 50% of the world’s population live in urban areas, and scientists calculate that this will increase to 70% by 2050. This means that preparedness for health emergencies in cities is especially important.

During this session the speakers will explore the capacities that make local actors essential in mitigating health hazards. They will also debate what constitutes preparedness and the role different stakeholders can play in this process.

Roberto Lucchini

Roberto Lucchini (TBC)

Florida International University

Professor of Environmental Health Sciences

Daniel Buss

Daniel Buss

Pan American Health Organization (PAHO)

Unit Chief Climate Change and Environmental Determinants of Health (CDE-CE)

Elizabet Diago

Elizabet Diago

ISGlobal

Preparedness Program Manager

Hafeez  Rehman

Hafeez Rehman

VITO Arabia Science and Technology LLC

CEO

Elis Borde

Elis Borde

Federal University of Minas Gerais

Professor

Moderated by

Clara Marín

Clara Marín

ISGlobal

Policy Program Officer

Health

Deep dive session: Preparedness and response to health emergencies – The role of cities

Share this session

14 February 2023, 15:00 - 16:15 BRT (Rio de Janeiro)

14 February 2023, 19:00 - 20:15 CET (Brussels)

14 February 2023, 19:00 - 20:15 WAT (Nigeria)

14 February 2023, 20:00 - 21:15 SAST (Cape Town)

14 February 2023, 13:00 - 14:15 EST (New York)

14 February 2023, 03:00 - 04:15 KST (Seoul)

14 February 2023, 02:00 - 03:15 CST (Beijing)

14 February 2023, 23:30 - 00:45 IST (New Delhi)

14 February 2023, 22:00 - 23:15 GST (Dubai)

Room Estácio & online

History has shown that a variety of hazards can affect health and well-being. These include natural disasters, chemical, radiological, physical, and biological hazards such as epidemics, pandemics, emerging infectious diseases (EIDs) and bioterrorism. Environmental hazards, particularly those exacerbated by the climate emergency, are also on the rise. The huge cost of these hazards and health emergencies on people and economies illustrate why preparedness to face such threats at all levels (local, regional, national, and international) is so vital.

Urban areas have unique vulnerabilities that make them more prone to the impacts of health emergencies. This is a concern as more than 50% of the world’s population live in urban areas, and scientists calculate that this will increase to 70% by 2050. This means that preparedness for health emergencies in cities is especially important.

During this session the speakers will explore the capacities that make local actors essential in mitigating health hazards. They will also debate what constitutes preparedness and the role different stakeholders can play in this process.

Roberto Lucchini

Roberto Lucchini (TBC)

Florida International University

Professor of Environmental Health Sciences

Daniel Buss

Daniel Buss

Pan American Health Organization (PAHO)

Unit Chief Climate Change and Environmental Determinants of Health (CDE-CE)

Elizabet Diago

Elizabet Diago

ISGlobal

Preparedness Program Manager

Hafeez  Rehman

Hafeez Rehman

VITO Arabia Science and Technology LLC

CEO

Elis Borde

Elis Borde

Federal University of Minas Gerais

Professor

Moderated by

Clara Marín

Clara Marín

ISGlobal

Policy Program Officer

Health

Deep dive session: Preparedness and response to health emergencies – The role of cities

Share this session

14 February 2023, 15:00 - 16:15 BRT (Rio de Janeiro)

14 February 2023, 19:00 - 20:15 CET (Brussels)

14 February 2023, 19:00 - 20:15 WAT (Nigeria)

14 February 2023, 20:00 - 21:15 SAST (Cape Town)

14 February 2023, 13:00 - 14:15 EST (New York)

14 February 2023, 03:00 - 04:15 KST (Seoul)

14 February 2023, 02:00 - 03:15 CST (Beijing)

14 February 2023, 23:30 - 00:45 IST (New Delhi)

14 February 2023, 22:00 - 23:15 GST (Dubai)

Room Estácio & online

History has shown that a variety of hazards can affect health and well-being. These include natural disasters, chemical, radiological, physical, and biological hazards such as epidemics, pandemics, emerging infectious diseases (EIDs) and bioterrorism. Environmental hazards, particularly those exacerbated by the climate emergency, are also on the rise. The huge cost of these hazards and health emergencies on people and economies illustrate why preparedness to face such threats at all levels (local, regional, national, and international) is so vital.

Urban areas have unique vulnerabilities that make them more prone to the impacts of health emergencies. This is a concern as more than 50% of the world’s population live in urban areas, and scientists calculate that this will increase to 70% by 2050. This means that preparedness for health emergencies in cities is especially important.

During this session the speakers will explore the capacities that make local actors essential in mitigating health hazards. They will also debate what constitutes preparedness and the role different stakeholders can play in this process.

Roberto Lucchini

Roberto Lucchini (TBC)

Florida International University

Professor of Environmental Health Sciences

Daniel Buss

Daniel Buss

Pan American Health Organization (PAHO)

Unit Chief Climate Change and Environmental Determinants of Health (CDE-CE)

Elizabet Diago

Elizabet Diago

ISGlobal

Preparedness Program Manager

Hafeez  Rehman

Hafeez Rehman

VITO Arabia Science and Technology LLC

CEO

Elis Borde

Elis Borde

Federal University of Minas Gerais

Professor

Moderated by

Clara Marín

Clara Marín

ISGlobal

Policy Program Officer

15 February 2023

09:00
13:00
13:00
14:00
07:00
21:00
20:00
17:30
16:00
Vaccines and immunization: Challenges and perspectives for local manufacturing

Health

×

Health

Vaccines and immunization: Challenges and perspectives for local manufacturing

Share this session

15 February 2023, 09:00 - 12:00 BRT (Rio de Janeiro)

15 February 2023, 13:00 - 16:00 CET (Brussels)

15 February 2023, 13:00 - 16:00 WAT (Nigeria)

15 February 2023, 14:00 - 17:00 SAST (Cape Town)

15 February 2023, 07:00 - 10:00 EST (New York)

15 February 2023, 21:00 - 00:00 KST (Seoul)

15 February 2023, 20:00 - 23:00 CST (Beijing)

15 February 2023, 17:30 - 20:30 IST (New Delhi)

15 February 2023, 16:00 - 19:00 GST (Dubai)

Room Flamengo & online

The COVID-19 pandemic highlighted the huge inequities in access to vaccines and the gap in the level of immunization between developed and developing countries and especially in the least developed countries. These disparities made global efforts to tackle the pandemic harder. They led to more hospitalizations and deaths, and exacerbated the impacts of long covid. Economies were also unevenly impacted as different countries emerged from the worst of the pandemic at different rates. These consequences were felt far more acutely in the most vulnerable countries.

The pandemic also exposed and exaggerated the imbalance in access to technology and the inequitable terms related to technology transfer agreements. The dependency on critical health goods and consumables manufactured by a few countries became even more evident, especially when the pandemic started to impact the supply chain and restrict the flow of goods around the world. All of these issues point to the urgent need for greater international collaboration and unity so the world is better prepared for the next major health emergency. This starts by addressing local health needs and ensuring that there is equal access to immunization and vaccines.

During this event, the speakers will discuss the challenges of local production, equity, intellectual property, and sustainable development in the context of access to vaccines and vaccination.

Keynote speech: Recovering vaccine coverage and challenges for the vaccine ecosystem

Akira  Homma

Akira Homma

Bio-Manguinhos

Senior scientific advisor

Coffee break & networking

Roundtable: Vaccine for all - equity, IPR and sustainable development

James  Fitzgerald

James Fitzgerald

PAHO/WHO

Director, Health Systems and Services

Xiaolan  Fu

Xiaolan Fu

Technology and Management Centre for Development

Founding Director

Ike James

Ike James

Medicines Patent Pool

Head of Technology Transfer

Renata Reis

Renata Reis

MSF Brazil

Executive Director

Jefferson Nascimento

Jefferson Nascimento

OXFAM Brazil

Social & Economic Justice Coordinator

Carla  Vizzotti

Carla Vizzotti

Argentina

Health Minister

Priya Basu

Priya Basu

The Pandemic Fund, World Bank Group

Executive Head

Moderated by

Mario Moreira

Mario Moreira

Oswaldo Cruz Foundation (Fiocruz)

President

Chaired by

Gianluca Breghi

Gianluca Breghi

Fondazione Sclavo

Managing DirectorDirector

Health

Vaccines and immunization: Challenges and perspectives for local manufacturing

Share this session

15 February 2023, 09:00 - 12:00 BRT (Rio de Janeiro)

15 February 2023, 13:00 - 16:00 CET (Brussels)

15 February 2023, 13:00 - 16:00 WAT (Nigeria)

15 February 2023, 14:00 - 17:00 SAST (Cape Town)

15 February 2023, 07:00 - 10:00 EST (New York)

15 February 2023, 21:00 - 00:00 KST (Seoul)

15 February 2023, 20:00 - 23:00 CST (Beijing)

15 February 2023, 17:30 - 20:30 IST (New Delhi)

15 February 2023, 16:00 - 19:00 GST (Dubai)

Room Flamengo & online

The COVID-19 pandemic highlighted the huge inequities in access to vaccines and the gap in the level of immunization between developed and developing countries and especially in the least developed countries. These disparities made global efforts to tackle the pandemic harder. They led to more hospitalizations and deaths, and exacerbated the impacts of long covid. Economies were also unevenly impacted as different countries emerged from the worst of the pandemic at different rates. These consequences were felt far more acutely in the most vulnerable countries.

The pandemic also exposed and exaggerated the imbalance in access to technology and the inequitable terms related to technology transfer agreements. The dependency on critical health goods and consumables manufactured by a few countries became even more evident, especially when the pandemic started to impact the supply chain and restrict the flow of goods around the world. All of these issues point to the urgent need for greater international collaboration and unity so the world is better prepared for the next major health emergency. This starts by addressing local health needs and ensuring that there is equal access to immunization and vaccines.

During this event, the speakers will discuss the challenges of local production, equity, intellectual property, and sustainable development in the context of access to vaccines and vaccination.

Keynote speech: Recovering vaccine coverage and challenges for the vaccine ecosystem

Akira  Homma

Akira Homma

Bio-Manguinhos

Senior scientific advisor

Coffee break & networking

Roundtable: Vaccine for all - equity, IPR and sustainable development

James  Fitzgerald

James Fitzgerald

PAHO/WHO

Director, Health Systems and Services

Xiaolan  Fu

Xiaolan Fu

Technology and Management Centre for Development

Founding Director

Ike James

Ike James

Medicines Patent Pool

Head of Technology Transfer

Renata Reis

Renata Reis

MSF Brazil

Executive Director

Jefferson Nascimento

Jefferson Nascimento

OXFAM Brazil

Social & Economic Justice Coordinator

Carla  Vizzotti

Carla Vizzotti

Argentina

Health Minister

Priya Basu

Priya Basu

The Pandemic Fund, World Bank Group

Executive Head

Moderated by

Mario Moreira

Mario Moreira

Oswaldo Cruz Foundation (Fiocruz)

President

Chaired by

Gianluca Breghi

Gianluca Breghi

Fondazione Sclavo

Managing DirectorDirector

Health

Vaccines and immunization: Challenges and perspectives for local manufacturing

Share this session

15 February 2023, 09:00 - 12:00 BRT (Rio de Janeiro)

15 February 2023, 13:00 - 16:00 CET (Brussels)

15 February 2023, 13:00 - 16:00 WAT (Nigeria)

15 February 2023, 14:00 - 17:00 SAST (Cape Town)

15 February 2023, 07:00 - 10:00 EST (New York)

15 February 2023, 21:00 - 00:00 KST (Seoul)

15 February 2023, 20:00 - 23:00 CST (Beijing)

15 February 2023, 17:30 - 20:30 IST (New Delhi)

15 February 2023, 16:00 - 19:00 GST (Dubai)

Room Flamengo & online

The COVID-19 pandemic highlighted the huge inequities in access to vaccines and the gap in the level of immunization between developed and developing countries and especially in the least developed countries. These disparities made global efforts to tackle the pandemic harder. They led to more hospitalizations and deaths, and exacerbated the impacts of long covid. Economies were also unevenly impacted as different countries emerged from the worst of the pandemic at different rates. These consequences were felt far more acutely in the most vulnerable countries.

The pandemic also exposed and exaggerated the imbalance in access to technology and the inequitable terms related to technology transfer agreements. The dependency on critical health goods and consumables manufactured by a few countries became even more evident, especially when the pandemic started to impact the supply chain and restrict the flow of goods around the world. All of these issues point to the urgent need for greater international collaboration and unity so the world is better prepared for the next major health emergency. This starts by addressing local health needs and ensuring that there is equal access to immunization and vaccines.

During this event, the speakers will discuss the challenges of local production, equity, intellectual property, and sustainable development in the context of access to vaccines and vaccination.

Keynote speech: Recovering vaccine coverage and challenges for the vaccine ecosystem

Akira  Homma

Akira Homma

Bio-Manguinhos

Senior scientific advisor

Coffee break & networking

Roundtable: Vaccine for all - equity, IPR and sustainable development

James  Fitzgerald

James Fitzgerald

PAHO/WHO

Director, Health Systems and Services

Xiaolan  Fu

Xiaolan Fu

Technology and Management Centre for Development

Founding Director

Ike James

Ike James

Medicines Patent Pool

Head of Technology Transfer

Renata Reis

Renata Reis

MSF Brazil

Executive Director

Jefferson Nascimento

Jefferson Nascimento

OXFAM Brazil

Social & Economic Justice Coordinator

Carla  Vizzotti

Carla Vizzotti

Argentina

Health Minister

Priya Basu

Priya Basu

The Pandemic Fund, World Bank Group

Executive Head

Moderated by

Mario Moreira

Mario Moreira

Oswaldo Cruz Foundation (Fiocruz)

President

Chaired by

Gianluca Breghi

Gianluca Breghi

Fondazione Sclavo

Managing DirectorDirector

Health

Vaccines and immunization: Challenges and perspectives for local manufacturing

Share this session

15 February 2023, 09:00 - 12:00 BRT (Rio de Janeiro)

15 February 2023, 13:00 - 16:00 CET (Brussels)

15 February 2023, 13:00 - 16:00 WAT (Nigeria)

15 February 2023, 14:00 - 17:00 SAST (Cape Town)

15 February 2023, 07:00 - 10:00 EST (New York)

15 February 2023, 21:00 - 00:00 KST (Seoul)

15 February 2023, 20:00 - 23:00 CST (Beijing)

15 February 2023, 17:30 - 20:30 IST (New Delhi)

15 February 2023, 16:00 - 19:00 GST (Dubai)

Room Flamengo & online

The COVID-19 pandemic highlighted the huge inequities in access to vaccines and the gap in the level of immunization between developed and developing countries and especially in the least developed countries. These disparities made global efforts to tackle the pandemic harder. They led to more hospitalizations and deaths, and exacerbated the impacts of long covid. Economies were also unevenly impacted as different countries emerged from the worst of the pandemic at different rates. These consequences were felt far more acutely in the most vulnerable countries.

The pandemic also exposed and exaggerated the imbalance in access to technology and the inequitable terms related to technology transfer agreements. The dependency on critical health goods and consumables manufactured by a few countries became even more evident, especially when the pandemic started to impact the supply chain and restrict the flow of goods around the world. All of these issues point to the urgent need for greater international collaboration and unity so the world is better prepared for the next major health emergency. This starts by addressing local health needs and ensuring that there is equal access to immunization and vaccines.

During this event, the speakers will discuss the challenges of local production, equity, intellectual property, and sustainable development in the context of access to vaccines and vaccination.

Keynote speech: Recovering vaccine coverage and challenges for the vaccine ecosystem

Akira  Homma

Akira Homma

Bio-Manguinhos

Senior scientific advisor

Coffee break & networking

Roundtable: Vaccine for all - equity, IPR and sustainable development

James  Fitzgerald

James Fitzgerald

PAHO/WHO

Director, Health Systems and Services

Xiaolan  Fu

Xiaolan Fu

Technology and Management Centre for Development

Founding Director

Ike James

Ike James

Medicines Patent Pool

Head of Technology Transfer

Renata Reis

Renata Reis

MSF Brazil

Executive Director

Jefferson Nascimento

Jefferson Nascimento

OXFAM Brazil

Social & Economic Justice Coordinator

Carla  Vizzotti

Carla Vizzotti

Argentina

Health Minister

Priya Basu

Priya Basu

The Pandemic Fund, World Bank Group

Executive Head

Moderated by

Mario Moreira

Mario Moreira

Oswaldo Cruz Foundation (Fiocruz)

President

Chaired by

Gianluca Breghi

Gianluca Breghi

Fondazione Sclavo

Managing DirectorDirector

Health

Vaccines and immunization: Challenges and perspectives for local manufacturing

Share this session

15 February 2023, 09:00 - 12:00 BRT (Rio de Janeiro)

15 February 2023, 13:00 - 16:00 CET (Brussels)

15 February 2023, 13:00 - 16:00 WAT (Nigeria)

15 February 2023, 14:00 - 17:00 SAST (Cape Town)

15 February 2023, 07:00 - 10:00 EST (New York)

15 February 2023, 21:00 - 00:00 KST (Seoul)

15 February 2023, 20:00 - 23:00 CST (Beijing)

15 February 2023, 17:30 - 20:30 IST (New Delhi)

15 February 2023, 16:00 - 19:00 GST (Dubai)

Room Flamengo & online

The COVID-19 pandemic highlighted the huge inequities in access to vaccines and the gap in the level of immunization between developed and developing countries and especially in the least developed countries. These disparities made global efforts to tackle the pandemic harder. They led to more hospitalizations and deaths, and exacerbated the impacts of long covid. Economies were also unevenly impacted as different countries emerged from the worst of the pandemic at different rates. These consequences were felt far more acutely in the most vulnerable countries.

The pandemic also exposed and exaggerated the imbalance in access to technology and the inequitable terms related to technology transfer agreements. The dependency on critical health goods and consumables manufactured by a few countries became even more evident, especially when the pandemic started to impact the supply chain and restrict the flow of goods around the world. All of these issues point to the urgent need for greater international collaboration and unity so the world is better prepared for the next major health emergency. This starts by addressing local health needs and ensuring that there is equal access to immunization and vaccines.

During this event, the speakers will discuss the challenges of local production, equity, intellectual property, and sustainable development in the context of access to vaccines and vaccination.

Keynote speech: Recovering vaccine coverage and challenges for the vaccine ecosystem

Akira  Homma

Akira Homma

Bio-Manguinhos

Senior scientific advisor

Coffee break & networking

Roundtable: Vaccine for all - equity, IPR and sustainable development

James  Fitzgerald

James Fitzgerald

PAHO/WHO

Director, Health Systems and Services

Xiaolan  Fu

Xiaolan Fu

Technology and Management Centre for Development

Founding Director

Ike James

Ike James

Medicines Patent Pool

Head of Technology Transfer

Renata Reis

Renata Reis

MSF Brazil

Executive Director

Jefferson Nascimento

Jefferson Nascimento

OXFAM Brazil

Social & Economic Justice Coordinator

Carla  Vizzotti

Carla Vizzotti

Argentina

Health Minister

Priya Basu

Priya Basu

The Pandemic Fund, World Bank Group

Executive Head

Moderated by

Mario Moreira

Mario Moreira

Oswaldo Cruz Foundation (Fiocruz)

President

Chaired by

Gianluca Breghi

Gianluca Breghi

Fondazione Sclavo

Managing DirectorDirector

Health

Vaccines and immunization: Challenges and perspectives for local manufacturing

Share this session

15 February 2023, 09:00 - 12:00 BRT (Rio de Janeiro)

15 February 2023, 13:00 - 16:00 CET (Brussels)

15 February 2023, 13:00 - 16:00 WAT (Nigeria)

15 February 2023, 14:00 - 17:00 SAST (Cape Town)

15 February 2023, 07:00 - 10:00 EST (New York)

15 February 2023, 21:00 - 00:00 KST (Seoul)

15 February 2023, 20:00 - 23:00 CST (Beijing)

15 February 2023, 17:30 - 20:30 IST (New Delhi)

15 February 2023, 16:00 - 19:00 GST (Dubai)

Room Flamengo & online

The COVID-19 pandemic highlighted the huge inequities in access to vaccines and the gap in the level of immunization between developed and developing countries and especially in the least developed countries. These disparities made global efforts to tackle the pandemic harder. They led to more hospitalizations and deaths, and exacerbated the impacts of long covid. Economies were also unevenly impacted as different countries emerged from the worst of the pandemic at different rates. These consequences were felt far more acutely in the most vulnerable countries.

The pandemic also exposed and exaggerated the imbalance in access to technology and the inequitable terms related to technology transfer agreements. The dependency on critical health goods and consumables manufactured by a few countries became even more evident, especially when the pandemic started to impact the supply chain and restrict the flow of goods around the world. All of these issues point to the urgent need for greater international collaboration and unity so the world is better prepared for the next major health emergency. This starts by addressing local health needs and ensuring that there is equal access to immunization and vaccines.

During this event, the speakers will discuss the challenges of local production, equity, intellectual property, and sustainable development in the context of access to vaccines and vaccination.

Keynote speech: Recovering vaccine coverage and challenges for the vaccine ecosystem

Akira  Homma

Akira Homma

Bio-Manguinhos

Senior scientific advisor

Coffee break & networking

Roundtable: Vaccine for all - equity, IPR and sustainable development

James  Fitzgerald

James Fitzgerald

PAHO/WHO

Director, Health Systems and Services

Xiaolan  Fu

Xiaolan Fu

Technology and Management Centre for Development

Founding Director

Ike James

Ike James

Medicines Patent Pool

Head of Technology Transfer

Renata Reis

Renata Reis

MSF Brazil

Executive Director

Jefferson Nascimento

Jefferson Nascimento

OXFAM Brazil

Social & Economic Justice Coordinator

Carla  Vizzotti

Carla Vizzotti

Argentina

Health Minister

Priya Basu

Priya Basu

The Pandemic Fund, World Bank Group

Executive Head

Moderated by

Mario Moreira

Mario Moreira

Oswaldo Cruz Foundation (Fiocruz)

President

Chaired by

Gianluca Breghi

Gianluca Breghi

Fondazione Sclavo

Managing DirectorDirector

Health

Vaccines and immunization: Challenges and perspectives for local manufacturing

Share this session

15 February 2023, 09:00 - 12:00 BRT (Rio de Janeiro)

15 February 2023, 13:00 - 16:00 CET (Brussels)

15 February 2023, 13:00 - 16:00 WAT (Nigeria)

15 February 2023, 14:00 - 17:00 SAST (Cape Town)

15 February 2023, 07:00 - 10:00 EST (New York)

15 February 2023, 21:00 - 00:00 KST (Seoul)

15 February 2023, 20:00 - 23:00 CST (Beijing)

15 February 2023, 17:30 - 20:30 IST (New Delhi)

15 February 2023, 16:00 - 19:00 GST (Dubai)

Room Flamengo & online

The COVID-19 pandemic highlighted the huge inequities in access to vaccines and the gap in the level of immunization between developed and developing countries and especially in the least developed countries. These disparities made global efforts to tackle the pandemic harder. They led to more hospitalizations and deaths, and exacerbated the impacts of long covid. Economies were also unevenly impacted as different countries emerged from the worst of the pandemic at different rates. These consequences were felt far more acutely in the most vulnerable countries.

The pandemic also exposed and exaggerated the imbalance in access to technology and the inequitable terms related to technology transfer agreements. The dependency on critical health goods and consumables manufactured by a few countries became even more evident, especially when the pandemic started to impact the supply chain and restrict the flow of goods around the world. All of these issues point to the urgent need for greater international collaboration and unity so the world is better prepared for the next major health emergency. This starts by addressing local health needs and ensuring that there is equal access to immunization and vaccines.

During this event, the speakers will discuss the challenges of local production, equity, intellectual property, and sustainable development in the context of access to vaccines and vaccination.

Keynote speech: Recovering vaccine coverage and challenges for the vaccine ecosystem

Akira  Homma

Akira Homma

Bio-Manguinhos

Senior scientific advisor

Coffee break & networking

Roundtable: Vaccine for all - equity, IPR and sustainable development

James  Fitzgerald

James Fitzgerald

PAHO/WHO

Director, Health Systems and Services

Xiaolan  Fu

Xiaolan Fu

Technology and Management Centre for Development

Founding Director

Ike James

Ike James

Medicines Patent Pool

Head of Technology Transfer

Renata Reis

Renata Reis

MSF Brazil

Executive Director

Jefferson Nascimento

Jefferson Nascimento

OXFAM Brazil

Social & Economic Justice Coordinator

Carla  Vizzotti

Carla Vizzotti

Argentina

Health Minister

Priya Basu

Priya Basu

The Pandemic Fund, World Bank Group

Executive Head

Moderated by

Mario Moreira

Mario Moreira

Oswaldo Cruz Foundation (Fiocruz)

President

Chaired by

Gianluca Breghi

Gianluca Breghi

Fondazione Sclavo

Managing DirectorDirector

Health

Vaccines and immunization: Challenges and perspectives for local manufacturing

Share this session

15 February 2023, 09:00 - 12:00 BRT (Rio de Janeiro)

15 February 2023, 13:00 - 16:00 CET (Brussels)

15 February 2023, 13:00 - 16:00 WAT (Nigeria)

15 February 2023, 14:00 - 17:00 SAST (Cape Town)

15 February 2023, 07:00 - 10:00 EST (New York)

15 February 2023, 21:00 - 00:00 KST (Seoul)

15 February 2023, 20:00 - 23:00 CST (Beijing)

15 February 2023, 17:30 - 20:30 IST (New Delhi)

15 February 2023, 16:00 - 19:00 GST (Dubai)

Room Flamengo & online

The COVID-19 pandemic highlighted the huge inequities in access to vaccines and the gap in the level of immunization between developed and developing countries and especially in the least developed countries. These disparities made global efforts to tackle the pandemic harder. They led to more hospitalizations and deaths, and exacerbated the impacts of long covid. Economies were also unevenly impacted as different countries emerged from the worst of the pandemic at different rates. These consequences were felt far more acutely in the most vulnerable countries.

The pandemic also exposed and exaggerated the imbalance in access to technology and the inequitable terms related to technology transfer agreements. The dependency on critical health goods and consumables manufactured by a few countries became even more evident, especially when the pandemic started to impact the supply chain and restrict the flow of goods around the world. All of these issues point to the urgent need for greater international collaboration and unity so the world is better prepared for the next major health emergency. This starts by addressing local health needs and ensuring that there is equal access to immunization and vaccines.

During this event, the speakers will discuss the challenges of local production, equity, intellectual property, and sustainable development in the context of access to vaccines and vaccination.

Keynote speech: Recovering vaccine coverage and challenges for the vaccine ecosystem

Akira  Homma

Akira Homma

Bio-Manguinhos

Senior scientific advisor

Coffee break & networking

Roundtable: Vaccine for all - equity, IPR and sustainable development

James  Fitzgerald

James Fitzgerald

PAHO/WHO

Director, Health Systems and Services

Xiaolan  Fu

Xiaolan Fu

Technology and Management Centre for Development

Founding Director

Ike James

Ike James

Medicines Patent Pool

Head of Technology Transfer

Renata Reis

Renata Reis

MSF Brazil

Executive Director

Jefferson Nascimento

Jefferson Nascimento

OXFAM Brazil

Social & Economic Justice Coordinator

Carla  Vizzotti

Carla Vizzotti

Argentina

Health Minister

Priya Basu

Priya Basu

The Pandemic Fund, World Bank Group

Executive Head

Moderated by

Mario Moreira

Mario Moreira

Oswaldo Cruz Foundation (Fiocruz)

President

Chaired by

Gianluca Breghi

Gianluca Breghi

Fondazione Sclavo

Managing DirectorDirector

Health

Vaccines and immunization: Challenges and perspectives for local manufacturing

Share this session

15 February 2023, 09:00 - 12:00 BRT (Rio de Janeiro)

15 February 2023, 13:00 - 16:00 CET (Brussels)

15 February 2023, 13:00 - 16:00 WAT (Nigeria)

15 February 2023, 14:00 - 17:00 SAST (Cape Town)

15 February 2023, 07:00 - 10:00 EST (New York)

15 February 2023, 21:00 - 00:00 KST (Seoul)

15 February 2023, 20:00 - 23:00 CST (Beijing)

15 February 2023, 17:30 - 20:30 IST (New Delhi)

15 February 2023, 16:00 - 19:00 GST (Dubai)

Room Flamengo & online

The COVID-19 pandemic highlighted the huge inequities in access to vaccines and the gap in the level of immunization between developed and developing countries and especially in the least developed countries. These disparities made global efforts to tackle the pandemic harder. They led to more hospitalizations and deaths, and exacerbated the impacts of long covid. Economies were also unevenly impacted as different countries emerged from the worst of the pandemic at different rates. These consequences were felt far more acutely in the most vulnerable countries.

The pandemic also exposed and exaggerated the imbalance in access to technology and the inequitable terms related to technology transfer agreements. The dependency on critical health goods and consumables manufactured by a few countries became even more evident, especially when the pandemic started to impact the supply chain and restrict the flow of goods around the world. All of these issues point to the urgent need for greater international collaboration and unity so the world is better prepared for the next major health emergency. This starts by addressing local health needs and ensuring that there is equal access to immunization and vaccines.

During this event, the speakers will discuss the challenges of local production, equity, intellectual property, and sustainable development in the context of access to vaccines and vaccination.

Keynote speech: Recovering vaccine coverage and challenges for the vaccine ecosystem

Akira  Homma

Akira Homma

Bio-Manguinhos

Senior scientific advisor

Coffee break & networking

Roundtable: Vaccine for all - equity, IPR and sustainable development

James  Fitzgerald

James Fitzgerald

PAHO/WHO

Director, Health Systems and Services

Xiaolan  Fu

Xiaolan Fu

Technology and Management Centre for Development

Founding Director

Ike James

Ike James

Medicines Patent Pool

Head of Technology Transfer

Renata Reis

Renata Reis

MSF Brazil

Executive Director

Jefferson Nascimento

Jefferson Nascimento

OXFAM Brazil

Social & Economic Justice Coordinator

Carla  Vizzotti

Carla Vizzotti

Argentina

Health Minister

Priya Basu

Priya Basu

The Pandemic Fund, World Bank Group

Executive Head

Moderated by

Mario Moreira

Mario Moreira

Oswaldo Cruz Foundation (Fiocruz)

President

Chaired by

Gianluca Breghi

Gianluca Breghi

Fondazione Sclavo

Managing DirectorDirector

10:00
14:00
14:00
15:00
08:00
22:00
21:00
18:30
17:00
Special session: STI and the 2023 Global Health Agenda

Health

×

Health

Special session: STI and the 2023 Global Health Agenda

Share this session

15 February 2023, 10:00 - 12:15 BRT (Rio de Janeiro)

15 February 2023, 14:00 - 16:15 CET (Brussels)

15 February 2023, 14:00 - 16:15 WAT (Nigeria)

15 February 2023, 15:00 - 17:15 SAST (Cape Town)

15 February 2023, 08:00 - 10:15 EST (New York)

15 February 2023, 22:00 - 00:15 KST (Seoul)

15 February 2023, 21:00 - 23:15 CST (Beijing)

15 February 2023, 18:30 - 20:45 IST (New Delhi)

15 February 2023, 17:00 - 19:15 GST (Dubai)

Online

Every year in March, the World Health Assembly (WHA) gathers to define the annual global health agenda of the World Health Organization (WHO). Although Covid-19 has been predominant in recent years, the agenda has been expanding to respond to more than the consequences of the pandemic. In addition to improving the mechanisms for preventing, preparing, and responding to public health emergencies, problems such as non-communicable diseases, immunization, and infectious and parasitic diseases are in focus. Providing equitable health systems and tackling the social determinants of health have also been added to the agenda, which demands more sophisticated and complex measures.

It is increasingly recognized that health is not restricted to biological phenomenon but is the result of much broader economic, social, political, and environmental conditions coupled with how health systems are organized. These are referred to as the determinants of health and they are rightly part of the 2030 Agenda and its 17 Sustainable Development Goals. It would be impossible to achieve the sustainable development goals and their 169 ambitious targets by 2030 without healthy populations.

Science, technology, and innovation (STI) has a big role to play in health systems and sustainable development around the world.  This session will discuss the 2023 WHO global health agenda and the role of STI in tackling the social determinants of health equity.

John  Reeder

John Reeder

WHO

Director of the Special Programme for Research and Training in Tropical Diseases

Kumanan  Rasanathan

Kumanan Rasanathan

WHO

Executive Director, Alliance for Health Policy and Systems Research

Deisy  Ventura

Deisy Ventura

University of São Paulo

Professor of Global health Ethics

Moderated by

Paul Buss

Paul Buss

Fiocruz

Director of the Center for Global Health and International Relations

Health

Special session: STI and the 2023 Global Health Agenda

Share this session

15 February 2023, 10:00 - 12:15 BRT (Rio de Janeiro)

15 February 2023, 14:00 - 16:15 CET (Brussels)

15 February 2023, 14:00 - 16:15 WAT (Nigeria)

15 February 2023, 15:00 - 17:15 SAST (Cape Town)

15 February 2023, 08:00 - 10:15 EST (New York)

15 February 2023, 22:00 - 00:15 KST (Seoul)

15 February 2023, 21:00 - 23:15 CST (Beijing)

15 February 2023, 18:30 - 20:45 IST (New Delhi)

15 February 2023, 17:00 - 19:15 GST (Dubai)

Online

Every year in March, the World Health Assembly (WHA) gathers to define the annual global health agenda of the World Health Organization (WHO). Although Covid-19 has been predominant in recent years, the agenda has been expanding to respond to more than the consequences of the pandemic. In addition to improving the mechanisms for preventing, preparing, and responding to public health emergencies, problems such as non-communicable diseases, immunization, and infectious and parasitic diseases are in focus. Providing equitable health systems and tackling the social determinants of health have also been added to the agenda, which demands more sophisticated and complex measures.

It is increasingly recognized that health is not restricted to biological phenomenon but is the result of much broader economic, social, political, and environmental conditions coupled with how health systems are organized. These are referred to as the determinants of health and they are rightly part of the 2030 Agenda and its 17 Sustainable Development Goals. It would be impossible to achieve the sustainable development goals and their 169 ambitious targets by 2030 without healthy populations.

Science, technology, and innovation (STI) has a big role to play in health systems and sustainable development around the world.  This session will discuss the 2023 WHO global health agenda and the role of STI in tackling the social determinants of health equity.

John  Reeder

John Reeder

WHO

Director of the Special Programme for Research and Training in Tropical Diseases

Kumanan  Rasanathan

Kumanan Rasanathan

WHO

Executive Director, Alliance for Health Policy and Systems Research

Deisy  Ventura

Deisy Ventura

University of São Paulo

Professor of Global health Ethics

Moderated by

Paul Buss

Paul Buss

Fiocruz

Director of the Center for Global Health and International Relations

Health

Special session: STI and the 2023 Global Health Agenda

Share this session

15 February 2023, 10:00 - 12:15 BRT (Rio de Janeiro)

15 February 2023, 14:00 - 16:15 CET (Brussels)

15 February 2023, 14:00 - 16:15 WAT (Nigeria)

15 February 2023, 15:00 - 17:15 SAST (Cape Town)

15 February 2023, 08:00 - 10:15 EST (New York)

15 February 2023, 22:00 - 00:15 KST (Seoul)

15 February 2023, 21:00 - 23:15 CST (Beijing)

15 February 2023, 18:30 - 20:45 IST (New Delhi)

15 February 2023, 17:00 - 19:15 GST (Dubai)

Online

Every year in March, the World Health Assembly (WHA) gathers to define the annual global health agenda of the World Health Organization (WHO). Although Covid-19 has been predominant in recent years, the agenda has been expanding to respond to more than the consequences of the pandemic. In addition to improving the mechanisms for preventing, preparing, and responding to public health emergencies, problems such as non-communicable diseases, immunization, and infectious and parasitic diseases are in focus. Providing equitable health systems and tackling the social determinants of health have also been added to the agenda, which demands more sophisticated and complex measures.

It is increasingly recognized that health is not restricted to biological phenomenon but is the result of much broader economic, social, political, and environmental conditions coupled with how health systems are organized. These are referred to as the determinants of health and they are rightly part of the 2030 Agenda and its 17 Sustainable Development Goals. It would be impossible to achieve the sustainable development goals and their 169 ambitious targets by 2030 without healthy populations.

Science, technology, and innovation (STI) has a big role to play in health systems and sustainable development around the world.  This session will discuss the 2023 WHO global health agenda and the role of STI in tackling the social determinants of health equity.

John  Reeder

John Reeder

WHO

Director of the Special Programme for Research and Training in Tropical Diseases

Kumanan  Rasanathan

Kumanan Rasanathan

WHO

Executive Director, Alliance for Health Policy and Systems Research

Deisy  Ventura

Deisy Ventura

University of São Paulo

Professor of Global health Ethics

Moderated by

Paul Buss

Paul Buss

Fiocruz

Director of the Center for Global Health and International Relations

Health

Special session: STI and the 2023 Global Health Agenda

Share this session

15 February 2023, 10:00 - 12:15 BRT (Rio de Janeiro)

15 February 2023, 14:00 - 16:15 CET (Brussels)

15 February 2023, 14:00 - 16:15 WAT (Nigeria)

15 February 2023, 15:00 - 17:15 SAST (Cape Town)

15 February 2023, 08:00 - 10:15 EST (New York)

15 February 2023, 22:00 - 00:15 KST (Seoul)

15 February 2023, 21:00 - 23:15 CST (Beijing)

15 February 2023, 18:30 - 20:45 IST (New Delhi)

15 February 2023, 17:00 - 19:15 GST (Dubai)

Online

Every year in March, the World Health Assembly (WHA) gathers to define the annual global health agenda of the World Health Organization (WHO). Although Covid-19 has been predominant in recent years, the agenda has been expanding to respond to more than the consequences of the pandemic. In addition to improving the mechanisms for preventing, preparing, and responding to public health emergencies, problems such as non-communicable diseases, immunization, and infectious and parasitic diseases are in focus. Providing equitable health systems and tackling the social determinants of health have also been added to the agenda, which demands more sophisticated and complex measures.

It is increasingly recognized that health is not restricted to biological phenomenon but is the result of much broader economic, social, political, and environmental conditions coupled with how health systems are organized. These are referred to as the determinants of health and they are rightly part of the 2030 Agenda and its 17 Sustainable Development Goals. It would be impossible to achieve the sustainable development goals and their 169 ambitious targets by 2030 without healthy populations.

Science, technology, and innovation (STI) has a big role to play in health systems and sustainable development around the world.  This session will discuss the 2023 WHO global health agenda and the role of STI in tackling the social determinants of health equity.

John  Reeder

John Reeder

WHO

Director of the Special Programme for Research and Training in Tropical Diseases

Kumanan  Rasanathan

Kumanan Rasanathan

WHO

Executive Director, Alliance for Health Policy and Systems Research

Deisy  Ventura

Deisy Ventura

University of São Paulo

Professor of Global health Ethics

Moderated by

Paul Buss

Paul Buss

Fiocruz

Director of the Center for Global Health and International Relations

Health

Special session: STI and the 2023 Global Health Agenda

Share this session

15 February 2023, 10:00 - 12:15 BRT (Rio de Janeiro)

15 February 2023, 14:00 - 16:15 CET (Brussels)

15 February 2023, 14:00 - 16:15 WAT (Nigeria)

15 February 2023, 15:00 - 17:15 SAST (Cape Town)

15 February 2023, 08:00 - 10:15 EST (New York)

15 February 2023, 22:00 - 00:15 KST (Seoul)

15 February 2023, 21:00 - 23:15 CST (Beijing)

15 February 2023, 18:30 - 20:45 IST (New Delhi)

15 February 2023, 17:00 - 19:15 GST (Dubai)

Online

Every year in March, the World Health Assembly (WHA) gathers to define the annual global health agenda of the World Health Organization (WHO). Although Covid-19 has been predominant in recent years, the agenda has been expanding to respond to more than the consequences of the pandemic. In addition to improving the mechanisms for preventing, preparing, and responding to public health emergencies, problems such as non-communicable diseases, immunization, and infectious and parasitic diseases are in focus. Providing equitable health systems and tackling the social determinants of health have also been added to the agenda, which demands more sophisticated and complex measures.

It is increasingly recognized that health is not restricted to biological phenomenon but is the result of much broader economic, social, political, and environmental conditions coupled with how health systems are organized. These are referred to as the determinants of health and they are rightly part of the 2030 Agenda and its 17 Sustainable Development Goals. It would be impossible to achieve the sustainable development goals and their 169 ambitious targets by 2030 without healthy populations.

Science, technology, and innovation (STI) has a big role to play in health systems and sustainable development around the world.  This session will discuss the 2023 WHO global health agenda and the role of STI in tackling the social determinants of health equity.

John  Reeder

John Reeder

WHO

Director of the Special Programme for Research and Training in Tropical Diseases

Kumanan  Rasanathan

Kumanan Rasanathan

WHO

Executive Director, Alliance for Health Policy and Systems Research

Deisy  Ventura

Deisy Ventura

University of São Paulo

Professor of Global health Ethics

Moderated by

Paul Buss

Paul Buss

Fiocruz

Director of the Center for Global Health and International Relations

Health

Special session: STI and the 2023 Global Health Agenda

Share this session

15 February 2023, 10:00 - 12:15 BRT (Rio de Janeiro)

15 February 2023, 14:00 - 16:15 CET (Brussels)

15 February 2023, 14:00 - 16:15 WAT (Nigeria)

15 February 2023, 15:00 - 17:15 SAST (Cape Town)

15 February 2023, 08:00 - 10:15 EST (New York)

15 February 2023, 22:00 - 00:15 KST (Seoul)

15 February 2023, 21:00 - 23:15 CST (Beijing)

15 February 2023, 18:30 - 20:45 IST (New Delhi)

15 February 2023, 17:00 - 19:15 GST (Dubai)

Online

Every year in March, the World Health Assembly (WHA) gathers to define the annual global health agenda of the World Health Organization (WHO). Although Covid-19 has been predominant in recent years, the agenda has been expanding to respond to more than the consequences of the pandemic. In addition to improving the mechanisms for preventing, preparing, and responding to public health emergencies, problems such as non-communicable diseases, immunization, and infectious and parasitic diseases are in focus. Providing equitable health systems and tackling the social determinants of health have also been added to the agenda, which demands more sophisticated and complex measures.

It is increasingly recognized that health is not restricted to biological phenomenon but is the result of much broader economic, social, political, and environmental conditions coupled with how health systems are organized. These are referred to as the determinants of health and they are rightly part of the 2030 Agenda and its 17 Sustainable Development Goals. It would be impossible to achieve the sustainable development goals and their 169 ambitious targets by 2030 without healthy populations.

Science, technology, and innovation (STI) has a big role to play in health systems and sustainable development around the world.  This session will discuss the 2023 WHO global health agenda and the role of STI in tackling the social determinants of health equity.

John  Reeder

John Reeder

WHO

Director of the Special Programme for Research and Training in Tropical Diseases

Kumanan  Rasanathan

Kumanan Rasanathan

WHO

Executive Director, Alliance for Health Policy and Systems Research

Deisy  Ventura

Deisy Ventura

University of São Paulo

Professor of Global health Ethics

Moderated by

Paul Buss

Paul Buss

Fiocruz

Director of the Center for Global Health and International Relations

Health

Special session: STI and the 2023 Global Health Agenda

Share this session

15 February 2023, 10:00 - 12:15 BRT (Rio de Janeiro)

15 February 2023, 14:00 - 16:15 CET (Brussels)

15 February 2023, 14:00 - 16:15 WAT (Nigeria)

15 February 2023, 15:00 - 17:15 SAST (Cape Town)

15 February 2023, 08:00 - 10:15 EST (New York)

15 February 2023, 22:00 - 00:15 KST (Seoul)

15 February 2023, 21:00 - 23:15 CST (Beijing)

15 February 2023, 18:30 - 20:45 IST (New Delhi)

15 February 2023, 17:00 - 19:15 GST (Dubai)

Online

Every year in March, the World Health Assembly (WHA) gathers to define the annual global health agenda of the World Health Organization (WHO). Although Covid-19 has been predominant in recent years, the agenda has been expanding to respond to more than the consequences of the pandemic. In addition to improving the mechanisms for preventing, preparing, and responding to public health emergencies, problems such as non-communicable diseases, immunization, and infectious and parasitic diseases are in focus. Providing equitable health systems and tackling the social determinants of health have also been added to the agenda, which demands more sophisticated and complex measures.

It is increasingly recognized that health is not restricted to biological phenomenon but is the result of much broader economic, social, political, and environmental conditions coupled with how health systems are organized. These are referred to as the determinants of health and they are rightly part of the 2030 Agenda and its 17 Sustainable Development Goals. It would be impossible to achieve the sustainable development goals and their 169 ambitious targets by 2030 without healthy populations.

Science, technology, and innovation (STI) has a big role to play in health systems and sustainable development around the world.  This session will discuss the 2023 WHO global health agenda and the role of STI in tackling the social determinants of health equity.

John  Reeder

John Reeder

WHO

Director of the Special Programme for Research and Training in Tropical Diseases

Kumanan  Rasanathan

Kumanan Rasanathan

WHO

Executive Director, Alliance for Health Policy and Systems Research

Deisy  Ventura

Deisy Ventura

University of São Paulo

Professor of Global health Ethics

Moderated by

Paul Buss

Paul Buss

Fiocruz

Director of the Center for Global Health and International Relations

Health

Special session: STI and the 2023 Global Health Agenda

Share this session

15 February 2023, 10:00 - 12:15 BRT (Rio de Janeiro)

15 February 2023, 14:00 - 16:15 CET (Brussels)

15 February 2023, 14:00 - 16:15 WAT (Nigeria)

15 February 2023, 15:00 - 17:15 SAST (Cape Town)

15 February 2023, 08:00 - 10:15 EST (New York)

15 February 2023, 22:00 - 00:15 KST (Seoul)

15 February 2023, 21:00 - 23:15 CST (Beijing)

15 February 2023, 18:30 - 20:45 IST (New Delhi)

15 February 2023, 17:00 - 19:15 GST (Dubai)

Online

Every year in March, the World Health Assembly (WHA) gathers to define the annual global health agenda of the World Health Organization (WHO). Although Covid-19 has been predominant in recent years, the agenda has been expanding to respond to more than the consequences of the pandemic. In addition to improving the mechanisms for preventing, preparing, and responding to public health emergencies, problems such as non-communicable diseases, immunization, and infectious and parasitic diseases are in focus. Providing equitable health systems and tackling the social determinants of health have also been added to the agenda, which demands more sophisticated and complex measures.

It is increasingly recognized that health is not restricted to biological phenomenon but is the result of much broader economic, social, political, and environmental conditions coupled with how health systems are organized. These are referred to as the determinants of health and they are rightly part of the 2030 Agenda and its 17 Sustainable Development Goals. It would be impossible to achieve the sustainable development goals and their 169 ambitious targets by 2030 without healthy populations.

Science, technology, and innovation (STI) has a big role to play in health systems and sustainable development around the world.  This session will discuss the 2023 WHO global health agenda and the role of STI in tackling the social determinants of health equity.

John  Reeder

John Reeder

WHO

Director of the Special Programme for Research and Training in Tropical Diseases

Kumanan  Rasanathan

Kumanan Rasanathan

WHO

Executive Director, Alliance for Health Policy and Systems Research

Deisy  Ventura

Deisy Ventura

University of São Paulo

Professor of Global health Ethics

Moderated by

Paul Buss

Paul Buss

Fiocruz

Director of the Center for Global Health and International Relations

Health

Special session: STI and the 2023 Global Health Agenda

Share this session

15 February 2023, 10:00 - 12:15 BRT (Rio de Janeiro)

15 February 2023, 14:00 - 16:15 CET (Brussels)

15 February 2023, 14:00 - 16:15 WAT (Nigeria)

15 February 2023, 15:00 - 17:15 SAST (Cape Town)

15 February 2023, 08:00 - 10:15 EST (New York)

15 February 2023, 22:00 - 00:15 KST (Seoul)

15 February 2023, 21:00 - 23:15 CST (Beijing)

15 February 2023, 18:30 - 20:45 IST (New Delhi)

15 February 2023, 17:00 - 19:15 GST (Dubai)

Online

Every year in March, the World Health Assembly (WHA) gathers to define the annual global health agenda of the World Health Organization (WHO). Although Covid-19 has been predominant in recent years, the agenda has been expanding to respond to more than the consequences of the pandemic. In addition to improving the mechanisms for preventing, preparing, and responding to public health emergencies, problems such as non-communicable diseases, immunization, and infectious and parasitic diseases are in focus. Providing equitable health systems and tackling the social determinants of health have also been added to the agenda, which demands more sophisticated and complex measures.

It is increasingly recognized that health is not restricted to biological phenomenon but is the result of much broader economic, social, political, and environmental conditions coupled with how health systems are organized. These are referred to as the determinants of health and they are rightly part of the 2030 Agenda and its 17 Sustainable Development Goals. It would be impossible to achieve the sustainable development goals and their 169 ambitious targets by 2030 without healthy populations.

Science, technology, and innovation (STI) has a big role to play in health systems and sustainable development around the world.  This session will discuss the 2023 WHO global health agenda and the role of STI in tackling the social determinants of health equity.

John  Reeder

John Reeder

WHO

Director of the Special Programme for Research and Training in Tropical Diseases

Kumanan  Rasanathan

Kumanan Rasanathan

WHO

Executive Director, Alliance for Health Policy and Systems Research

Deisy  Ventura

Deisy Ventura

University of São Paulo

Professor of Global health Ethics

Moderated by

Paul Buss

Paul Buss

Fiocruz

Director of the Center for Global Health and International Relations

10:30
14:30
14:30
15:30
08:30
22:30
21:30
19:00
17:30
Special session by SDSN: Global Solutions Forum

Health

×

Health

Special session by SDSN: Global Solutions Forum

Share this session

15 February 2023, 10:30 - 12:00 BRT (Rio de Janeiro)

15 February 2023, 14:30 - 16:00 CET (Brussels)

15 February 2023, 14:30 - 16:00 WAT (Nigeria)

15 February 2023, 15:30 - 17:00 SAST (Cape Town)

15 February 2023, 08:30 - 10:00 EST (New York)

15 February 2023, 22:30 - 00:00 KST (Seoul)

15 February 2023, 21:30 - 23:00 CST (Beijing)

15 February 2023, 19:00 - 20:30 IST (New Delhi)

15 February 2023, 17:30 - 19:00 GST (Dubai)

Room Lapa & online

The pandemic has exacerbated existing global problems, but solutions to many of those challenges already exist. Too often highly effective local solutions do not reach their full potential because they are not scaled, thus limiting their potential to contribute to the SDGs.

In this context, it is more important than ever to shine light on the most transformative and scalable solutions from within SDSN’s unique knowledge network – those that shape the path towards a sustainable future, leaving no one behind.

In partnership with G-STIC, the German Corporation for International Cooperation (GIZ) and PANORAMA – Solutions for a Healthy Planet, a group of five global innovators from SDSN’s National and Regional Networks will present their breakthrough efforts. This session will showcase solutions from Canada, the Mediterranean, Mexico, the Sahel and South Africa.

Welcome and opening remarks

Jeffrey Sachs

Jeffrey Sachs

SDSN

President

María Cortés Puch

María Cortés Puch

Sustainable Development Solutions Network (SDSN)

Vice President Networks

Presentation of solutions and discussion

Gianluca Breghi

Gianluca Breghi

Fondazione Sclavo

Managing DirectorDirector

Alí Ruiz Coronel

Alí Ruiz Coronel

Institute for Social Research, National Autonomous University of Mexico

Researcher-Lecturer

Darelle  Van Greunen

Darelle Van Greunen

Nelson Mandela University

Distinguished Professor and Director Centre for Community Technologies

Ibrahima Kampo

Ibrahima Kampo

SDSN Sahel

Network Manager

John Lavis

John Lavis

McMaster University

Director McMaster Health Forum, and Co-Lead, Global Commission on Evidence to Address Societal Challenges

Solutions Committee

Michael Shank

Michael Shank

Carbon Neutral Cities Alliance

Director of Engagement

Maria Elena Bottazzi

Maria Elena Bottazzi

Baylor College of Medicine

Co-Director, Texas Children's Hospital Center for Vaccine Development

Susanne  Grimm

Susanne Grimm

Competence Centre Health and Social Protection GIZ

Senior Advisor

Moderated by

Clara Marín

Clara Marín

ISGlobal

Policy Program Officer

Health

Special session by SDSN: Global Solutions Forum

Share this session

15 February 2023, 10:30 - 12:00 BRT (Rio de Janeiro)

15 February 2023, 14:30 - 16:00 CET (Brussels)

15 February 2023, 14:30 - 16:00 WAT (Nigeria)

15 February 2023, 15:30 - 17:00 SAST (Cape Town)

15 February 2023, 08:30 - 10:00 EST (New York)

15 February 2023, 22:30 - 00:00 KST (Seoul)

15 February 2023, 21:30 - 23:00 CST (Beijing)

15 February 2023, 19:00 - 20:30 IST (New Delhi)

15 February 2023, 17:30 - 19:00 GST (Dubai)

Room Lapa & online

The pandemic has exacerbated existing global problems, but solutions to many of those challenges already exist. Too often highly effective local solutions do not reach their full potential because they are not scaled, thus limiting their potential to contribute to the SDGs.

In this context, it is more important than ever to shine light on the most transformative and scalable solutions from within SDSN’s unique knowledge network – those that shape the path towards a sustainable future, leaving no one behind.

In partnership with G-STIC, the German Corporation for International Cooperation (GIZ) and PANORAMA – Solutions for a Healthy Planet, a group of five global innovators from SDSN’s National and Regional Networks will present their breakthrough efforts. This session will showcase solutions from Canada, the Mediterranean, Mexico, the Sahel and South Africa.

Welcome and opening remarks

Jeffrey Sachs

Jeffrey Sachs

SDSN

President

María Cortés Puch

María Cortés Puch

Sustainable Development Solutions Network (SDSN)

Vice President Networks

Presentation of solutions and discussion

Gianluca Breghi

Gianluca Breghi

Fondazione Sclavo

Managing DirectorDirector

Alí Ruiz Coronel

Alí Ruiz Coronel

Institute for Social Research, National Autonomous University of Mexico

Researcher-Lecturer

Darelle  Van Greunen

Darelle Van Greunen

Nelson Mandela University

Distinguished Professor and Director Centre for Community Technologies

Ibrahima Kampo

Ibrahima Kampo

SDSN Sahel

Network Manager

John Lavis

John Lavis

McMaster University

Director McMaster Health Forum, and Co-Lead, Global Commission on Evidence to Address Societal Challenges

Solutions Committee

Michael Shank

Michael Shank

Carbon Neutral Cities Alliance

Director of Engagement

Maria Elena Bottazzi

Maria Elena Bottazzi

Baylor College of Medicine

Co-Director, Texas Children's Hospital Center for Vaccine Development

Susanne  Grimm

Susanne Grimm

Competence Centre Health and Social Protection GIZ

Senior Advisor

Moderated by

Clara Marín

Clara Marín

ISGlobal

Policy Program Officer

Health

Special session by SDSN: Global Solutions Forum

Share this session

15 February 2023, 10:30 - 12:00 BRT (Rio de Janeiro)

15 February 2023, 14:30 - 16:00 CET (Brussels)

15 February 2023, 14:30 - 16:00 WAT (Nigeria)

15 February 2023, 15:30 - 17:00 SAST (Cape Town)

15 February 2023, 08:30 - 10:00 EST (New York)

15 February 2023, 22:30 - 00:00 KST (Seoul)

15 February 2023, 21:30 - 23:00 CST (Beijing)

15 February 2023, 19:00 - 20:30 IST (New Delhi)

15 February 2023, 17:30 - 19:00 GST (Dubai)

Room Lapa & online

The pandemic has exacerbated existing global problems, but solutions to many of those challenges already exist. Too often highly effective local solutions do not reach their full potential because they are not scaled, thus limiting their potential to contribute to the SDGs.

In this context, it is more important than ever to shine light on the most transformative and scalable solutions from within SDSN’s unique knowledge network – those that shape the path towards a sustainable future, leaving no one behind.

In partnership with G-STIC, the German Corporation for International Cooperation (GIZ) and PANORAMA – Solutions for a Healthy Planet, a group of five global innovators from SDSN’s National and Regional Networks will present their breakthrough efforts. This session will showcase solutions from Canada, the Mediterranean, Mexico, the Sahel and South Africa.

Welcome and opening remarks

Jeffrey Sachs

Jeffrey Sachs

SDSN

President

María Cortés Puch

María Cortés Puch

Sustainable Development Solutions Network (SDSN)

Vice President Networks

Presentation of solutions and discussion

Gianluca Breghi

Gianluca Breghi

Fondazione Sclavo

Managing DirectorDirector

Alí Ruiz Coronel

Alí Ruiz Coronel

Institute for Social Research, National Autonomous University of Mexico

Researcher-Lecturer

Darelle  Van Greunen

Darelle Van Greunen

Nelson Mandela University

Distinguished Professor and Director Centre for Community Technologies

Ibrahima Kampo

Ibrahima Kampo

SDSN Sahel

Network Manager

John Lavis

John Lavis

McMaster University

Director McMaster Health Forum, and Co-Lead, Global Commission on Evidence to Address Societal Challenges

Solutions Committee

Michael Shank

Michael Shank

Carbon Neutral Cities Alliance

Director of Engagement

Maria Elena Bottazzi

Maria Elena Bottazzi

Baylor College of Medicine

Co-Director, Texas Children's Hospital Center for Vaccine Development

Susanne  Grimm

Susanne Grimm

Competence Centre Health and Social Protection GIZ

Senior Advisor

Moderated by

Clara Marín

Clara Marín

ISGlobal

Policy Program Officer

Health

Special session by SDSN: Global Solutions Forum

Share this session

15 February 2023, 10:30 - 12:00 BRT (Rio de Janeiro)

15 February 2023, 14:30 - 16:00 CET (Brussels)

15 February 2023, 14:30 - 16:00 WAT (Nigeria)

15 February 2023, 15:30 - 17:00 SAST (Cape Town)

15 February 2023, 08:30 - 10:00 EST (New York)

15 February 2023, 22:30 - 00:00 KST (Seoul)

15 February 2023, 21:30 - 23:00 CST (Beijing)

15 February 2023, 19:00 - 20:30 IST (New Delhi)

15 February 2023, 17:30 - 19:00 GST (Dubai)

Room Lapa & online

The pandemic has exacerbated existing global problems, but solutions to many of those challenges already exist. Too often highly effective local solutions do not reach their full potential because they are not scaled, thus limiting their potential to contribute to the SDGs.

In this context, it is more important than ever to shine light on the most transformative and scalable solutions from within SDSN’s unique knowledge network – those that shape the path towards a sustainable future, leaving no one behind.

In partnership with G-STIC, the German Corporation for International Cooperation (GIZ) and PANORAMA – Solutions for a Healthy Planet, a group of five global innovators from SDSN’s National and Regional Networks will present their breakthrough efforts. This session will showcase solutions from Canada, the Mediterranean, Mexico, the Sahel and South Africa.

Welcome and opening remarks

Jeffrey Sachs

Jeffrey Sachs

SDSN

President

María Cortés Puch

María Cortés Puch

Sustainable Development Solutions Network (SDSN)

Vice President Networks

Presentation of solutions and discussion

Gianluca Breghi

Gianluca Breghi

Fondazione Sclavo

Managing DirectorDirector

Alí Ruiz Coronel

Alí Ruiz Coronel

Institute for Social Research, National Autonomous University of Mexico

Researcher-Lecturer

Darelle  Van Greunen

Darelle Van Greunen

Nelson Mandela University

Distinguished Professor and Director Centre for Community Technologies

Ibrahima Kampo

Ibrahima Kampo

SDSN Sahel

Network Manager

John Lavis

John Lavis

McMaster University

Director McMaster Health Forum, and Co-Lead, Global Commission on Evidence to Address Societal Challenges

Solutions Committee

Michael Shank

Michael Shank

Carbon Neutral Cities Alliance

Director of Engagement

Maria Elena Bottazzi

Maria Elena Bottazzi

Baylor College of Medicine

Co-Director, Texas Children's Hospital Center for Vaccine Development

Susanne  Grimm

Susanne Grimm

Competence Centre Health and Social Protection GIZ

Senior Advisor

Moderated by

Clara Marín

Clara Marín

ISGlobal

Policy Program Officer

Health

Special session by SDSN: Global Solutions Forum

Share this session

15 February 2023, 10:30 - 12:00 BRT (Rio de Janeiro)

15 February 2023, 14:30 - 16:00 CET (Brussels)

15 February 2023, 14:30 - 16:00 WAT (Nigeria)

15 February 2023, 15:30 - 17:00 SAST (Cape Town)

15 February 2023, 08:30 - 10:00 EST (New York)

15 February 2023, 22:30 - 00:00 KST (Seoul)

15 February 2023, 21:30 - 23:00 CST (Beijing)

15 February 2023, 19:00 - 20:30 IST (New Delhi)

15 February 2023, 17:30 - 19:00 GST (Dubai)

Room Lapa & online

The pandemic has exacerbated existing global problems, but solutions to many of those challenges already exist. Too often highly effective local solutions do not reach their full potential because they are not scaled, thus limiting their potential to contribute to the SDGs.

In this context, it is more important than ever to shine light on the most transformative and scalable solutions from within SDSN’s unique knowledge network – those that shape the path towards a sustainable future, leaving no one behind.

In partnership with G-STIC, the German Corporation for International Cooperation (GIZ) and PANORAMA – Solutions for a Healthy Planet, a group of five global innovators from SDSN’s National and Regional Networks will present their breakthrough efforts. This session will showcase solutions from Canada, the Mediterranean, Mexico, the Sahel and South Africa.

Welcome and opening remarks

Jeffrey Sachs

Jeffrey Sachs

SDSN

President

María Cortés Puch

María Cortés Puch

Sustainable Development Solutions Network (SDSN)

Vice President Networks

Presentation of solutions and discussion

Gianluca Breghi

Gianluca Breghi

Fondazione Sclavo

Managing DirectorDirector

Alí Ruiz Coronel

Alí Ruiz Coronel

Institute for Social Research, National Autonomous University of Mexico

Researcher-Lecturer

Darelle  Van Greunen

Darelle Van Greunen

Nelson Mandela University

Distinguished Professor and Director Centre for Community Technologies

Ibrahima Kampo

Ibrahima Kampo

SDSN Sahel

Network Manager

John Lavis

John Lavis

McMaster University

Director McMaster Health Forum, and Co-Lead, Global Commission on Evidence to Address Societal Challenges

Solutions Committee

Michael Shank

Michael Shank

Carbon Neutral Cities Alliance

Director of Engagement

Maria Elena Bottazzi

Maria Elena Bottazzi

Baylor College of Medicine

Co-Director, Texas Children's Hospital Center for Vaccine Development

Susanne  Grimm

Susanne Grimm

Competence Centre Health and Social Protection GIZ

Senior Advisor

Moderated by

Clara Marín

Clara Marín

ISGlobal

Policy Program Officer

Health

Special session by SDSN: Global Solutions Forum

Share this session

15 February 2023, 10:30 - 12:00 BRT (Rio de Janeiro)

15 February 2023, 14:30 - 16:00 CET (Brussels)

15 February 2023, 14:30 - 16:00 WAT (Nigeria)

15 February 2023, 15:30 - 17:00 SAST (Cape Town)

15 February 2023, 08:30 - 10:00 EST (New York)

15 February 2023, 22:30 - 00:00 KST (Seoul)

15 February 2023, 21:30 - 23:00 CST (Beijing)

15 February 2023, 19:00 - 20:30 IST (New Delhi)

15 February 2023, 17:30 - 19:00 GST (Dubai)

Room Lapa & online

The pandemic has exacerbated existing global problems, but solutions to many of those challenges already exist. Too often highly effective local solutions do not reach their full potential because they are not scaled, thus limiting their potential to contribute to the SDGs.

In this context, it is more important than ever to shine light on the most transformative and scalable solutions from within SDSN’s unique knowledge network – those that shape the path towards a sustainable future, leaving no one behind.

In partnership with G-STIC, the German Corporation for International Cooperation (GIZ) and PANORAMA – Solutions for a Healthy Planet, a group of five global innovators from SDSN’s National and Regional Networks will present their breakthrough efforts. This session will showcase solutions from Canada, the Mediterranean, Mexico, the Sahel and South Africa.

Welcome and opening remarks

Jeffrey Sachs

Jeffrey Sachs

SDSN

President

María Cortés Puch

María Cortés Puch

Sustainable Development Solutions Network (SDSN)

Vice President Networks

Presentation of solutions and discussion

Gianluca Breghi

Gianluca Breghi

Fondazione Sclavo

Managing DirectorDirector

Alí Ruiz Coronel

Alí Ruiz Coronel

Institute for Social Research, National Autonomous University of Mexico

Researcher-Lecturer

Darelle  Van Greunen

Darelle Van Greunen

Nelson Mandela University

Distinguished Professor and Director Centre for Community Technologies

Ibrahima Kampo

Ibrahima Kampo

SDSN Sahel

Network Manager

John Lavis

John Lavis

McMaster University

Director McMaster Health Forum, and Co-Lead, Global Commission on Evidence to Address Societal Challenges

Solutions Committee

Michael Shank

Michael Shank

Carbon Neutral Cities Alliance

Director of Engagement

Maria Elena Bottazzi

Maria Elena Bottazzi

Baylor College of Medicine

Co-Director, Texas Children's Hospital Center for Vaccine Development

Susanne  Grimm

Susanne Grimm

Competence Centre Health and Social Protection GIZ

Senior Advisor

Moderated by

Clara Marín

Clara Marín

ISGlobal

Policy Program Officer

Health

Special session by SDSN: Global Solutions Forum

Share this session

15 February 2023, 10:30 - 12:00 BRT (Rio de Janeiro)

15 February 2023, 14:30 - 16:00 CET (Brussels)

15 February 2023, 14:30 - 16:00 WAT (Nigeria)

15 February 2023, 15:30 - 17:00 SAST (Cape Town)

15 February 2023, 08:30 - 10:00 EST (New York)

15 February 2023, 22:30 - 00:00 KST (Seoul)

15 February 2023, 21:30 - 23:00 CST (Beijing)

15 February 2023, 19:00 - 20:30 IST (New Delhi)

15 February 2023, 17:30 - 19:00 GST (Dubai)

Room Lapa & online

The pandemic has exacerbated existing global problems, but solutions to many of those challenges already exist. Too often highly effective local solutions do not reach their full potential because they are not scaled, thus limiting their potential to contribute to the SDGs.

In this context, it is more important than ever to shine light on the most transformative and scalable solutions from within SDSN’s unique knowledge network – those that shape the path towards a sustainable future, leaving no one behind.

In partnership with G-STIC, the German Corporation for International Cooperation (GIZ) and PANORAMA – Solutions for a Healthy Planet, a group of five global innovators from SDSN’s National and Regional Networks will present their breakthrough efforts. This session will showcase solutions from Canada, the Mediterranean, Mexico, the Sahel and South Africa.

Welcome and opening remarks

Jeffrey Sachs

Jeffrey Sachs

SDSN

President

María Cortés Puch

María Cortés Puch

Sustainable Development Solutions Network (SDSN)

Vice President Networks

Presentation of solutions and discussion

Gianluca Breghi

Gianluca Breghi

Fondazione Sclavo

Managing DirectorDirector

Alí Ruiz Coronel

Alí Ruiz Coronel

Institute for Social Research, National Autonomous University of Mexico

Researcher-Lecturer

Darelle  Van Greunen

Darelle Van Greunen

Nelson Mandela University

Distinguished Professor and Director Centre for Community Technologies

Ibrahima Kampo

Ibrahima Kampo

SDSN Sahel

Network Manager

John Lavis

John Lavis

McMaster University

Director McMaster Health Forum, and Co-Lead, Global Commission on Evidence to Address Societal Challenges

Solutions Committee

Michael Shank

Michael Shank

Carbon Neutral Cities Alliance

Director of Engagement

Maria Elena Bottazzi

Maria Elena Bottazzi

Baylor College of Medicine

Co-Director, Texas Children's Hospital Center for Vaccine Development

Susanne  Grimm

Susanne Grimm

Competence Centre Health and Social Protection GIZ

Senior Advisor

Moderated by

Clara Marín

Clara Marín

ISGlobal

Policy Program Officer

Health

Special session by SDSN: Global Solutions Forum

Share this session

15 February 2023, 10:30 - 12:00 BRT (Rio de Janeiro)

15 February 2023, 14:30 - 16:00 CET (Brussels)

15 February 2023, 14:30 - 16:00 WAT (Nigeria)

15 February 2023, 15:30 - 17:00 SAST (Cape Town)

15 February 2023, 08:30 - 10:00 EST (New York)

15 February 2023, 22:30 - 00:00 KST (Seoul)

15 February 2023, 21:30 - 23:00 CST (Beijing)

15 February 2023, 19:00 - 20:30 IST (New Delhi)

15 February 2023, 17:30 - 19:00 GST (Dubai)

Room Lapa & online

The pandemic has exacerbated existing global problems, but solutions to many of those challenges already exist. Too often highly effective local solutions do not reach their full potential because they are not scaled, thus limiting their potential to contribute to the SDGs.

In this context, it is more important than ever to shine light on the most transformative and scalable solutions from within SDSN’s unique knowledge network – those that shape the path towards a sustainable future, leaving no one behind.

In partnership with G-STIC, the German Corporation for International Cooperation (GIZ) and PANORAMA – Solutions for a Healthy Planet, a group of five global innovators from SDSN’s National and Regional Networks will present their breakthrough efforts. This session will showcase solutions from Canada, the Mediterranean, Mexico, the Sahel and South Africa.

Welcome and opening remarks

Jeffrey Sachs

Jeffrey Sachs

SDSN

President

María Cortés Puch

María Cortés Puch

Sustainable Development Solutions Network (SDSN)

Vice President Networks

Presentation of solutions and discussion

Gianluca Breghi

Gianluca Breghi

Fondazione Sclavo

Managing DirectorDirector

Alí Ruiz Coronel

Alí Ruiz Coronel

Institute for Social Research, National Autonomous University of Mexico

Researcher-Lecturer

Darelle  Van Greunen

Darelle Van Greunen

Nelson Mandela University

Distinguished Professor and Director Centre for Community Technologies

Ibrahima Kampo

Ibrahima Kampo

SDSN Sahel

Network Manager

John Lavis

John Lavis

McMaster University

Director McMaster Health Forum, and Co-Lead, Global Commission on Evidence to Address Societal Challenges

Solutions Committee

Michael Shank

Michael Shank

Carbon Neutral Cities Alliance

Director of Engagement

Maria Elena Bottazzi

Maria Elena Bottazzi

Baylor College of Medicine

Co-Director, Texas Children's Hospital Center for Vaccine Development

Susanne  Grimm

Susanne Grimm

Competence Centre Health and Social Protection GIZ

Senior Advisor

Moderated by

Clara Marín

Clara Marín

ISGlobal

Policy Program Officer

Health

Special session by SDSN: Global Solutions Forum

Share this session

15 February 2023, 10:30 - 12:00 BRT (Rio de Janeiro)

15 February 2023, 14:30 - 16:00 CET (Brussels)

15 February 2023, 14:30 - 16:00 WAT (Nigeria)

15 February 2023, 15:30 - 17:00 SAST (Cape Town)

15 February 2023, 08:30 - 10:00 EST (New York)

15 February 2023, 22:30 - 00:00 KST (Seoul)

15 February 2023, 21:30 - 23:00 CST (Beijing)

15 February 2023, 19:00 - 20:30 IST (New Delhi)

15 February 2023, 17:30 - 19:00 GST (Dubai)

Room Lapa & online

The pandemic has exacerbated existing global problems, but solutions to many of those challenges already exist. Too often highly effective local solutions do not reach their full potential because they are not scaled, thus limiting their potential to contribute to the SDGs.

In this context, it is more important than ever to shine light on the most transformative and scalable solutions from within SDSN’s unique knowledge network – those that shape the path towards a sustainable future, leaving no one behind.

In partnership with G-STIC, the German Corporation for International Cooperation (GIZ) and PANORAMA – Solutions for a Healthy Planet, a group of five global innovators from SDSN’s National and Regional Networks will present their breakthrough efforts. This session will showcase solutions from Canada, the Mediterranean, Mexico, the Sahel and South Africa.

Welcome and opening remarks

Jeffrey Sachs

Jeffrey Sachs

SDSN

President

María Cortés Puch

María Cortés Puch

Sustainable Development Solutions Network (SDSN)

Vice President Networks

Presentation of solutions and discussion

Gianluca Breghi

Gianluca Breghi

Fondazione Sclavo

Managing DirectorDirector

Alí Ruiz Coronel

Alí Ruiz Coronel

Institute for Social Research, National Autonomous University of Mexico

Researcher-Lecturer

Darelle  Van Greunen

Darelle Van Greunen

Nelson Mandela University

Distinguished Professor and Director Centre for Community Technologies

Ibrahima Kampo

Ibrahima Kampo

SDSN Sahel

Network Manager

John Lavis

John Lavis

McMaster University

Director McMaster Health Forum, and Co-Lead, Global Commission on Evidence to Address Societal Challenges

Solutions Committee

Michael Shank

Michael Shank

Carbon Neutral Cities Alliance

Director of Engagement

Maria Elena Bottazzi

Maria Elena Bottazzi

Baylor College of Medicine

Co-Director, Texas Children's Hospital Center for Vaccine Development

Susanne  Grimm

Susanne Grimm

Competence Centre Health and Social Protection GIZ

Senior Advisor

Moderated by

Clara Marín

Clara Marín

ISGlobal

Policy Program Officer

Meet world-renowned keynote speakers during the G-STIC Conference February 2023

Get inspired by real-life examples of technological solutions for the SDGs

Nísia Trindade Lima
Meet
Nísia Trindade Lima
Nísia Trindade Lima
Brazil
Minister of Health
×
Nísia Trindade Lima
Nísia Trindade Lima
Brazil
Minister of Health

Cross-thematic Health

Meet Nísia Trindade Lima during these sessions

13 February, 09:30 - 10:30 BRT (Rio de Janeiro)

13 February, 13:30 - 14:30 CET (Brussels)

13 February, 13:30 - 14:30 WAT (Nigeria)

13 February, 14:30 - 15:30 SAST (Cape Town)

13 February, 07:30 - 08:30 EST (New York)

13 February, 21:30 - 22:30 KST (Seoul)

13 February, 20:30 - 21:30 CST (Beijing)

13 February, 18:00 - 19:00 IST (New Delhi)

13 February, 16:30 - 17:30 GST (Dubai)

Plenary session: Opening Ceremony – Innovative technological solutions for a post-pandemic recovery

13 February, 10:30 - 12:00 BRT (Rio de Janeiro)

13 February, 14:30 - 16:00 CET (Brussels)

13 February, 14:30 - 16:00 WAT (Nigeria)

13 February, 15:30 - 17:00 SAST (Cape Town)

13 February, 08:30 - 10:00 EST (New York)

13 February, 22:30 - 00:00 KST (Seoul)

13 February, 21:30 - 23:00 CST (Beijing)

13 February, 19:00 - 20:30 IST (New Delhi)

13 February, 17:30 - 19:00 GST (Dubai)

High-level plenary session: Toward an equitable and sustainable future
Phoebe Koundouri
Meet
Phoebe Koundouri
Phoebe Koundouri
Athens University of Economics and Business and Technical University of Denmark
Professor in Economics
×
Phoebe Koundouri
Phoebe Koundouri
Athens University of Economics and Business and Technical University of Denmark
Professor in Economics

Cross-thematic Climate Health

Meet Phoebe Koundouri during these sessions

13 February, 10:30 - 12:00 BRT (Rio de Janeiro)

13 February, 14:30 - 16:00 CET (Brussels)

13 February, 14:30 - 16:00 WAT (Nigeria)

13 February, 15:30 - 17:00 SAST (Cape Town)

13 February, 08:30 - 10:00 EST (New York)

13 February, 22:30 - 00:00 KST (Seoul)

13 February, 21:30 - 23:00 CST (Beijing)

13 February, 19:00 - 20:30 IST (New Delhi)

13 February, 17:30 - 19:00 GST (Dubai)

High-level plenary session: Toward an equitable and sustainable future

13 February, 15:00 - 16:15 BRT (Rio de Janeiro)

13 February, 19:00 - 20:15 CET (Brussels)

13 February, 19:00 - 20:15 WAT (Nigeria)

13 February, 20:00 - 21:15 SAST (Cape Town)

13 February, 13:00 - 14:15 EST (New York)

13 February, 03:00 - 04:15 KST (Seoul)

13 February, 02:00 - 03:15 CST (Beijing)

13 February, 23:30 - 00:45 IST (New Delhi)

13 February, 22:00 - 23:15 GST (Dubai)

Special session: Challenges and opportunities in planetary health

14 February, 10:30 - 12:00 BRT (Rio de Janeiro)

14 February, 14:30 - 16:00 CET (Brussels)

14 February, 14:30 - 16:00 WAT (Nigeria)

14 February, 15:30 - 17:00 SAST (Cape Town)

14 February, 08:30 - 10:00 EST (New York)

14 February, 22:30 - 00:00 KST (Seoul)

14 February, 21:30 - 23:00 CST (Beijing)

14 February, 19:00 - 20:30 IST (New Delhi)

14 February, 17:30 - 19:00 GST (Dubai)

Plenary session: Integrated innovative technologies and supporting financing mechanisms to prevent, adapt and manage climate change impacts
Ana Bento
Meet
Ana Bento
Ana Bento
The Rockefeller Foundation
Director of Science, Pandemic Prevention Institute Health Initiative
×
Ana Bento
Ana Bento
The Rockefeller Foundation
Director of Science, Pandemic Prevention Institute Health Initiative

Health

Meet Ana Bento during these sessions

13 February, 16:30 - 17:45 BRT (Rio de Janeiro)

13 February, 20:30 - 21:45 CET (Brussels)

13 February, 20:30 - 21:45 WAT (Nigeria)

13 February, 21:30 - 22:45 SAST (Cape Town)

13 February, 14:30 - 15:45 EST (New York)

13 February, 04:30 - 05:45 KST (Seoul)

13 February, 03:30 - 04:45 CST (Beijing)

13 February, 01:00 - 02:15 IST (New Delhi)

13 February, 23:30 - 00:45 GST (Dubai)

Special session: Challenges in building health surveillance systems

14 February, 13:30 - 14:45 BRT (Rio de Janeiro)

14 February, 17:30 - 18:45 CET (Brussels)

14 February, 17:30 - 18:45 WAT (Nigeria)

14 February, 18:30 - 19:45 SAST (Cape Town)

14 February, 11:30 - 12:45 EST (New York)

14 February, 01:30 - 02:45 KST (Seoul)

14 February, 00:30 - 01:45 CST (Beijing)

14 February, 22:00 - 23:15 IST (New Delhi)

14 February, 20:30 - 21:45 GST (Dubai)

Special session: Alert-early warning system for outbreaks with pandemic potential (AESOP)
Jeremy Farrar
Meet
Jeremy Farrar
Jeremy Farrar
Wellcome Trust
Director
×
Jeremy Farrar
Jeremy Farrar
Wellcome Trust
Director

Health

Meet Jeremy Farrar during this session

13 February, 13:30 - 14:45 BRT (Rio de Janeiro)

13 February, 17:30 - 18:45 CET (Brussels)

13 February, 17:30 - 18:45 WAT (Nigeria)

13 February, 18:30 - 19:45 SAST (Cape Town)

13 February, 11:30 - 12:45 EST (New York)

13 February, 01:30 - 02:45 KST (Seoul)

13 February, 00:30 - 01:45 CST (Beijing)

13 February, 22:00 - 23:15 IST (New Delhi)

13 February, 20:30 - 21:45 GST (Dubai)

Plenary session: Strategies for a better Covid-19 recovery and preparedness for future healthcare crises
Rachel  Chikwamba
Meet
Rachel Chikwamba
Rachel Chikwamba
CSIR
Group Executive: Advanced Chemistry and Life Sciences
×
Rachel  Chikwamba
Rachel Chikwamba
CSIR
Group Executive: Advanced Chemistry and Life Sciences

Cross-thematic Health

Meet Rachel Chikwamba during these sessions

13 February, 09:30 - 10:30 BRT (Rio de Janeiro)

13 February, 13:30 - 14:30 CET (Brussels)

13 February, 13:30 - 14:30 WAT (Nigeria)

13 February, 14:30 - 15:30 SAST (Cape Town)

13 February, 07:30 - 08:30 EST (New York)

13 February, 21:30 - 22:30 KST (Seoul)

13 February, 20:30 - 21:30 CST (Beijing)

13 February, 18:00 - 19:00 IST (New Delhi)

13 February, 16:30 - 17:30 GST (Dubai)

Plenary session: Opening Ceremony – Innovative technological solutions for a post-pandemic recovery

14 February, 09:00 - 16:15 BRT (Rio de Janeiro)

14 February, 13:00 - 20:15 CET (Brussels)

14 February, 13:00 - 20:15 WAT (Nigeria)

14 February, 14:00 - 21:15 SAST (Cape Town)

14 February, 07:00 - 14:15 EST (New York)

14 February, 21:00 - 04:15 KST (Seoul)

14 February, 20:00 - 03:15 CST (Beijing)

14 February, 17:30 - 00:45 IST (New Delhi)

14 February, 16:00 - 23:15 GST (Dubai)

Vaccines and immunization: Challenges and perspectives for local manufacturing

15 February, 15:15 - 16:30 BRT (Rio de Janeiro)

15 February, 19:15 - 20:30 CET (Brussels)

15 February, 19:15 - 20:30 WAT (Nigeria)

15 February, 20:15 - 21:30 SAST (Cape Town)

15 February, 13:15 - 14:30 EST (New York)

15 February, 03:15 - 04:30 KST (Seoul)

15 February, 02:15 - 03:30 CST (Beijing)

15 February, 23:45 - 01:00 IST (New Delhi)

15 February, 22:15 - 23:30 GST (Dubai)

High-level closing ceremony
Sylvain  Aldighieri
Meet
Sylvain Aldighieri
Sylvain Aldighieri
Pan American Health Organization (PAHO)
Incident manager for COVID-19
×
Sylvain  Aldighieri
Sylvain Aldighieri
Pan American Health Organization (PAHO)
Incident manager for COVID-19

Health

Meet Sylvain Aldighieri during this session

13 February, 13:30 - 14:45 BRT (Rio de Janeiro)

13 February, 17:30 - 18:45 CET (Brussels)

13 February, 17:30 - 18:45 WAT (Nigeria)

13 February, 18:30 - 19:45 SAST (Cape Town)

13 February, 11:30 - 12:45 EST (New York)

13 February, 01:30 - 02:45 KST (Seoul)

13 February, 00:30 - 01:45 CST (Beijing)

13 February, 22:00 - 23:15 IST (New Delhi)

13 February, 20:30 - 21:45 GST (Dubai)

Plenary session: Strategies for a better Covid-19 recovery and preparedness for future healthcare crises
Frank Vandenbroucke
Meet
Frank Vandenbroucke
Frank Vandenbroucke
Belgium
Deputy Prime Minister and Minister of Social Affairs and Public Health
×
Frank Vandenbroucke
Frank Vandenbroucke
Belgium
Deputy Prime Minister and Minister of Social Affairs and Public Health

Cross-thematic Health

Meet Frank Vandenbroucke during this session

13 February, 13:30 - 14:45 BRT (Rio de Janeiro)

13 February, 17:30 - 18:45 CET (Brussels)

13 February, 17:30 - 18:45 WAT (Nigeria)

13 February, 18:30 - 19:45 SAST (Cape Town)

13 February, 11:30 - 12:45 EST (New York)

13 February, 01:30 - 02:45 KST (Seoul)

13 February, 00:30 - 01:45 CST (Beijing)

13 February, 22:00 - 23:15 IST (New Delhi)

13 February, 20:30 - 21:45 GST (Dubai)

Plenary session: Strategies for a better Covid-19 recovery and preparedness for future healthcare crises
James  Fitzgerald
Meet
James Fitzgerald
James Fitzgerald
PAHO/WHO
Director, Health Systems and Services
×
James  Fitzgerald
James Fitzgerald
PAHO/WHO
Director, Health Systems and Services

Health

Meet James Fitzgerald during these sessions

14 February, 09:00 - 16:15 BRT (Rio de Janeiro)

14 February, 13:00 - 20:15 CET (Brussels)

14 February, 13:00 - 20:15 WAT (Nigeria)

14 February, 14:00 - 21:15 SAST (Cape Town)

14 February, 07:00 - 14:15 EST (New York)

14 February, 21:00 - 04:15 KST (Seoul)

14 February, 20:00 - 03:15 CST (Beijing)

14 February, 17:30 - 00:45 IST (New Delhi)

14 February, 16:00 - 23:15 GST (Dubai)

Vaccines and immunization: Challenges and perspectives for local manufacturing

15 February, 09:00 - 12:00 BRT (Rio de Janeiro)

15 February, 13:00 - 16:00 CET (Brussels)

15 February, 13:00 - 16:00 WAT (Nigeria)

15 February, 14:00 - 17:00 SAST (Cape Town)

15 February, 07:00 - 10:00 EST (New York)

15 February, 21:00 - 00:00 KST (Seoul)

15 February, 20:00 - 23:00 CST (Beijing)

15 February, 17:30 - 20:30 IST (New Delhi)

15 February, 16:00 - 19:00 GST (Dubai)

Vaccines and immunization: Challenges and perspectives for local manufacturing
Carla  Vizzotti
Meet
Carla Vizzotti
Carla Vizzotti
Argentina
Health Minister
×
Carla  Vizzotti
Carla Vizzotti
Argentina
Health Minister

Health

Meet Carla Vizzotti during these sessions

14 February, 09:00 - 16:15 BRT (Rio de Janeiro)

14 February, 13:00 - 20:15 CET (Brussels)

14 February, 13:00 - 20:15 WAT (Nigeria)

14 February, 14:00 - 21:15 SAST (Cape Town)

14 February, 07:00 - 14:15 EST (New York)

14 February, 21:00 - 04:15 KST (Seoul)

14 February, 20:00 - 03:15 CST (Beijing)

14 February, 17:30 - 00:45 IST (New Delhi)

14 February, 16:00 - 23:15 GST (Dubai)

Vaccines and immunization: Challenges and perspectives for local manufacturing

15 February, 09:00 - 12:00 BRT (Rio de Janeiro)

15 February, 13:00 - 16:00 CET (Brussels)

15 February, 13:00 - 16:00 WAT (Nigeria)

15 February, 14:00 - 17:00 SAST (Cape Town)

15 February, 07:00 - 10:00 EST (New York)

15 February, 21:00 - 00:00 KST (Seoul)

15 February, 20:00 - 23:00 CST (Beijing)

15 February, 17:30 - 20:30 IST (New Delhi)

15 February, 16:00 - 19:00 GST (Dubai)

Vaccines and immunization: Challenges and perspectives for local manufacturing
Karin Bok
Meet
Karin Bok
Karin Bok
National Institute of Allergy and Infectious Diseases (NIAID), Vaccine Research Center
Deputy Director (Acting), Director of Pandemic Preparedness and Emergency Response
×
Karin Bok
Karin Bok
National Institute of Allergy and Infectious Diseases (NIAID), Vaccine Research Center
Deputy Director (Acting), Director of Pandemic Preparedness and Emergency Response

Health

Meet Karin Bok during this session

14 February, 09:00 - 16:15 BRT (Rio de Janeiro)

14 February, 13:00 - 20:15 CET (Brussels)

14 February, 13:00 - 20:15 WAT (Nigeria)

14 February, 14:00 - 21:15 SAST (Cape Town)

14 February, 07:00 - 14:15 EST (New York)

14 February, 21:00 - 04:15 KST (Seoul)

14 February, 20:00 - 03:15 CST (Beijing)

14 February, 17:30 - 00:45 IST (New Delhi)

14 February, 16:00 - 23:15 GST (Dubai)

Vaccines and immunization: Challenges and perspectives for local manufacturing
Akira  Homma
Meet
Akira Homma
Akira Homma
Bio-Manguinhos
Senior scientific advisor
×
Akira  Homma
Akira Homma
Bio-Manguinhos
Senior scientific advisor

Health

Meet Akira Homma during this session

15 February, 09:00 - 12:00 BRT (Rio de Janeiro)

15 February, 13:00 - 16:00 CET (Brussels)

15 February, 13:00 - 16:00 WAT (Nigeria)

15 February, 14:00 - 17:00 SAST (Cape Town)

15 February, 07:00 - 10:00 EST (New York)

15 February, 21:00 - 00:00 KST (Seoul)

15 February, 20:00 - 23:00 CST (Beijing)

15 February, 17:30 - 20:30 IST (New Delhi)

15 February, 16:00 - 19:00 GST (Dubai)

Vaccines and immunization: Challenges and perspectives for local manufacturing
Nísia Trindade Lima
Nísia Trindade Lima
Brazil
Minister of Health
Phoebe Koundouri
Phoebe Koundouri
Athens University of Economics and Business and Technical University of Denmark
Professor in Economics
Ana Bento
Ana Bento
The Rockefeller Foundation
Director of Science, Pandemic Prevention Institute Health Initiative
Jeremy Farrar
Jeremy Farrar
Wellcome Trust
Director
Rachel  Chikwamba
Rachel Chikwamba
CSIR
Group Executive: Advanced Chemistry and Life Sciences
Sylvain  Aldighieri
Sylvain Aldighieri
Pan American Health Organization (PAHO)
Incident manager for COVID-19
Frank Vandenbroucke
Frank Vandenbroucke
Belgium
Deputy Prime Minister and Minister of Social Affairs and Public Health
James  Fitzgerald
James Fitzgerald
PAHO/WHO
Director, Health Systems and Services
Carla  Vizzotti
Carla Vizzotti
Argentina
Health Minister
Karin Bok
Karin Bok
National Institute of Allergy and Infectious Diseases (NIAID), Vaccine Research Center
Deputy Director (Acting), Director of Pandemic Preparedness and Emergency Response
Akira  Homma
Akira Homma
Bio-Manguinhos
Senior scientific advisor

Have a discussion with top experts during the G-STIC Conference February 2023

Get new insights about technological solutions for the SDGs

Lav Agarwal
Meet
Lav Agarwal
Lav Agarwal
Government of India
Additional Secretary, Ministry of Health & Family Welfare
×
Lav Agarwal
Lav Agarwal
Government of India
Additional Secretary, Ministry of Health & Family Welfare

Health

Meet Lav Agarwal during this session

14 February, 09:00 - 16:15 BRT (Rio de Janeiro)

14 February, 13:00 - 20:15 CET (Brussels)

14 February, 13:00 - 20:15 WAT (Nigeria)

14 February, 14:00 - 21:15 SAST (Cape Town)

14 February, 07:00 - 14:15 EST (New York)

14 February, 21:00 - 04:15 KST (Seoul)

14 February, 20:00 - 03:15 CST (Beijing)

14 February, 17:30 - 00:45 IST (New Delhi)

14 February, 16:00 - 23:15 GST (Dubai)

Vaccines and immunization: Challenges and perspectives for local manufacturing
Luiz Paulo Assad
Meet
Luiz Paulo Assad
Luiz Paulo Assad
Federal University Rio de Janeiro (UFRJ)
Professor
×
Luiz Paulo Assad
Luiz Paulo Assad
Federal University Rio de Janeiro (UFRJ)
Professor

Energy Health Oceans

Meet Luiz Paulo Assad during these sessions

13 February, 16:30 - 17:45 BRT (Rio de Janeiro)

13 February, 20:30 - 21:45 CET (Brussels)

13 February, 20:30 - 21:45 WAT (Nigeria)

13 February, 21:30 - 22:45 SAST (Cape Town)

13 February, 14:30 - 15:45 EST (New York)

13 February, 04:30 - 05:45 KST (Seoul)

13 February, 03:30 - 04:45 CST (Beijing)

13 February, 01:00 - 02:15 IST (New Delhi)

13 February, 23:30 - 00:45 GST (Dubai)

Plenary session: Accelerating the uptake of renewable energy and carbon neutrality

14 February, 13:30 - 14:45 BRT (Rio de Janeiro)

14 February, 17:30 - 18:45 CET (Brussels)

14 February, 17:30 - 18:45 WAT (Nigeria)

14 February, 18:30 - 19:45 SAST (Cape Town)

14 February, 11:30 - 12:45 EST (New York)

14 February, 01:30 - 02:45 KST (Seoul)

14 February, 00:30 - 01:45 CST (Beijing)

14 February, 22:00 - 23:15 IST (New Delhi)

14 February, 20:30 - 21:45 GST (Dubai)

Plenary session: The future of our oceans
Manoel Barral
Meet
Manoel Barral
Manoel Barral
Fiocruz
CIDACs Senior Researcher
×
Manoel Barral
Manoel Barral
Fiocruz
CIDACs Senior Researcher

Cross-thematic Health

Meet Manoel Barral during these sessions

13 February, 16:30 - 17:45 BRT (Rio de Janeiro)

13 February, 20:30 - 21:45 CET (Brussels)

13 February, 20:30 - 21:45 WAT (Nigeria)

13 February, 21:30 - 22:45 SAST (Cape Town)

13 February, 14:30 - 15:45 EST (New York)

13 February, 04:30 - 05:45 KST (Seoul)

13 February, 03:30 - 04:45 CST (Beijing)

13 February, 01:00 - 02:15 IST (New Delhi)

13 February, 23:30 - 00:45 GST (Dubai)

Special session: Challenges in building health surveillance systems

14 February, 13:30 - 14:45 BRT (Rio de Janeiro)

14 February, 17:30 - 18:45 CET (Brussels)

14 February, 17:30 - 18:45 WAT (Nigeria)

14 February, 18:30 - 19:45 SAST (Cape Town)

14 February, 11:30 - 12:45 EST (New York)

14 February, 01:30 - 02:45 KST (Seoul)

14 February, 00:30 - 01:45 CST (Beijing)

14 February, 22:00 - 23:15 IST (New Delhi)

14 February, 20:30 - 21:45 GST (Dubai)

Special session: Alert-early warning system for outbreaks with pandemic potential (AESOP)
Maurício Barreto
Meet
Maurício Barreto
Maurício Barreto
Oswaldo Cruz Foundation
Senior Researcher
×
Maurício Barreto
Maurício Barreto
Oswaldo Cruz Foundation
Senior Researcher

Health

Meet Maurício Barreto during this session

13 February, 15:00 - 16:15 BRT (Rio de Janeiro)

13 February, 19:00 - 20:15 CET (Brussels)

13 February, 19:00 - 20:15 WAT (Nigeria)

13 February, 20:00 - 21:15 SAST (Cape Town)

13 February, 13:00 - 14:15 EST (New York)

13 February, 03:00 - 04:15 KST (Seoul)

13 February, 02:00 - 03:15 CST (Beijing)

13 February, 23:30 - 00:45 IST (New Delhi)

13 February, 22:00 - 23:15 GST (Dubai)

Special session: Challenges and opportunities in planetary health
Priya Basu
Meet
Priya Basu
Priya Basu
The Pandemic Fund, World Bank Group
Executive Head
×
Priya Basu
Priya Basu
The Pandemic Fund, World Bank Group
Executive Head

Health

Meet Priya Basu during this session

15 February, 09:00 - 12:00 BRT (Rio de Janeiro)

15 February, 13:00 - 16:00 CET (Brussels)

15 February, 13:00 - 16:00 WAT (Nigeria)

15 February, 14:00 - 17:00 SAST (Cape Town)

15 February, 07:00 - 10:00 EST (New York)

15 February, 21:00 - 00:00 KST (Seoul)

15 February, 20:00 - 23:00 CST (Beijing)

15 February, 17:30 - 20:30 IST (New Delhi)

15 February, 16:00 - 19:00 GST (Dubai)

Vaccines and immunization: Challenges and perspectives for local manufacturing
Daniel Buss
Meet
Daniel Buss
Daniel Buss
Pan American Health Organization (PAHO)
Unit Chief Climate Change and Environmental Determinants of Health (CDE-CE)
×
Daniel Buss
Daniel Buss
Pan American Health Organization (PAHO)
Unit Chief Climate Change and Environmental Determinants of Health (CDE-CE)

Health

Meet Daniel Buss during these sessions

13 February, 15:00 - 16:15 BRT (Rio de Janeiro)

13 February, 19:00 - 20:15 CET (Brussels)

13 February, 19:00 - 20:15 WAT (Nigeria)

13 February, 20:00 - 21:15 SAST (Cape Town)

13 February, 13:00 - 14:15 EST (New York)

13 February, 03:00 - 04:15 KST (Seoul)

13 February, 02:00 - 03:15 CST (Beijing)

13 February, 23:30 - 00:45 IST (New Delhi)

13 February, 22:00 - 23:15 GST (Dubai)

Special session: Challenges and opportunities in planetary health

14 February, 15:00 - 16:15 BRT (Rio de Janeiro)

14 February, 19:00 - 20:15 CET (Brussels)

14 February, 19:00 - 20:15 WAT (Nigeria)

14 February, 20:00 - 21:15 SAST (Cape Town)

14 February, 13:00 - 14:15 EST (New York)

14 February, 03:00 - 04:15 KST (Seoul)

14 February, 02:00 - 03:15 CST (Beijing)

14 February, 23:30 - 00:45 IST (New Delhi)

14 February, 22:00 - 23:15 GST (Dubai)

Deep dive session: Preparedness and response to health emergencies – The role of cities
Paul Buss
Meet
Paul Buss
Paul Buss
Fiocruz
Director of the Center for Global Health and International Relations
×
Paul Buss
Paul Buss
Fiocruz
Director of the Center for Global Health and International Relations

Health

Meet Paul Buss during this session

15 February, 10:00 - 12:15 BRT (Rio de Janeiro)

15 February, 14:00 - 16:15 CET (Brussels)

15 February, 14:00 - 16:15 WAT (Nigeria)

15 February, 15:00 - 17:15 SAST (Cape Town)

15 February, 08:00 - 10:15 EST (New York)

15 February, 22:00 - 00:15 KST (Seoul)

15 February, 21:00 - 23:15 CST (Beijing)

15 February, 18:30 - 20:45 IST (New Delhi)

15 February, 17:00 - 19:15 GST (Dubai)

Special session: STI and the 2023 Global Health Agenda
Márcia Chame
Meet
Márcia Chame
Márcia Chame
Oswaldo Cruz Foundation
Researcher
×
Márcia Chame
Márcia Chame
Oswaldo Cruz Foundation
Researcher

Cross-thematic Health

Meet Márcia Chame during this session

15 February, 13:30 - 15:15 BRT (Rio de Janeiro)

15 February, 17:30 - 19:15 CET (Brussels)

15 February, 17:30 - 19:15 WAT (Nigeria)

15 February, 18:30 - 20:15 SAST (Cape Town)

15 February, 11:30 - 13:15 EST (New York)

15 February, 01:30 - 03:15 KST (Seoul)

15 February, 00:30 - 02:15 CST (Beijing)

15 February, 22:00 - 23:45 IST (New Delhi)

15 February, 20:30 - 22:15 GST (Dubai)

Plenary session: Biodiversity – We are all nature
Rosane Cuber
Meet
Rosane Cuber
Rosane Cuber
Bio-Manguinhos
Deputy Director of Quality
×
Rosane Cuber
Rosane Cuber
Bio-Manguinhos
Deputy Director of Quality

Health

Hugo G.  da Silva
Meet
Hugo G. da Silva
Hugo G. da Silva
AstraZeneca
Global Head of Vaccines
×
Hugo G.  da Silva
Hugo G. da Silva
AstraZeneca
Global Head of Vaccines

Health

Meet Hugo G. da Silva during this session

14 February, 09:00 - 16:15 BRT (Rio de Janeiro)

14 February, 13:00 - 20:15 CET (Brussels)

14 February, 13:00 - 20:15 WAT (Nigeria)

14 February, 14:00 - 21:15 SAST (Cape Town)

14 February, 07:00 - 14:15 EST (New York)

14 February, 21:00 - 04:15 KST (Seoul)

14 February, 20:00 - 03:15 CST (Beijing)

14 February, 17:30 - 00:45 IST (New Delhi)

14 February, 16:00 - 23:15 GST (Dubai)

Vaccines and immunization: Challenges and perspectives for local manufacturing
Elizabet Diago
Meet
Elizabet Diago
Elizabet Diago
ISGlobal
Preparedness Program Manager
×
Elizabet Diago
Elizabet Diago
ISGlobal
Preparedness Program Manager

Health

Meet Elizabet Diago during this session

14 February, 15:00 - 16:15 BRT (Rio de Janeiro)

14 February, 19:00 - 20:15 CET (Brussels)

14 February, 19:00 - 20:15 WAT (Nigeria)

14 February, 20:00 - 21:15 SAST (Cape Town)

14 February, 13:00 - 14:15 EST (New York)

14 February, 03:00 - 04:15 KST (Seoul)

14 February, 02:00 - 03:15 CST (Beijing)

14 February, 23:30 - 00:45 IST (New Delhi)

14 February, 22:00 - 23:15 GST (Dubai)

Deep dive session: Preparedness and response to health emergencies – The role of cities
Anand  Ekambaram
Meet
Anand Ekambaram
Anand Ekambaram
CEPI
Executive Director Manufacturing and Supply Chain Management
×
Anand  Ekambaram
Anand Ekambaram
CEPI
Executive Director Manufacturing and Supply Chain Management

Health

Meet Anand Ekambaram during this session

14 February, 09:00 - 16:15 BRT (Rio de Janeiro)

14 February, 13:00 - 20:15 CET (Brussels)

14 February, 13:00 - 20:15 WAT (Nigeria)

14 February, 14:00 - 21:15 SAST (Cape Town)

14 February, 07:00 - 14:15 EST (New York)

14 February, 21:00 - 04:15 KST (Seoul)

14 February, 20:00 - 03:15 CST (Beijing)

14 February, 17:30 - 00:45 IST (New Delhi)

14 February, 16:00 - 23:15 GST (Dubai)

Vaccines and immunization: Challenges and perspectives for local manufacturing
Lieve Fransen
Meet
Lieve Fransen
Lieve Fransen
European Policy Centre
Senior Adviser on Health, Social, and Migration Policies
×
Lieve Fransen
Lieve Fransen
European Policy Centre
Senior Adviser on Health, Social, and Migration Policies

Health

Meet Lieve Fransen during this session

13 February, 13:30 - 14:45 BRT (Rio de Janeiro)

13 February, 17:30 - 18:45 CET (Brussels)

13 February, 17:30 - 18:45 WAT (Nigeria)

13 February, 18:30 - 19:45 SAST (Cape Town)

13 February, 11:30 - 12:45 EST (New York)

13 February, 01:30 - 02:45 KST (Seoul)

13 February, 00:30 - 01:45 CST (Beijing)

13 February, 22:00 - 23:15 IST (New Delhi)

13 February, 20:30 - 21:45 GST (Dubai)

Plenary session: Strategies for a better Covid-19 recovery and preparedness for future healthcare crises
Xiaolan  Fu
Meet
Xiaolan Fu
Xiaolan Fu
Technology and Management Centre for Development
Founding Director
×
Xiaolan  Fu
Xiaolan Fu
Technology and Management Centre for Development
Founding Director

Health

Meet Xiaolan Fu during this session

15 February, 09:00 - 12:00 BRT (Rio de Janeiro)

15 February, 13:00 - 16:00 CET (Brussels)

15 February, 13:00 - 16:00 WAT (Nigeria)

15 February, 14:00 - 17:00 SAST (Cape Town)

15 February, 07:00 - 10:00 EST (New York)

15 February, 21:00 - 00:00 KST (Seoul)

15 February, 20:00 - 23:00 CST (Beijing)

15 February, 17:30 - 20:30 IST (New Delhi)

15 February, 16:00 - 19:00 GST (Dubai)

Vaccines and immunization: Challenges and perspectives for local manufacturing
Harikumar  Gadde
Meet
Harikumar Gadde
Harikumar Gadde
World Bank
Senior Climate Change Specialist
×
Harikumar  Gadde
Harikumar Gadde
World Bank
Senior Climate Change Specialist

Climate Health

Meet Harikumar Gadde during this session

14 February, 10:30 - 12:00 BRT (Rio de Janeiro)

14 February, 14:30 - 16:00 CET (Brussels)

14 February, 14:30 - 16:00 WAT (Nigeria)

14 February, 15:30 - 17:00 SAST (Cape Town)

14 February, 08:30 - 10:00 EST (New York)

14 February, 22:30 - 00:00 KST (Seoul)

14 February, 21:30 - 23:00 CST (Beijing)

14 February, 19:00 - 20:30 IST (New Delhi)

14 February, 17:30 - 19:00 GST (Dubai)

Plenary session: Integrated innovative technologies and supporting financing mechanisms to prevent, adapt and manage climate change impacts
Paulo Gadelha
Meet
Paulo Gadelha
Paulo Gadelha
Fiocruz Strategy for 2030 Agenda
Coordinator
×
Paulo Gadelha
Paulo Gadelha
Fiocruz Strategy for 2030 Agenda
Coordinator

Cross-thematic Health

Meet Paulo Gadelha during these sessions

13 February, 09:30 - 10:30 BRT (Rio de Janeiro)

13 February, 13:30 - 14:30 CET (Brussels)

13 February, 13:30 - 14:30 WAT (Nigeria)

13 February, 14:30 - 15:30 SAST (Cape Town)

13 February, 07:30 - 08:30 EST (New York)

13 February, 21:30 - 22:30 KST (Seoul)

13 February, 20:30 - 21:30 CST (Beijing)

13 February, 18:00 - 19:00 IST (New Delhi)

13 February, 16:30 - 17:30 GST (Dubai)

Plenary session: Opening Ceremony – Innovative technological solutions for a post-pandemic recovery

13 February, 13:30 - 14:45 BRT (Rio de Janeiro)

13 February, 17:30 - 18:45 CET (Brussels)

13 February, 17:30 - 18:45 WAT (Nigeria)

13 February, 18:30 - 19:45 SAST (Cape Town)

13 February, 11:30 - 12:45 EST (New York)

13 February, 01:30 - 02:45 KST (Seoul)

13 February, 00:30 - 01:45 CST (Beijing)

13 February, 22:00 - 23:15 IST (New Delhi)

13 February, 20:30 - 21:45 GST (Dubai)

Plenary session: Strategies for a better Covid-19 recovery and preparedness for future healthcare crises

15 February, 15:15 - 16:30 BRT (Rio de Janeiro)

15 February, 19:15 - 20:30 CET (Brussels)

15 February, 19:15 - 20:30 WAT (Nigeria)

15 February, 20:15 - 21:30 SAST (Cape Town)

15 February, 13:15 - 14:30 EST (New York)

15 February, 03:15 - 04:30 KST (Seoul)

15 February, 02:15 - 03:30 CST (Beijing)

15 February, 23:45 - 01:00 IST (New Delhi)

15 February, 22:15 - 23:30 GST (Dubai)

High-level closing ceremony
Biography

As coordinator of the Fiocruz Strategy for the 2030 Agenda, Gadelha is in charge of promoting strategic engagement between Fiocruz and the UN Sustainable Development Goals (SDGs). His background includes studies of the application of technology in public health, healthcare models, and enhancing Science, Technology, and Innovation (STI) for the SDGs.

Gadelha served as president of Fiocruz from 2009 to 2016, leading scientific achievements in biomedical sciences, generation of scientific and technological knowledge, and health and social development promotion. Between 2016 and 2021, Dr. Gadelha was appointed by the UN Secretary-General as a member of the Technology Facilitation Mechanism (UN-TFM) ‘10-Member Group’ to provide expertise and support to the UN Inter-agency Task Team (IATT) on STI for the SDGs.

Previously, he founded and directed the “Casa de Oswaldo Cruz,” a Fiocruz institute dedicated to the sociology and history of science and health. Dr. Gadelha also served as a member of the National Health Council’s Science and Technology Intersectoral Commission. As President of the Brazilian Association of Collective Health, he chaired the 11th World Congress on Public Health. In 2017, with UN/DESA, he chaired the efforts of Fiocruz in organizing the 1st Consultation on Health and STI in the 2030 Agenda’s implementation.

Luiz Augusto Galvão
Meet
Luiz Augusto Galvão
Luiz Augusto Galvão
Oswaldo Cruz Foundation
Senior Researcher
×
Luiz Augusto Galvão
Luiz Augusto Galvão
Oswaldo Cruz Foundation
Senior Researcher

Health

Meet Luiz Augusto Galvão during this session

13 February, 15:00 - 16:15 BRT (Rio de Janeiro)

13 February, 19:00 - 20:15 CET (Brussels)

13 February, 19:00 - 20:15 WAT (Nigeria)

13 February, 20:00 - 21:15 SAST (Cape Town)

13 February, 13:00 - 14:15 EST (New York)

13 February, 03:00 - 04:15 KST (Seoul)

13 February, 02:00 - 03:15 CST (Beijing)

13 February, 23:30 - 00:45 IST (New Delhi)

13 February, 22:00 - 23:15 GST (Dubai)

Special session: Challenges and opportunities in planetary health
Nicolo Gligo
Meet
Nicolo Gligo
Nicolo Gligo
Economic Commission for Latin America and the Caribbean (ECLAC)
Economic Affairs Officer
×
Nicolo Gligo
Nicolo Gligo
Economic Commission for Latin America and the Caribbean (ECLAC)
Economic Affairs Officer

Health

Meet Nicolo Gligo during this session

14 February, 09:00 - 16:15 BRT (Rio de Janeiro)

14 February, 13:00 - 20:15 CET (Brussels)

14 February, 13:00 - 20:15 WAT (Nigeria)

14 February, 14:00 - 21:15 SAST (Cape Town)

14 February, 07:00 - 14:15 EST (New York)

14 February, 21:00 - 04:15 KST (Seoul)

14 February, 20:00 - 03:15 CST (Beijing)

14 February, 17:30 - 00:45 IST (New Delhi)

14 February, 16:00 - 23:15 GST (Dubai)

Vaccines and immunization: Challenges and perspectives for local manufacturing
Andrew Haines
Meet
Andrew Haines
Andrew Haines
London School of Hygiene and Tropical Medicine
Professor of Environmental Change and Public Health
×
Andrew Haines
Andrew Haines
London School of Hygiene and Tropical Medicine
Professor of Environmental Change and Public Health

Health

Meet Andrew Haines during this session

13 February, 15:00 - 16:15 BRT (Rio de Janeiro)

13 February, 19:00 - 20:15 CET (Brussels)

13 February, 19:00 - 20:15 WAT (Nigeria)

13 February, 20:00 - 21:15 SAST (Cape Town)

13 February, 13:00 - 14:15 EST (New York)

13 February, 03:00 - 04:15 KST (Seoul)

13 February, 02:00 - 03:15 CST (Beijing)

13 February, 23:30 - 00:45 IST (New Delhi)

13 February, 22:00 - 23:15 GST (Dubai)

Special session: Challenges and opportunities in planetary health
William  Hall
Meet
William Hall
William Hall
Wellcome Trust
Head of Global Government Relations
×
William  Hall
William Hall
Wellcome Trust
Head of Global Government Relations

Health

Meet William Hall during this session

14 February, 09:00 - 16:15 BRT (Rio de Janeiro)

14 February, 13:00 - 20:15 CET (Brussels)

14 February, 13:00 - 20:15 WAT (Nigeria)

14 February, 14:00 - 21:15 SAST (Cape Town)

14 February, 07:00 - 14:15 EST (New York)

14 February, 21:00 - 04:15 KST (Seoul)

14 February, 20:00 - 03:15 CST (Beijing)

14 February, 17:30 - 00:45 IST (New Delhi)

14 February, 16:00 - 23:15 GST (Dubai)

Vaccines and immunization: Challenges and perspectives for local manufacturing
John Haynes
Meet
John Haynes
John Haynes
Applied Sciences Program of the NASA Earth Science Division
Program Manager for Health and Air Quality Applications
×
John Haynes
John Haynes
Applied Sciences Program of the NASA Earth Science Division
Program Manager for Health and Air Quality Applications

Health

Meet John Haynes during this session

13 February, 16:30 - 17:45 BRT (Rio de Janeiro)

13 February, 20:30 - 21:45 CET (Brussels)

13 February, 20:30 - 21:45 WAT (Nigeria)

13 February, 21:30 - 22:45 SAST (Cape Town)

13 February, 14:30 - 15:45 EST (New York)

13 February, 04:30 - 05:45 KST (Seoul)

13 February, 03:30 - 04:45 CST (Beijing)

13 February, 01:00 - 02:15 IST (New Delhi)

13 February, 23:30 - 00:45 GST (Dubai)

Special session: Challenges in building health surveillance systems
Ike James
Meet
Ike James
Ike James
Medicines Patent Pool
Head of Technology Transfer
×
Ike James
Ike James
Medicines Patent Pool
Head of Technology Transfer

Health

Meet Ike James during this session

15 February, 09:00 - 12:00 BRT (Rio de Janeiro)

15 February, 13:00 - 16:00 CET (Brussels)

15 February, 13:00 - 16:00 WAT (Nigeria)

15 February, 14:00 - 17:00 SAST (Cape Town)

15 February, 07:00 - 10:00 EST (New York)

15 February, 21:00 - 00:00 KST (Seoul)

15 February, 20:00 - 23:00 CST (Beijing)

15 February, 17:30 - 20:30 IST (New Delhi)

15 February, 16:00 - 19:00 GST (Dubai)

Vaccines and immunization: Challenges and perspectives for local manufacturing
Marco Krieger
Meet
Marco Krieger
Marco Krieger
Oswaldo Cruz Foundation (Fiocruz)
Vice-president of Health Production and Innovation in Health
×
Marco Krieger
Marco Krieger
Oswaldo Cruz Foundation (Fiocruz)
Vice-president of Health Production and Innovation in Health

Cross-thematic Health

Meet Marco Krieger during these sessions

13 February, 13:30 - 14:45 BRT (Rio de Janeiro)

13 February, 17:30 - 18:45 CET (Brussels)

13 February, 17:30 - 18:45 WAT (Nigeria)

13 February, 18:30 - 19:45 SAST (Cape Town)

13 February, 11:30 - 12:45 EST (New York)

13 February, 01:30 - 02:45 KST (Seoul)

13 February, 00:30 - 01:45 CST (Beijing)

13 February, 22:00 - 23:15 IST (New Delhi)

13 February, 20:30 - 21:45 GST (Dubai)

Plenary session: Strategies for a better Covid-19 recovery and preparedness for future healthcare crises

14 February, 15:00 - 16:15 BRT (Rio de Janeiro)

14 February, 19:00 - 20:15 CET (Brussels)

14 February, 19:00 - 20:15 WAT (Nigeria)

14 February, 20:00 - 21:15 SAST (Cape Town)

14 February, 13:00 - 14:15 EST (New York)

14 February, 03:00 - 04:15 KST (Seoul)

14 February, 02:00 - 03:15 CST (Beijing)

14 February, 23:30 - 00:45 IST (New Delhi)

14 February, 22:00 - 23:15 GST (Dubai)

Building mission-driven innovation ecosystems for sustainability
Roberto Lucchini
Meet
Roberto Lucchini (TBC)
Roberto Lucchini (TBC)
Florida International University
Professor of Environmental Health Sciences
×
Roberto Lucchini
Roberto Lucchini (TBC)
Florida International University
Professor of Environmental Health Sciences

Health

Meet Roberto Lucchini during this session

14 February, 15:00 - 16:15 BRT (Rio de Janeiro)

14 February, 19:00 - 20:15 CET (Brussels)

14 February, 19:00 - 20:15 WAT (Nigeria)

14 February, 20:00 - 21:15 SAST (Cape Town)

14 February, 13:00 - 14:15 EST (New York)

14 February, 03:00 - 04:15 KST (Seoul)

14 February, 02:00 - 03:15 CST (Beijing)

14 February, 23:30 - 00:45 IST (New Delhi)

14 February, 22:00 - 23:15 GST (Dubai)

Deep dive session: Preparedness and response to health emergencies – The role of cities
Ethel Maciel
Meet
Ethel Maciel
Ethel Maciel
Brazilian Ministry of Health
Secretary of Health and Environment Surveillance
×
Ethel Maciel
Ethel Maciel
Brazilian Ministry of Health
Secretary of Health and Environment Surveillance

Health

Meet Ethel Maciel during these sessions

13 February, 16:30 - 17:45 BRT (Rio de Janeiro)

13 February, 20:30 - 21:45 CET (Brussels)

13 February, 20:30 - 21:45 WAT (Nigeria)

13 February, 21:30 - 22:45 SAST (Cape Town)

13 February, 14:30 - 15:45 EST (New York)

13 February, 04:30 - 05:45 KST (Seoul)

13 February, 03:30 - 04:45 CST (Beijing)

13 February, 01:00 - 02:15 IST (New Delhi)

13 February, 23:30 - 00:45 GST (Dubai)

Special session: Challenges in building health surveillance systems

14 February, 09:00 - 16:15 BRT (Rio de Janeiro)

14 February, 13:00 - 20:15 CET (Brussels)

14 February, 13:00 - 20:15 WAT (Nigeria)

14 February, 14:00 - 21:15 SAST (Cape Town)

14 February, 07:00 - 14:15 EST (New York)

14 February, 21:00 - 04:15 KST (Seoul)

14 February, 20:00 - 03:15 CST (Beijing)

14 February, 17:30 - 00:45 IST (New Delhi)

14 February, 16:00 - 23:15 GST (Dubai)

Vaccines and immunization: Challenges and perspectives for local manufacturing
Clara Marín
Meet
Clara Marín
Clara Marín
ISGlobal
Policy Program Officer
×
Clara Marín
Clara Marín
ISGlobal
Policy Program Officer

Cross-thematic Health

Meet Clara Marín during these sessions

14 February, 15:00 - 16:15 BRT (Rio de Janeiro)

14 February, 19:00 - 20:15 CET (Brussels)

14 February, 19:00 - 20:15 WAT (Nigeria)

14 February, 20:00 - 21:15 SAST (Cape Town)

14 February, 13:00 - 14:15 EST (New York)

14 February, 03:00 - 04:15 KST (Seoul)

14 February, 02:00 - 03:15 CST (Beijing)

14 February, 23:30 - 00:45 IST (New Delhi)

14 February, 22:00 - 23:15 GST (Dubai)

Deep dive session: Preparedness and response to health emergencies – The role of cities

15 February, 10:30 - 12:00 BRT (Rio de Janeiro)

15 February, 14:30 - 16:00 CET (Brussels)

15 February, 14:30 - 16:00 WAT (Nigeria)

15 February, 15:30 - 17:00 SAST (Cape Town)

15 February, 08:30 - 10:00 EST (New York)

15 February, 22:30 - 00:00 KST (Seoul)

15 February, 21:30 - 23:00 CST (Beijing)

15 February, 19:00 - 20:30 IST (New Delhi)

15 February, 17:30 - 19:00 GST (Dubai)

Special session by SDSN: Global Solutions Forum
Oliver Morgan
Meet
Oliver Morgan
Oliver Morgan
World Health Organization
Director Health Emergency Information and Risk Assessment
×
Oliver Morgan
Oliver Morgan
World Health Organization
Director Health Emergency Information and Risk Assessment

Health

Meet Oliver Morgan during this session

13 February, 16:30 - 17:45 BRT (Rio de Janeiro)

13 February, 20:30 - 21:45 CET (Brussels)

13 February, 20:30 - 21:45 WAT (Nigeria)

13 February, 21:30 - 22:45 SAST (Cape Town)

13 February, 14:30 - 15:45 EST (New York)

13 February, 04:30 - 05:45 KST (Seoul)

13 February, 03:30 - 04:45 CST (Beijing)

13 February, 01:00 - 02:15 IST (New Delhi)

13 February, 23:30 - 00:45 GST (Dubai)

Special session: Challenges in building health surveillance systems
Juliette Morgan
Meet
Juliette Morgan
Juliette Morgan
US Centers for Disease Control and Prevention (CDC)
South America Regional Director
×
Juliette Morgan
Juliette Morgan
US Centers for Disease Control and Prevention (CDC)
South America Regional Director

Health

Meet Juliette Morgan during this session

13 February, 16:30 - 17:45 BRT (Rio de Janeiro)

13 February, 20:30 - 21:45 CET (Brussels)

13 February, 20:30 - 21:45 WAT (Nigeria)

13 February, 21:30 - 22:45 SAST (Cape Town)

13 February, 14:30 - 15:45 EST (New York)

13 February, 04:30 - 05:45 KST (Seoul)

13 February, 03:30 - 04:45 CST (Beijing)

13 February, 01:00 - 02:15 IST (New Delhi)

13 February, 23:30 - 00:45 GST (Dubai)

Special session: Challenges in building health surveillance systems
Jefferson Nascimento
Meet
Jefferson Nascimento
Jefferson Nascimento
OXFAM Brazil
Social & Economic Justice Coordinator
×
Jefferson Nascimento
Jefferson Nascimento
OXFAM Brazil
Social & Economic Justice Coordinator

Health

Meet Jefferson Nascimento during this session

15 February, 09:00 - 12:00 BRT (Rio de Janeiro)

15 February, 13:00 - 16:00 CET (Brussels)

15 February, 13:00 - 16:00 WAT (Nigeria)

15 February, 14:00 - 17:00 SAST (Cape Town)

15 February, 07:00 - 10:00 EST (New York)

15 February, 21:00 - 00:00 KST (Seoul)

15 February, 20:00 - 23:00 CST (Beijing)

15 February, 17:30 - 20:30 IST (New Delhi)

15 February, 16:00 - 19:00 GST (Dubai)

Vaccines and immunization: Challenges and perspectives for local manufacturing
Maria Neira
Meet
Maria Neira
Maria Neira
WHO headquarters
Assistant Director-General a.i., Division of UHC/Healthier Populations
×
Maria Neira
Maria Neira
WHO headquarters
Assistant Director-General a.i., Division of UHC/Healthier Populations

Health

Meet Maria Neira during this session

13 February, 15:00 - 16:15 BRT (Rio de Janeiro)

13 February, 19:00 - 20:15 CET (Brussels)

13 February, 19:00 - 20:15 WAT (Nigeria)

13 February, 20:00 - 21:15 SAST (Cape Town)

13 February, 13:00 - 14:15 EST (New York)

13 February, 03:00 - 04:15 KST (Seoul)

13 February, 02:00 - 03:15 CST (Beijing)

13 February, 23:30 - 00:45 IST (New Delhi)

13 February, 22:00 - 23:15 GST (Dubai)

Special session: Challenges and opportunities in planetary health
Cristiano G. Pereira
Meet
Cristiano G. Pereira
Cristiano G. Pereira
Butantan Institute
Innovation Tech Licensing Manager
×
Cristiano G. Pereira
Cristiano G. Pereira
Butantan Institute
Innovation Tech Licensing Manager

Health

Meet Cristiano G. Pereira during this session

14 February, 09:00 - 16:15 BRT (Rio de Janeiro)

14 February, 13:00 - 20:15 CET (Brussels)

14 February, 13:00 - 20:15 WAT (Nigeria)

14 February, 14:00 - 21:15 SAST (Cape Town)

14 February, 07:00 - 14:15 EST (New York)

14 February, 21:00 - 04:15 KST (Seoul)

14 February, 20:00 - 03:15 CST (Beijing)

14 February, 17:30 - 00:45 IST (New Delhi)

14 February, 16:00 - 23:15 GST (Dubai)

Vaccines and immunization: Challenges and perspectives for local manufacturing
Antoni Plasència
Meet
Antoni Plasència
Antoni Plasència
Barcelona Institute of Global Health (ISGlobal)
Director-General
×
Antoni Plasència
Antoni Plasència
Barcelona Institute of Global Health (ISGlobal)
Director-General

Health

Meet Antoni Plasència during this session

13 February, 13:30 - 14:45 BRT (Rio de Janeiro)

13 February, 17:30 - 18:45 CET (Brussels)

13 February, 17:30 - 18:45 WAT (Nigeria)

13 February, 18:30 - 19:45 SAST (Cape Town)

13 February, 11:30 - 12:45 EST (New York)

13 February, 01:30 - 02:45 KST (Seoul)

13 February, 00:30 - 01:45 CST (Beijing)

13 February, 22:00 - 23:15 IST (New Delhi)

13 February, 20:30 - 21:45 GST (Dubai)

Plenary session: Strategies for a better Covid-19 recovery and preparedness for future healthcare crises
Naveen  Rao
Meet
Naveen Rao
Naveen Rao
Global Health Rockefeller Foundation
Senior Executive Vice President
×
Naveen  Rao
Naveen Rao
Global Health Rockefeller Foundation
Senior Executive Vice President

Health

Meet Naveen Rao during this session

13 February, 13:30 - 14:45 BRT (Rio de Janeiro)

13 February, 17:30 - 18:45 CET (Brussels)

13 February, 17:30 - 18:45 WAT (Nigeria)

13 February, 18:30 - 19:45 SAST (Cape Town)

13 February, 11:30 - 12:45 EST (New York)

13 February, 01:30 - 02:45 KST (Seoul)

13 February, 00:30 - 01:45 CST (Beijing)

13 February, 22:00 - 23:15 IST (New Delhi)

13 February, 20:30 - 21:45 GST (Dubai)

Plenary session: Strategies for a better Covid-19 recovery and preparedness for future healthcare crises
Kumanan  Rasanathan
Meet
Kumanan Rasanathan
Kumanan Rasanathan
WHO
Executive Director, Alliance for Health Policy and Systems Research
×
Kumanan  Rasanathan
Kumanan Rasanathan
WHO
Executive Director, Alliance for Health Policy and Systems Research

Health

Meet Kumanan Rasanathan during this session

15 February, 10:00 - 12:15 BRT (Rio de Janeiro)

15 February, 14:00 - 16:15 CET (Brussels)

15 February, 14:00 - 16:15 WAT (Nigeria)

15 February, 15:00 - 17:15 SAST (Cape Town)

15 February, 08:00 - 10:15 EST (New York)

15 February, 22:00 - 00:15 KST (Seoul)

15 February, 21:00 - 23:15 CST (Beijing)

15 February, 18:30 - 20:45 IST (New Delhi)

15 February, 17:00 - 19:15 GST (Dubai)

Special session: STI and the 2023 Global Health Agenda
John  Reeder
Meet
John Reeder
John Reeder
WHO
Director of the Special Programme for Research and Training in Tropical Diseases
×
John  Reeder
John Reeder
WHO
Director of the Special Programme for Research and Training in Tropical Diseases

Health

Meet John Reeder during this session

15 February, 10:00 - 12:15 BRT (Rio de Janeiro)

15 February, 14:00 - 16:15 CET (Brussels)

15 February, 14:00 - 16:15 WAT (Nigeria)

15 February, 15:00 - 17:15 SAST (Cape Town)

15 February, 08:00 - 10:15 EST (New York)

15 February, 22:00 - 00:15 KST (Seoul)

15 February, 21:00 - 23:15 CST (Beijing)

15 February, 18:30 - 20:45 IST (New Delhi)

15 February, 17:00 - 19:15 GST (Dubai)

Special session: STI and the 2023 Global Health Agenda
Renata Reis
Meet
Renata Reis
Renata Reis
MSF Brazil
Executive Director
×
Renata Reis
Renata Reis
MSF Brazil
Executive Director

Health

Meet Renata Reis during this session

15 February, 09:00 - 12:00 BRT (Rio de Janeiro)

15 February, 13:00 - 16:00 CET (Brussels)

15 February, 13:00 - 16:00 WAT (Nigeria)

15 February, 14:00 - 17:00 SAST (Cape Town)

15 February, 07:00 - 10:00 EST (New York)

15 February, 21:00 - 00:00 KST (Seoul)

15 February, 20:00 - 23:00 CST (Beijing)

15 February, 17:30 - 20:30 IST (New Delhi)

15 February, 16:00 - 19:00 GST (Dubai)

Vaccines and immunization: Challenges and perspectives for local manufacturing
Vital Ribeiro
Meet
Vital Ribeiro
Vital Ribeiro
Healthy Hospitals Project
President of the Board
×
Vital Ribeiro
Vital Ribeiro
Healthy Hospitals Project
President of the Board

Health

Meet Vital Ribeiro during this session

13 February, 15:00 - 16:15 BRT (Rio de Janeiro)

13 February, 19:00 - 20:15 CET (Brussels)

13 February, 19:00 - 20:15 WAT (Nigeria)

13 February, 20:00 - 21:15 SAST (Cape Town)

13 February, 13:00 - 14:15 EST (New York)

13 February, 03:00 - 04:15 KST (Seoul)

13 February, 02:00 - 03:15 CST (Beijing)

13 February, 23:30 - 00:45 IST (New Delhi)

13 February, 22:00 - 23:15 GST (Dubai)

Special session: Challenges and opportunities in planetary health
Tiago  Rocca
Meet
Tiago Rocca
Tiago Rocca
Developing Countries Vaccine Manufacturers (DCVMN)
Deputy Chair - Board of Members
×
Tiago  Rocca
Tiago Rocca
Developing Countries Vaccine Manufacturers (DCVMN)
Deputy Chair - Board of Members

Health

Meet Tiago Rocca during this session

14 February, 09:00 - 16:15 BRT (Rio de Janeiro)

14 February, 13:00 - 20:15 CET (Brussels)

14 February, 13:00 - 20:15 WAT (Nigeria)

14 February, 14:00 - 21:15 SAST (Cape Town)

14 February, 07:00 - 14:15 EST (New York)

14 February, 21:00 - 04:15 KST (Seoul)

14 February, 20:00 - 03:15 CST (Beijing)

14 February, 17:30 - 00:45 IST (New Delhi)

14 February, 16:00 - 23:15 GST (Dubai)

Vaccines and immunization: Challenges and perspectives for local manufacturing
Benjamin Roche
Meet
Benjamin Roche
Benjamin Roche
Research Institute for Development (IRD)
Research Director
×
Benjamin Roche
Benjamin Roche
Research Institute for Development (IRD)
Research Director

Health

Meet Benjamin Roche during this session

15 February, 13:30 - 15:15 BRT (Rio de Janeiro)

15 February, 17:30 - 19:15 CET (Brussels)

15 February, 17:30 - 19:15 WAT (Nigeria)

15 February, 18:30 - 20:15 SAST (Cape Town)

15 February, 11:30 - 13:15 EST (New York)

15 February, 01:30 - 03:15 KST (Seoul)

15 February, 00:30 - 02:15 CST (Beijing)

15 February, 22:00 - 23:45 IST (New Delhi)

15 February, 20:30 - 22:15 GST (Dubai)

Plenary session: Biodiversity – We are all nature
Mariangela  Simão
Meet
Mariangela Simão
Mariangela Simão
Todos pela Saúde Institute
Executive Director
×
Mariangela  Simão
Mariangela Simão
Todos pela Saúde Institute
Executive Director

Health

Meet Mariangela Simão during this session

14 February, 09:00 - 16:15 BRT (Rio de Janeiro)

14 February, 13:00 - 20:15 CET (Brussels)

14 February, 13:00 - 20:15 WAT (Nigeria)

14 February, 14:00 - 21:15 SAST (Cape Town)

14 February, 07:00 - 14:15 EST (New York)

14 February, 21:00 - 04:15 KST (Seoul)

14 February, 20:00 - 03:15 CST (Beijing)

14 February, 17:30 - 00:45 IST (New Delhi)

14 February, 16:00 - 23:15 GST (Dubai)

Vaccines and immunization: Challenges and perspectives for local manufacturing
Júlia  Spinardi
Meet
Júlia Spinardi
Júlia Spinardi
Pfizer
Medical and Scientific Affairs Senior Director
×
Júlia  Spinardi
Júlia Spinardi
Pfizer
Medical and Scientific Affairs Senior Director

Health

Meet Júlia Spinardi during this session

14 February, 09:00 - 16:15 BRT (Rio de Janeiro)

14 February, 13:00 - 20:15 CET (Brussels)

14 February, 13:00 - 20:15 WAT (Nigeria)

14 February, 14:00 - 21:15 SAST (Cape Town)

14 February, 07:00 - 14:15 EST (New York)

14 February, 21:00 - 04:15 KST (Seoul)

14 February, 20:00 - 03:15 CST (Beijing)

14 February, 17:30 - 00:45 IST (New Delhi)

14 February, 16:00 - 23:15 GST (Dubai)

Vaccines and immunization: Challenges and perspectives for local manufacturing
Deisy  Ventura
Meet
Deisy Ventura
Deisy Ventura
University of São Paulo
Professor of Global health Ethics
×
Deisy  Ventura
Deisy Ventura
University of São Paulo
Professor of Global health Ethics

Health

Meet Deisy Ventura during this session

15 February, 10:00 - 12:15 BRT (Rio de Janeiro)

15 February, 14:00 - 16:15 CET (Brussels)

15 February, 14:00 - 16:15 WAT (Nigeria)

15 February, 15:00 - 17:15 SAST (Cape Town)

15 February, 08:00 - 10:15 EST (New York)

15 February, 22:00 - 00:15 KST (Seoul)

15 February, 21:00 - 23:15 CST (Beijing)

15 February, 18:30 - 20:45 IST (New Delhi)

15 February, 17:00 - 19:15 GST (Dubai)

Special session: STI and the 2023 Global Health Agenda
Mauricio Zuma
Meet
Mauricio Zuma
Mauricio Zuma
Bio-Manguinhos
CEO
×
Mauricio Zuma
Mauricio Zuma
Bio-Manguinhos
CEO

Health

Meet Mauricio Zuma during this session

14 February, 09:00 - 16:15 BRT (Rio de Janeiro)

14 February, 13:00 - 20:15 CET (Brussels)

14 February, 13:00 - 20:15 WAT (Nigeria)

14 February, 14:00 - 21:15 SAST (Cape Town)

14 February, 07:00 - 14:15 EST (New York)

14 February, 21:00 - 04:15 KST (Seoul)

14 February, 20:00 - 03:15 CST (Beijing)

14 February, 17:30 - 00:45 IST (New Delhi)

14 February, 16:00 - 23:15 GST (Dubai)

Vaccines and immunization: Challenges and perspectives for local manufacturing
Lav Agarwal
Lav Agarwal
Government of India
Additional Secretary, Ministry of Health & Family Welfare
Luiz Paulo Assad
Luiz Paulo Assad
Federal University Rio de Janeiro (UFRJ)
Professor
Manoel Barral
Manoel Barral
Fiocruz
CIDACs Senior Researcher
Maurício Barreto
Maurício Barreto
Oswaldo Cruz Foundation
Senior Researcher
Priya Basu
Priya Basu
The Pandemic Fund, World Bank Group
Executive Head
Daniel Buss
Daniel Buss
Pan American Health Organization (PAHO)
Unit Chief Climate Change and Environmental Determinants of Health (CDE-CE)
Paul Buss
Paul Buss
Fiocruz
Director of the Center for Global Health and International Relations
Márcia Chame
Márcia Chame
Oswaldo Cruz Foundation
Researcher
Rosane Cuber
Rosane Cuber
Bio-Manguinhos
Deputy Director of Quality
Hugo G.  da Silva
Hugo G. da Silva
AstraZeneca
Global Head of Vaccines
Elizabet Diago
Elizabet Diago
ISGlobal
Preparedness Program Manager
Anand  Ekambaram
Anand Ekambaram
CEPI
Executive Director Manufacturing and Supply Chain Management
Lieve Fransen
Lieve Fransen
European Policy Centre
Senior Adviser on Health, Social, and Migration Policies
Xiaolan  Fu
Xiaolan Fu
Technology and Management Centre for Development
Founding Director
Harikumar  Gadde
Harikumar Gadde
World Bank
Senior Climate Change Specialist
Paulo Gadelha
Paulo Gadelha
Fiocruz Strategy for 2030 Agenda
Coordinator
Luiz Augusto Galvão
Luiz Augusto Galvão
Oswaldo Cruz Foundation
Senior Researcher
Nicolo Gligo
Nicolo Gligo
Economic Commission for Latin America and the Caribbean (ECLAC)
Economic Affairs Officer
Andrew Haines
Andrew Haines
London School of Hygiene and Tropical Medicine
Professor of Environmental Change and Public Health
William  Hall
William Hall
Wellcome Trust
Head of Global Government Relations
John Haynes
John Haynes
Applied Sciences Program of the NASA Earth Science Division
Program Manager for Health and Air Quality Applications
Ike James
Ike James
Medicines Patent Pool
Head of Technology Transfer
Marco Krieger
Marco Krieger
Oswaldo Cruz Foundation (Fiocruz)
Vice-president of Health Production and Innovation in Health
Roberto Lucchini
Roberto Lucchini (TBC)
Florida International University
Professor of Environmental Health Sciences
Ethel Maciel
Ethel Maciel
Brazilian Ministry of Health
Secretary of Health and Environment Surveillance
Clara Marín
Clara Marín
ISGlobal
Policy Program Officer
Oliver Morgan
Oliver Morgan
World Health Organization
Director Health Emergency Information and Risk Assessment
Juliette Morgan
Juliette Morgan
US Centers for Disease Control and Prevention (CDC)
South America Regional Director
Jefferson Nascimento
Jefferson Nascimento
OXFAM Brazil
Social & Economic Justice Coordinator
Maria Neira
Maria Neira
WHO headquarters
Assistant Director-General a.i., Division of UHC/Healthier Populations
Cristiano G. Pereira
Cristiano G. Pereira
Butantan Institute
Innovation Tech Licensing Manager
Antoni Plasència
Antoni Plasència
Barcelona Institute of Global Health (ISGlobal)
Director-General
Naveen  Rao
Naveen Rao
Global Health Rockefeller Foundation
Senior Executive Vice President
Kumanan  Rasanathan
Kumanan Rasanathan
WHO
Executive Director, Alliance for Health Policy and Systems Research
John  Reeder
John Reeder
WHO
Director of the Special Programme for Research and Training in Tropical Diseases
Renata Reis
Renata Reis
MSF Brazil
Executive Director
Vital Ribeiro
Vital Ribeiro
Healthy Hospitals Project
President of the Board
Tiago  Rocca
Tiago Rocca
Developing Countries Vaccine Manufacturers (DCVMN)
Deputy Chair - Board of Members
Benjamin Roche
Benjamin Roche
Research Institute for Development (IRD)
Research Director
Mariangela  Simão
Mariangela Simão
Todos pela Saúde Institute
Executive Director
Júlia  Spinardi
Júlia Spinardi
Pfizer
Medical and Scientific Affairs Senior Director
Deisy  Ventura
Deisy Ventura
University of São Paulo
Professor of Global health Ethics
Mauricio Zuma
Mauricio Zuma
Bio-Manguinhos
CEO